# Feedback

comment:
please change the first 3 lines aas the following:During a recent data safety review the CRP identified the need to lowered the initial dose amount of the compound. the review did not note an immediate risk of safety for the patients currently ongoing.


comment:
In the process documentation it mentions the following:

for training:
Project management tools (for example, project plan, cutover plan, communication plan)  can be used to document the project implementation steps/plans.

These supporting documents should be attached to the change record to support the implementation plan overview.

SHould we add here? Question for the SMEs


comment:
In Roles involved I only see the Change Owner and the Study Team. I may be missing something...


comment:
SHould we add Change Reviewer as a role involved?


comment:
The Study Manager needs to be involved.
I don't see the Change Evaluator involved?


comment:
In order to avoid confusion, is it possible to have only 6 chairs in the table since there should be only 6 participants?


comment:
Can we put a check mark to the first section on 'What is Change Management'?


comment:
We can refer to process maps in the course (process map titles are locked)- maybe we should then add the title of this process 'Manage Trial Change'


comment:
the content of executive summary doesn't flow very smoothly and logically. i suggest to break it in two major parts: 1. what should be included in executive summary; 2. what are the major usage of executive summary


comment:
the portion that has been highlighted in bold seems incomplete


comment:
it seems that we narrowed the customer analysis only to the people, actually it is much broader  than that. for example, the financial status of the company, the strategy, the competitive advantage, the culture, etc.


comment:
I had to think about the word "commutability" Not sure affiliates will understand?


comment:
I do not quite understand what we mean by opportunity and fit and how to prioritize accounts thinking about these two


comment:
is the strategic vision too vague?

Last bullet point - EMEA and Africa: EMEA usually stands for Europe, Middle East and Africa. therefore it already includes Africa


comment:
It was a little confusing when I clicked on all items in tent and then I didn't get 'next' button.  I didn't consider the person 'in the tent'


comment:
I'm not sure I understand the Financial - Total Cummins Inc. and relevance to the account plan


comment:
The instructions tell you to click on each term then click to find out which types of customer.  I wasn't sure where to click after clicking on terms.  Possibly be a bit more specific on where to go for third click


comment:
It begins when a change has been identified that may impact the protocol


comment:
The assessment plan  is the impact analysis and we should use that name instead of assessment plan.


comment:
Revise button should list Study Manager, Quality approver and Business approver the other roles are not correct.


comment:
Remove trials from the example, this process is typically performed at a trial level, so this is not a good example. Maybe use "For example, adding a country or updating the impact assessment."


comment:
CT materials-I will help determine the impact to product labeling, packaging, formulation and other elements  related to ancillary materials and Investigative Medicinal Product (IMP)

Regulatory-If the study is being performed in the European Union (EU), I will help determine  if the amendment is substantial in consultation with the medical director. If yes, then I will determine and document the change per EU regulations of the impact to recruitment and regulatory reporting.  I can also recommend steps to include in the implementation plan to eliminate adverse impact of the change. 

Site manager- I will help determine the impacts and approximate timelines for ethics approvals and regulatory documents impacted by the change. 

Statistician-  I will help determine the statistical consequences of the change and impacts to the analysis plan, sample size.

CRP- I will help determine if the change should pause screening and enrollment and things such as impacts to the study blind or  inclusion/exclusion criteria

DSS- I will help determine impacts to data validation and/or data review systems


comment:
site manager and CT materials do need to be added to the table. Training does not.


comment:
These will be pretty much the same reasons as the other case study. May want to add different people at the table such as CLO, study manager, CTPMA (CTPMA as a role that does not need to be at the table but needs notified)


comment:
I didn't think either one is required but I am not certain- lets verify this


comment:
What functions should be notified of the change and potential for impact? 
All trial team function representatives
CRP, CLO, DSS, Stats, Regulatory
CRP, CLO, Site manager, training


comment:
Now you are ready to complete the last module of the Transplant Academy


comment:
To answer SP's comments - yes, there are multiple CMV tests for this is fine.

Yes, affiliates should know about commutability as we introduce this concept in earlier modules


comment:
Remember learning about Masahiko's journey as a transplant patient in Module 1?


comment:
Yes, the third filter should be CE-IVD and US-IVD tests only. 
The second filter should be LDTs, including those made from CE-IVD reagents (here both homebrew LDTs and CE-IVD reagent based LDTs can be included as long as they report in IU/mL)


comment:
...that the Roche CMV tests offer key advantages for their lab.


comment:
...report in IU/mL to meet the current recommendations in guidelines. 

Want to remove "the best choice" throughout.


comment:
...second filters section removes tests that may report in IU/mL but are either homebrew LDTs or LDTs built from CE-IVD reagents.


comment:
Label on third funnel should just be CE-IVD or US-IVD tests

FDA approval is redundant if already say US-IVD


comment:
The third filter removes competitors CE-IVD or US-IVD tests based on key performance criteria such as clinical validation and workflow efficiency.


comment:
...you can position Roche CMV Tests as the solution to meet their needs.


comment:
For the second filter in the funnel PDF need to have the logos together in the middle or somehow placed differently...the current layout seems to suggest that the objection and Roche counter are specific to that company (ex; Argene)...the objections and counters in this level of the funnel apply to all the competitors shown at this level.


comment:
Agree with Tera's comments.  1 and 2 seen redundant.


comment:
Would like to change this counter on the funnel second level:
Thresholds are institution specific, which impacts patient management.

Thresholds are only institution specific; lack of universal guidelines impacts patient management


comment:
On funnel PDF for Siemens - capitalize "Test" in the name.


comment:
It is not research that is recommending...

but the current guidelines for management of CMV in SOT patients recommend IU/mL and proficiency tests organisations provide samples in IU/mL for testing.  This is the first objection to overcome.


comment:
Check for use of "z" vs "s" for British English


comment:
Agree.. the last part of the funnel should only be CE-IVD Tests and US-IVD tests..no LDTs


comment:
As per my comment on the PDF, can you move the logos for the companies to the middle as all these objections apply to each of them...here is looks like there are specific to each company.


comment:
These manufacturers provide CE-IVD detection reagents that laboratories can use to build LDTs.


comment:
Not eliminates.. 

The cobas(R) CMV tests minimise risk for the lab and provide operational efficiency that reduces the time and resources required.


comment:
Can we move from FDA approved to "US-IVD" throughput the module for consistency?


comment:
some typos and changes needed for the slide. Will send updated one through Basecamp


comment:
Typo of "LTDs" in answer...check to make sure this is correct throughout


comment:
It seems that the correct answers are always at the top of the conversations. Can we mix these up a bit?


comment:
These are the same competitors with just one more added...

Here is the list of top competitors. These competitors manufacture CE-IVD and/or US-IVD tests.

Let me demonstrate how to use the positioning statements from your reference guide in a conversation with a customer on the following screen.


comment:
Will need to discuss this on the call together as we did not have time to meet before hand.


comment:
Roche has decades of experience in setting the standard in infectious disease testing including for CMV.


comment:
This is incorrect. There is only one right answer here..the first answer


comment:
Let's discuss this question and the answers


comment:
This is the first time we use the word "harmonised". I think we should change to "standardised"


comment:
Will this be confusing if we answer with FDA approved if we change it to US-IVD every where else in the module?


comment:
This is not correct...we don't have EBV and BK tests at this time.  We need to discuss how to re-word this response.


comment:
We OK with using just an icon vs the whole image of an organ from the SPOT campaign here?


comment:
For the first filter - does it make sense to remind them that the arguments to using IU/mL can be found in academy course xx?


comment:
If we move the LDTs including those made from CE-IVD reagents is there a way to show hierarchy within the second filter- e.g. through a color gradation?


comment:
I'm not sure if I understand what is meant by "purchase calibrators"


comment:
A thought - what if the customer asks about what they can do with their current data / results assuming they work with copies/mL?


comment:
My previous comment would depend on if it's an existing customer (as opposed to a new customera0


comment:
Flexibility may mean that standardization may be difficult to achieve


comment:
I like this. I wanted to see if I could get a better result on the conversation so I went back and redid the conversation.


comment:
The last sentence "..their system just is not as.." is awkward. perhaps rephrase to ...their system is just not as..."


comment:
a fully automated transplant menu to me implies that Roche currently has many transplant assays not just CMV


comment:
Is the image supposed to look like a heart? For transplant?


comment:
I would use the image from the SPOT campaign to tie things together.


comment:
LSAM role should be added as they can advice on countries impact


comment:
When clicking on the professor, the slide does not leave enough time to read all, for non-English native speakers. needs 5 sec more time


comment:
we can use the following scenario: The Ministery of health in France required the addition of day 8 chemistry to be collected in the first three cycles of treatment for all patients enrolled in the country


comment:
The red text that popups up if you don't include your name should not say to include your WWID.


comment:
Does this actually take you to the warehouse as described in the text?


comment:
When coming back to this page, make next button live.


comment:
As stated earlier, the Hint shouldn't show up if picking all 4 already.


comment:
And having the continue, submit and next/back buttons is confusing.


comment:
Transfer spelling incorrect 3rd paragraph


comment:
First sheet doesn't get a blue check until I clicked it twice


comment:
The header needs to be consistent across courses.  Can't have the text as a lock up with the C.


comment:
Would like to reword 'Define a generator..', maybe "Describe" what a genset is or something else


comment:
Missed edit - the lab manager should say "Sure! Go right ahead." if the learner selects correctly.  There is no need for the popup and continue button.


comment:
The dry ice box needs to be bigger.  Maybe reduce the size of the tubes to give you more counter space?


comment:
The dry ice fumes should be there before the learner clicks.  I would also make the fumes smaller and appear to be coming out of the box top since that is where it is open.


comment:
I clicked the 2nd analyzer last and the "All of these..." text appeared at the same time as the popup box about why it's an environmental issue.  Learner should click the X on the popup before the "All of these..." text and Examine the samples button appears.


comment:
Box should be bigger here too.  Consider making test tubes/rack smaller to make it fit on the counter better.


comment:
To be consistent with the previous activity, we should force the learner to click the X before moving on to the next item.


comment:
Also to be consistent, I'd show the "fumes" from the dry ice coming out of the box here too.


comment:
The map is Set up, manage and close out trial in Impact so it is bigger than managing impact data.


comment:
I'm not sure that we use our internal collab spaces to manage site information.


comment:
I don't think we should mixt the IMPACT system with the collaboration sites since they are used completely different.  The wording on this page is reflective of IMPACT and not necessarily the colab space.


comment:
I may be wrong but I don't believe that IMPACT is used to manage the trial-level design.  It manages trial milestones at the trial, country and site levels.


comment:
I do not believe sites are entered during the set up phase in IMPACT


comment:
I think a review of the map may be helpful.  The trial is set up first and once that is done countries then sites can be set up and managed in IMPACT.


comment:
Maybe I'm reading this incorrectly but if the FPV date is April 1 and then move to August 1 we are giving the functions more time and not less time.


comment:
I am not sure this applicable across the globe.  I don't think we have sites wait until we hear back from the FDA if they have comments on the protocol they do not approve the protocol.


comment:
TMF documents are not considered transitory.  I think this should say depending if the trial has an eTMF or paper TMF will determine where TMF documents should be stored.  If the team is using an eTMF the documents that are required to tell the story of the trial should be housed within the TMF and not on the collab space. For paper TMF the documents should be printed and sent to the TMF file.


comment:
The audio portion is limited to two slides with some digging and scraping noise. I would not have audio at all if that is the only use of it.


comment:
The young professor/graduate school starting point sets a tone that might switch off more experienced hires, for me its better that this is rephrased to broaden the appeal.


comment:
The term journal may not be understood by all  not really sure what it could be replaced by, perhaps note book/note pad/diary?


comment:
Change to "an account plan isn't a one-time activity.  Today.."


comment:
The tent and images look great, but make the people and background appear low res and poor quality.


comment:
We need to edit the professor image to remove the shovel so he is not always holding a shovel throughout the course.  If he was going to always hold something it would be the journal.


comment:
Why is Simon gray, faceless, and low-res when all the other people look so much better. Is he like a BLP mascot/default figure?


comment:
Change the wording here from keeping in mind the following guidelines to keeping the following guidelines in mind


comment:
Change last sentence to "You need a plan or you're not going to be very successful"


comment:
Change ending sentences to "because I hadn't thought about where I wanted to dig and who I need to bring with me to be most successful, I wandered and wandered.  I didn't find anything."


comment:
I find myself having to click Start twice in order to advance.


comment:
Bold the ending "s" in Resources in the last sentence.


comment:
Need to be consistent with our language.  If the resource we have is the template, should we refer to it as the "Planning Framework" as we have in the text or is it really the template we have noted in the Resources?  Pick one to use throughout if we're referring to it more than once.


comment:
Re-word to read:  The agreement contains appropriate legal terms and conditions including, but not limited to, intellectual property, confidentiality, work product, etc. and establishes:


comment:
Recommend changing "would not be reasonable." to "may not be reasonable".


comment:
When I click the Monthly flag, I don't get new text.  it shows whatever was on screen previously.


comment:
When I clicked back to see the setup of this section again, then reached this screen, the text with Click Next to continue appears.  I wanted to see the setup again.  Am I thinking about this incorrectly from a functional standpoint?


comment:
I think we should say "How often an account team meets..." since our learners are managers.


comment:
After going backwards and coming forwards again, I don't get a Next button after I re-complete this activity.


comment:
We're using "sellers" and "account managers" interchangeably.  Let's pick one to use throughout.  My vote is "account managers."


comment:
change "mangify glass" to "magnifying glass"


comment:
change magnify glass to "magnifying glass"


comment:
When I click back then progress forward, I don't get a Next button on this screen, even if I've completed it.


comment:
Delete the extra period at the end of Simon's sentence.


comment:
This feels like another wall 'o text.  Can we break up or bullet some of the content?


comment:
Remove extra space between "a" and "(bi-)weekly" at bottom of journal.


comment:
"We" havent' applied strong coaching skills.  I'd frame this as "you."


comment:
This animation took forever.  The one in the other course seemed faster.  Can we check?


comment:
Perhaps the first sentence on this feedback screen should say "We need to get information on customer roles, whether the people in those roles are promoters or detractors, and how the customer selects vendors."


comment:
Change "magnify glass" to "magnifying glass".


comment:
Simon's speech bubble changes too quickly on this screen once the initial animation finishes.


comment:
The slide master for this screen needs to be updated so that the title reads "Sales Manager", not "Account Manager". The subtitle also needs to be updated to "Coach to Align the Cummins Team".


comment:
Again, we can just delete a sentence, in this case, the third one: "You coach your account managers to make the right decisions, to dig deeper so that they can reach their goals." I also suggest changing the second sentence as follows: "You coach your account managers and  provide ongoing support by checking in with them regularly, asking questions, and providing them feedback."


comment:
The slide master needs to be updated during the animation. That is, on the final slide in the animation, the slide title read "Account Managers" instead of "Sales Managers."


comment:
Re: jc's comment about language consistency, the actual Excel file for the template/framework is labeled "Corporate Account Planning Framework".


comment:
Update the account manager's speech bubble on the incorrect feedback layer: "Are you sure that's what I should be thinking about? Try again."


comment:
Change text to "It's important to prioritize which accounts need an account plan.  You can consider opportunity and fit so we allocate.."


comment:
Elaborate on opportunity and fit labels to  "Revenue Opportunity" and "Strategic Fit".

Guide people to the corporate template in the resource link to use the Account Qualification tab to see criteria for opportunity and fit that may be useful.


comment:
correct "and this is the ideal" and change to "account team for this customer"


comment:
Change "owner" label to "Team Members" and add Application Engineering to second initiative


comment:
The graphics feel like they are taking different approaches.  The background looks glossy, high res and good and the professor now looks like a low res drawing/cut out. We need to talk about updating the professor to align with the look of these sections.


comment:
Use a modern computer image like a laptop and a cell phone instead of walkie talkies


comment:
Adjust this section to focus less on the options for how to handle since multiple answers would be appropriate to tie better into the account plan - the intent is you learned about this new contact so make sure they are incorporated into the account plan, the team is notified and you decide how and with who to engage them.


comment:
Same adjustment as first, less about response and more about taking action to incorporate into the account plan and update the team.  It would be correct for the account mgr to reach out to learn more versus tell the account team this cryptic message since more information is needed in order to take action.


comment:
Correct to - "help you and your team stay aligned and make the most of each..."


comment:
I'd really like to hear about key initiatives Cummins will deliver for us.


comment:
Revise Financials label to "Account Financials" and for both answers clarify they wouldn't share those financials, but the customer specific measures (what the customer measures them on or is important to them) should be shared.


comment:
Speed up uncovering of dinosaur animation and revise text from the Professor to "Congratulations, you completed the course!".


comment:
On the c6000 Data Management Print View Quick Reference Card it states that Print View holds 1000 pages and then it is First in, First out (FIFO).


comment:
The blue on key words - GOALS, PROCESS, etc. looks a little odd to me... was this used in courses 1 & 2? If not, Let's use the same regular darker teal that is the standard template color, or a dark gray for these.


comment:
Can the background images go all the way to the top of the content area so there isn't a white bar above?


comment:
Is this supposed to be the same guy as earlier? Before he didn't have gray hair/beard and had on an orange sweater.


comment:
GLOBAL: Make text in these boxes left aligned instead of center. It will increase legibility when the eye can start at the same place line after line on bigger blocks of text


comment:
Let me send you an updated icon where the pen is yellow instead of red per the template changes


comment:
Well, he did have a beard, but he's not the same guy ;)


comment:
Financial Disclosure Defined in the top left of UI bounces around a little from screen to screen, and here the end of Defined sort of "bleeds" into the other part of top bar that is teal


comment:
The next button has the word next but no arrow showing until you rollover it


comment:
The screen titles on screen don't align with what is in the menu dropdown


comment:
Remove close captioning option from the menu since there is no audio


comment:
My previous comment applies to the onscreen text under the section "Use the menu to access:"


comment:
The module title text in the top left corner (white box, teal) is in a slightly different position from the previous screen


comment:
Resource link: I saw Jenn's comment that the only link to include for all courses is to the CDOS landing page, and that this goes on the reference page for the course. Were these other resources approved to be included in this course by the Lilly team?


comment:
Best Practice 1 text: "If there are any financial disclosures that have a "yes" on specific questions, the Study Manager needs to be informed." add "on specific questions" and a comma


comment:
Does the process map say "disclose-able"? The correct spelling (perhaps only outside of Lilly) is "disclosable"


comment:
Step 6 text: I think the 1st paragraph should be bulleted after "to list" since the 2 times they must complete the form are so different. The sentence is confusing otherwise.


comment:
This is a fairly extensive list of items to include - why aren't we using a process graphic to represent this conceptually? A graphic that breaks up the columns of the process map would help chunk this information together. Let's talk about this!


comment:
Anything we can do to tighten this up a bit? This screen is a little text overload


comment:
Make the blond lady the same direction in both instances


comment:
Third bullet point re-word to read:  "Lilly's responsibilities as established by the Lilly Law Division and local laws and regulations and/or procurement."


comment:
Reword:  . . . relevant scientific questions for customers (including patients, Health Care Providers and, regulators).


comment:
Suggest re-wording:  Consultants for medical research provide legitimate scientific advice and feedback related to clinical trial research.


comment:
Consultants are not always global thought leaders.  They may be local or regional.  Reword to say Consultants may be global, regional or local thought leaders and Lilly values their real world-feedback and expertise.


comment:
Re-word fourth bullet point to read:  "Confidentiality, intellectual property and other legal provisions to safeguard Lilly's information"  Suggest throughout the training when you reference confidentiality also mention "intellectual property".


comment:
Second example - reword:  A consultant has agreed to participate in a medical research advisory board related to a clinical trial and review data and/or answer important relevant scientific questions regarding the study for patients, investigators, etc.


comment:
The CBSO may not necessarily be the Requester's primary contact.  Sometimes the requester doesn't communicate with the CBSO.


comment:
Agree with comments regarding objectives 1 and 2 and removing CBSO in the last objective. If we do keep CBSO, should we spell out the acronym?


comment:
KB only provided the payment process for payments made out of the US.  This doesn't accurately state the Mercury process.  Should we make this more "high level"?
&. Change starting &. In some countries, the approver submits the invoice for payment along with supporting documentation, if any, and the payment is made via wire transfer or by check.  There are other situations where payments may be reviewed in a system and payment is triggered without submission of an invoice.


comment:
second information button to read:  Forms submitted through CPS are received and processed by Physician's World for Lilly.


comment:
Throughout the documents please add "medical research advisory boards" because there are other advisory boards that are not medical research.  Also a suggestion-- throughout the training please either capitalize the word consultant or use lower case.  I see it both ways.


comment:
Information button:  Please re-word:  For consultants outside the U.S. the request is submitted through the medical research portion of the "International Meeting and HCP Approval Collaboration Site"


comment:
Include "local laws and regulations" in third bullet; do we need to include "GCBC"?


comment:
See previous comment about the correct name OUS consulting  "International Meeting and HCP Approval Collaboration Site"


comment:
Re-word to say:  These forms may include consents, banking, tax forms, etc.


comment:
Reword to say:  The banking, tax forms, IN forms must match the name of the party listed in the contract who will be receiving the payment for services.


comment:
Reword to say:  CBSO rep would ask the requester for more detail with regard to the services and may recommend that the hours be adjusted to more accurately reflect the work to be performed.


comment:
Reword:  The changes may have to go through an approval process and if they are not approved, the agreement request could be terminated.


comment:
do we need to include other tasks they could potentially be contracted to do (ie: national coordinator, present/speak at meetings)?


comment:
Per the c6000 Quick Reference Card Data Management Print View holds 1000 pages.


comment:
directional text doesn't have any words bolded to follow convention of other screens


comment:
There's storyline Prev and Next buttons on this screen


comment:
directional text doesn't have any words bolded


comment:
Let's break this up into a few separate paragraphs to make it not such a big block of text


comment:
Make a separate paragraph starting with "Without teamwork..."


comment:
Incorrect feedback - body text - some is gray, some is black


comment:
module title in white area at top left - here it is center aligned... was left aligned everywhere else


comment:
Module title in white box at top left - also aligned center here


comment:
have directional text change to click next directions after you've clicked downstream impact


comment:
GLOBAL: N in Next for Click the Next button.... should be capitalized. do a find and replace


comment:
There are "Click the arrow..." directions here and the previous screen of this sequence, but not the others. I think you could probably get away fine with just having it on the first screen of the sequence (soccer field with no person on it screen)


comment:
Would a 24 hour lab with an e-module only have a daily pipe?


comment:
Align all text in gold boxes to the same x point


comment:
As you click through this, the people look like they get a little taller/shorter...


comment:
Would some of this text be better suited as a table where you're comparing rental agreement to consulting agreement with rows for each of the things that are "similar" ?


comment:
2nd paragraph - add a comma after responsibilities


comment:
Also a comma after responsibilities in the 3rd paragraph


comment:
Is this the right gold color on the outlines on popups? It looks a little orange-er to me than usual.


comment:
Move teal instance of execution "tab" down a little so you don't see a line of white between it and the outer teal shell of the course


comment:
Move the teal invoice tab down a little so you don't have a line of white between it and the outer teal shell


comment:
Do we have a headshot for a Budget Approver to include in the top bar here?


comment:
Include CBSO Rep headshot in top bar here


comment:
Move Execution tab down here too to get rid of white line below


comment:
Change directions to click next... once all clicks have been completed.


comment:
In the change management course, Lilly wants to focus on character's role (rather than giving them a name). This is a global approach, unless the character's name is part of a scenario. In addition, I think the first time a character appears in the course, they should have a box with their title called out. So in this case, the learning agent would have "Study Manager" as their title. Use a the same format as the popup box (white background, yellow outline, same font) for this


comment:
Use active voice for the 3 feedback boxes that pop-up: "Financial disclosure is not required", e.g.


comment:
Nice to have: each character goes into a visited state once clicked


comment:
See earlier comment on adding a "role" title for each character here


comment:
Regulatory character text: the sentence is confusing; I think you need to add some commas "I am consulted by a Study Manager, when financially disclosable information is reported, for guidance on..."


comment:
Per change management alpha review, Lilly would like check marks added to the modules that have been completed


comment:
Directional text: Change to "Click The Study Manager's Role button to continue."


comment:
The character is floating here - he should be flush with the top of the teal bar at the bottom. He may need to be shrunk down to fit


comment:
Either replace "Edwin" with his role (e.g., Study Manager) or identify his role in the onscreen text.


comment:
There is a comment in here from the change management external alpha...from RT (Rachel Turbeville, Lilly)


comment:
What is the purpose of the investigate icon? When I hover over it, it gets jumps to a bigger size. Recommend removing any hover state actions


comment:
Same issue on this screen with the icon - once it's clicked, it gets bigger and flashes between normal size and large size


comment:
It seems that there should be a set up slide before this process that explains the icons and why they are onscreen - this would introduce the process to the learner before they apply it


comment:
Since these questions are not "select all that apply" then they shouldn't be able to select more than one answer before submitting


comment:
The submit button hangs outside of the answer option box


comment:
Is there a reason that the learning agent here is a silhouette?


comment:
See previous comment on including the name of each character's role onscreen


comment:
Add a comma in the last sentence: "...is updated, which will..."


comment:
Feedback pulls from the previous menu screen here as well


comment:
Change directional text to "Click SAM Role in Financial Disclosure button to continue."


comment:
SAM needs to be defined in this paragraph (Site Activation Manager) before using it as an acronym throughout.


comment:
Same previous comment, add a label identifying the character's role as "Site Manager".


comment:
It's fine that we call them Site Managers throughout, but it is confusing when we call them SAMs as well. I'd recommend the 2nd sentence changes to: "One other important role is the Site Activation Manager (SAM), also called a Site Manager."


comment:
Incorrect feedback tool: It calls out that there are still steps to take, but doesn't identify them. Do we know what those steps are?


comment:
This isn't a true/false statement (it's more of a truth/lie statement, if you will). Recommend changing the 2nd sentence to "Because the trail was moving at a fast pace, I did not need to provide information to the Study Manager."


comment:
For all of these menu screens, there's the same introductory text. Recommend changing it up a bit to give the learner an idea of what will be covered in the module before they click the button to go into it.


comment:
Delete comma after analysis in sentence 1. I'd split this into two sentences for readability


comment:
Agree with Christa - info could be better digested via two columns, one with a house icon and one with a document/contract icon. Beneath house icon, bullets include: -cost of the rental; -tenant's responsibilities; -landlord's responsibilities. Beneath contract icon, bullets include: -basis for pay; -Lilly's responsibilities; - consultant's responsibilities; - confidentiality provisions to safeguard Lilly's information; -advice and feedback from a consultant (not intended for consultants providing tangible services)


comment:
Is there a way to make the steps look more clickable? Maybe a hover state?


comment:
Make sure slides reset to initial state, unless a different decision has been made with client


comment:
I have seen Requestor capitalized elsewhere, but here it's lowercase. Should this be a global standard?


comment:
CHange instruction to Click Next once all icons are clicked


comment:
I feel this screen should move to right after the "Is it a consulting agreement?" screen. You use the roles liberally in the process description, so defining them would be useful up front.


comment:
Is there a 2-heads icon you could use for Exception & budget approvers?


comment:
Change instruction to click next after all roles clicked


comment:
Not sure if this is a navigational fluke, but I'm at the screen where it says "Click the Requestor's Role Button," but the CBSO Rep button is flashing


comment:
...Never got text telling me to click the CBSO button


comment:
Add the word "the" - "...if the consultant is in the U.S., it goes through..."


comment:
Edit: "...in advance of the start date."


comment:
Add comma: "...in the trial, that may or may not be..."


comment:
IMPACT and collaborations sites are the 2 process to cover in this course, but they are very different and used for different purposes. I think we need to look at these 1st couple of introduction screens and maybe mention the 2 systems seperately?


comment:
CT Materials is called Product Delivery as a function.


comment:
IMPACT activities begin once the LY number is assigned?


comment:
1st bullet to be reviewed:
When the trial is set up in Impact, site-level and country-level updates can be made, or Impact data can be managed...


comment:
Lilly requested that we list the process steps in these splash screen boxes. I would recommend these be the column headers in the process maps - that makes sense to me, but I'm open to an alternative approach.


comment:
If you keep the first box text, "Definition" is misspelled.


comment:
Remove the "CC" menu option, and the onscreen icon/text for the transcript, since there is no audio.


comment:
Include a label at the base of each character the first time they are introduced to identify their role - white box, yellow outline, black text for role.


comment:
Payments for Services Needed at This Time? text: says go onto the next milestone: Invoices Approved. I see the tab for Invoice, but not Invoices Approved. I'm not sure that these line up...?


comment:
I see why you did what you did with this subprocess - it feels like it should be a secondary process while the learner is reviewing the execution tab the first time - mainly because this subprocess covers all the other stuff that happens before the invoicing process occurs.


comment:
Intro text is repetitive; change 2nd sentence to: "Let's take a look at the beginning of the request process."


comment:
Change red popup buttons to yellow - Lilly requested that we not use red at all to avoid learners getting confused about what's required vs. not in the process maps.


comment:
Per first alpha review call, Lilly would like completed modules to have check marks on these menu screens.


comment:
4th sentence, add "The" in front of Requestor


comment:
Directional text: words are out of order, change to "What should the requestor do?"


comment:
It's fine that no new information pops up when you click each box, but we can include some limited learner engagement here. I recommend that the column headers are onscreen at the beginning and only the Share row label. Learners click the Share button to see the row's information. Then Confirm comes onscreen and they click that to see the Confirm row's information. Include directional text at each point so they know what to do.


comment:
Update directional text to reflect which module button is active.


comment:
Include updated directional text to click the Next button to proceed.


comment:
Directional text out of order, change to "What should the requestor do?"


comment:
Recommend changing the scenario text to include a bulleted listed after "...including, but not limited to:" for easier readability.


comment:
Directional text, in addition to previous comment, change "requestor" to "CBSO rep"


comment:
Same interaction recommendation for the table as the requestor key decision table.


comment:
Per first course alpha review, include introductory paragraph that says: "Process maps, quality documents (procedures, required tools), and supporting materials are available to support the performance of your work."


comment:
I would like to talk about this section. A couple of thoughts/concerns 1) It does not seem to be aligned to the learning objectives you identified back in April. Where does it fit in? 2) We don't tell them anything about this, so are we assuming that they know how to categorize these customers? 3) The feedback for each one is so generic that it doesn't really tell them why that was a good selection.


comment:
Check all of these interactions - they should "reset" when you return to the course, but keep next button active so that you can redo them if you need to.


comment:
How does this magnifying glass activity help them be a better coach? would it be better to have them identify from a select all or something - what informatoin does the AM still need to get? Or which people might the AM want to talk to and why?


comment:
Title is incorrect. Should be Clinical Trial: Set Up, Manage, and Close Out Systems


comment:
In last sentence of orange box, delete EITHER the "or" or the comma after personnel


comment:
Confirm: When "CBSO rep" is used, should rep be lower case? When it's spelled out, it seems like it is always capitalized


comment:
When adding bullets as suggested by DOC, make sure to use parallel construction, in this case, starting each with a verb


comment:
In order to be consistent with process map - its not clear which piece is being discussed. 3 stages of highest level map is Trial Set Up, Trial Managed, trial Closed. If you are talking about the Manage Impact Data map - its 3 stages are Site and Countries Set Up, Data Managed, and Site and Countries closed


comment:
Per the process map - the last sentence about when this process begins should say "when resources have been assigned and trial funding committed


comment:
Add where/how to submit request to create a site?


comment:
Should first sentence say - when trial design elements are finalized and country allocation is finalized - need to clarify better which stage this bullet is referring to (data managed space?)


comment:
Should any wording be added to clarify that these activities may happen when a trial is early terminated?


comment:
Agree with Lesli - wording is not clear here. They wont be prepared for FPV when Apr 1 hits - or they wont be prepared when they later discover date is Apr 1 instead of Aug 1


comment:
3rd bullet: either say periodic, or annually (not both)


comment:
1st bullet: all records on the collaboration site?


comment:
The last bullet is also true if there was no litigation hold


comment:
Should we say CPM? Does that apply to ClinPharm as well?


comment:
Instead of just saying CDOS landing page, can we say:
- Set Up, Manage & Close Out Trial in IMPACT
- Set Up, Manage & Close Out Trial Collaboration Site
With the same URL as for the CDOS page


comment:
Audio, last sentence should read "verifies the baseline mechanism check again". Currently says verify


comment:
Could we extend the video a little longer at the very end showing him connecting the tubing?


comment:
Do we have video of him attaching the other end of the FPC cable? If so would be nice to include that.


comment:
I like the articulate background. Is there a way to put a menu on the left?  thinking of leaving it this way if you don't think there would be publishing issues because of file size.


comment:
tw = teri Womack
agree with collab site & impact comments from LS.

also, could we use "information" rather than "data" for the accuracy of information?  I know it is data but "data" usually is clinical trial data...


comment:
ct material isn't a function .. I think they are PR&D and they supply CT material


comment:
schematic shows "functional systems" but text shows "functions".  does it need to match?


comment:
should first line be "manage data" in order to be parallel with "set up" and close out"?


comment:
slide before says that the study team does trial, country, and site at each phase (set up, manage, and closeout).  for Set up there is nothing about trial.


comment:
see previous comment about ct material not being a function


comment:
agree with LS.  trial sites in some countries can get ERB approval in parallel with reg approval


comment:
for the other (BSCOTA, CPTMA) could we add a for example here?  it will be the study manager for ClinPharm and I would like for the clinpharm reps to know that it won't be BSCOTA or CPTMA for them.


comment:
Not sure what sTMF is ... old paper TMF process?  If so is it imperative that we have an electronic copy on the collab site if there is a paper in the box somewhere?


comment:
not sure I understand what the 2nd bullet is about... "required for the index"?


comment:
suggest rewording first bullet to "study teams use IMPACT to manage and maintain information about the trial design and milestones".  The actual trial design is in the trial protocol and the milestones, in the CC timeline.


comment:
think the first paragraph needs team added ... supports the clinical trial team.  not sure that the systems alone help the trial run efficiently


comment:
2nd sentence:  we keep information updated and accurate so that the trial team, associated systems, and other functions have current information about the trial. preventing and resolving mistakes is a result of current information being available for all...  follow?


comment:
appears "a" and "c" are both correct.  I would either make it so both option can be picked or make it so one is clearly wrong.  

as an FYI, study managers in ClinPHarm will have the trial level dates available before our CPMs will.


comment:
While I agree that "a" is the correct answer about getting the date in the system long term, wouldn't we do something so that the safey mailings for the week are not missed?


comment:
not sure that saying that the roster review is ruth's priority will land well when we have people dealing with SAEs, etc.  Could we soften this that Ruth should prioritize the review and discuss options with her manager about getting the review completed?


comment:
again since there are multiple correct answers could we make it so that one is clearly wrong or both can be selected?


comment:
please remove "all" from the second bullet.  We do not have follow the blue boxes so I think saying that we follow all is a contradiction.


comment:
supervisors should be added to final bullet


comment:
one of the learning examples was showing how patient safety could be affected by potentially having a missed safety mailing. Recommend using that as an example since timeline and budget while important are not our primary concern.


comment:
IMP stock ... we usually say IMP supply don't we?


comment:
does new addenda include revisions to existing addenda?


comment:
STEAM is not a term used in ClinPHarm.  Could you replace with trial team meeting?


comment:
is it new protocol or amended protocol for the training rep?


comment:
For STMF - Electronic copy on the collab site is optional.  It makes retrieving and sending documents easier but is not required.


comment:
I don't think transitory documents belong in the eTMF, because they can not go away.


comment:
Remove the words "If there is..." from the three examples


comment:
I agree as they are not always considered thought leaders


comment:
Example one needs to be worded (agree with Tera)....feedback on the protocol for the trial, and agree with Karen regarding expanding example two (ie: include related to clinical trial)


comment:
Do we need to say CBSO is primary contact? I have submitted requests and never spoke with someone in CBSO. Not sure if I'm missing something! 

Also, spell out acronym (Clinical Trial Project Management Assistant - CTPMA)


comment:
Change period at the end to a question mark.


comment:
Should Reagent Load/Unload List be changed to Reagent Load Unload List to be consistent with other screens?


comment:
Many questions have feedback for the incorrect answers. Should this question have incorrect feedback?


comment:
Pop-up for the Japan example:
Should there be a period after "study participant safety"?
so "When using a drug, regulations are stricter"?


comment:
The 3rd example u-is not listed as an exception in the procedure - is it a correct example?


comment:
1st sentence "financial disclosure documentation is obtained"? instead of filled out


comment:
I ticked the 3rd answer thinking it could be a non-BA or non-BE trial - maybe say "A new phase 3 trial"... to the scenario?


comment:
In the incorrect feedback, add that financial disclosure information is trial-specific?


comment:
Not sure if these examples are to be considered best practices - maybe it's more a debrief.


comment:
Process map was revised. 1st step is now "Facilitate decision of financial disclosure"


comment:
Lesli's wanted to ensure that we cover the "Decision of Sponsorship & Roles" in the training. It's a blue step - so could that be included here?


comment:
I don't believe a 24/7 e-module only lab would have a pipe


comment:
The word 'of' is not necessary in the first sentence


comment:
The word 'of' is not necessary in the first sentence.


comment:
Phase 2 in Japan - shouldn't it be "more strict" vs. stricter?


comment:
On the incorrect feed back: Must have Fin Disc information for each trial


comment:
The reconciliation reports are ran at the end of the study.  This would be too late to obtain a new PI.


comment:
Objectives 1 and 2 seem very similar. could they be combined?


comment:
Describe the roles involved in the medical research consulting agreement process.


comment:
Describe the medical research consulting agreement process ....

Also, is it facilitate or submit requests for medical research consulting agreements?


comment:
...when generating medical research consulting agreements.


comment:
Seems interesting we only call out confidentiality provisions...should we expand list for required contract elements?


comment:
.....of what a medical research consulting agreement, the process and who is involved.


comment:
or we do not have the expertise interally


comment:
Let's take a look at the agreement Lilly uses to contract with medical research consultants.


comment:
What about when we contract with an institution vs. directly with the consultant?


comment:
I am not sure advice and feedback is needed here.  We are talking about the agreement, and this is a service they are providing.  So maybe it's scope of services?


comment:
A consultant has agreed to give feedback on the protocol for the trial.


comment:
So here you refer to Develop and Manage Consulting agreements process but in objectives slide you refer to Medical Research Consulting agreements process I think.  I would use the Develop and Manage Consulting Agreements process and then mention the scope of that process and that we are focused on medical research consulting agreements...


comment:
The Requestor conducts the following activities:


comment:
I would switch bullets 2 and 3.  First should ensure confidentiality agreements are in place and then shares info.


comment:
The CBSO is responsible for the following:


comment:
Under CBSO: Drafts and negotiates the consulting agreement,


comment:
I would separate out exception approver and budget approver


comment:
are prework, execution and invoice the real milestones in the BWL process map?


comment:
It is a judgment-based decision for whether to determine whether they want to participate as a consultant vs. in the trial.


comment:
If confidentiality agreement is needed because confidential information will be shared prior to execution of the consulting agreement, the Requestor collects a signed Letter of Confidentiality (LOC).


comment:
I'm in progress of trying to sort through the non-ba and non-BE wording. It is pulled straight from the requirements, but isn't quite right.  I need to discuss with Ally when she's back in the office


comment:
The request is received and processed by either Physician's World or the CBSO.  

The Clinical Contracts and Grants Office is only overseeing US agreements....


comment:
I think ACDD was used in a previous slide without defining.  Please define in first slide and can use ACDD here


comment:
Institutional notifications are a type of Anti-Corruption Due Diligence.


comment:
Does the requestor really sign off on IN or ACDD?  ALso, ACDD/IN is only required outside of the US.


comment:
Is it Develop and Execute Consulting Agreement process or Develop and Manage?


comment:
minor point ... but soccer fields do not have goal posts like football.


comment:
I would say Representative vs. using Rep in the course


comment:
The Representative must also determine the cost for other items included in the agreement such as ....


comment:
The institutional notification must be obtained from the consultant before proceeding?


comment:
I would be consistent with how you refer to CBSO in this course.  I think it differs depending upon slide.  CBSO Representative, Rep, CBSO Rep, etc.


comment:
should we mention data integrity as something that could be affected in addition to patient safety?


comment:
Here's the first time you mention Institution...I would ensure this is consistent across course because we can contract with consultant individually or with institution or both


comment:
I don't understand the first sentence that the invoice Requestor shepherds the invoice through the process.  Should this be something like: The person that receives the invoice determines next steps to ensure that payment for services performed are received?


comment:
Here you say budget approver but then mention invoice Requestor....


comment:
Suggested re-wording: The approver completes the internal payment requestor form and submits the form along with the invoice and supporting documentation to Purchase to Pay.  The invoice is sent electronically to the approver for approval, and the consultant is paid once the invoice is approved.


comment:
As you have seen, the process begins with the Requestor submitting the consulting agreement request.


comment:
the example needs to make sure that it is clear that the trial would need financial disclosure.  I assumed that I would need to know whether it was a phase 1 etc so selected need more information.


comment:
..have been asked to consult on CoLab sessions for a complex trial.


comment:
Make the text in the information boxes consistent for locations.  Should it be Location of the Consultant or US Consultant and OUS Consultant


comment:
The title for the information text box may need to be revised to something like Centralized Payment Services


comment:
the first "best practice" involves a form that we have not been introduced to at all.  I would suggest that it is modified to state that if there are responses on the financial disclosure that may indicate financial ties inform the study manager


comment:
The Requestor has submitted a request for a medical research consulting agreement for Dr. Smith.  He will be providing input into the design for a trial as well as he is a consultant for the marketing strategy.


comment:
The Requestor is asking to add time into the existing medical research agreement in place with Dr. Smith to include the consulting services for the marketing strategy since it is for the same compound.


comment:
I thought the form 3454 was only done at the time of submission and not for every trial.


comment:
Correct!  The agreements cannot be combined even though they are for the same compound.  Medical research and marketing services cannot be combined into the same agreement.


comment:
not sure how #8 ties into financial disclosure process.


comment:
In the response, we mentioned the cap for the first time here.  I wonder if we should mention something where we describe the medical research consulting agreement.


comment:
thought 3455 form was only at submission and not on a trial by trial basis.


comment:
I am not sure if this exercise is value added here since you already went through this process and discussed this at length in a previous slide.


comment:
May want to either say medical research consulting agreement throughout or make a statement at the beginning of the course to say the focus is medical research consulting agreements (referred to as consulting agreement throughout the rest of this course)


comment:
I would say contracting department vs. contracting shop.


comment:
If the consultant resides outside of the U.S., the request is submitted via SharePoint.  If the consultant resides in the U.S., the request is submitted via CPS.


comment:
the correct answer is not correct for the reason provided.  the phase 1 trial may be an exception so that may be why the financial disclosures do not need to be collected


comment:
Should we have a directive to click on the analyzer?


comment:
Can you make the hot spot for syringes bigger? Bottom half of doors


comment:
Is there a way to make the individual close the last check box before the directive comes up? (Talk to lab manager) Both come up same time.


comment:
Depending upon the change requested, it may be acceptable for the CBSO Representative to accept the change.  Alternatively, the CBSO Representative may need to seek input from the Lilly Medical team, patent/regulatory attorneys, affiliate personnel or Ethics and Compliance for resolution.


comment:
The CBSO Representative may also need to work with the consultant, consultant's legal counsel, consultant's institution and/or the institution's legal counsel until resolution or the request is terminated.


comment:
request for changes may not be approved though....so may want to revise this to say something like negotiations of the requested changes are complete...


comment:
...as there are no associated trials with this work.


comment:
Whenever a request for a consulting agreement is submitted, ...


comment:
Ensures the consulting agreement timelines can be met, ensures that the required documentation is provided and the request has been submitted to the correct contracting department.


comment:
Consultant or Institution requests changes.


comment:
The changes may need to go through an approval process.  If the changes are not accepted, the agreement could be terminated if agreement cannot be achieved by both the consultant/institution and Lilly.


comment:
In title, I would just have Knowledge Check vs. Knowledge Check Introduction


comment:
You've learned a lot about consulting agreements throughout this course, but do you recall the key points?


comment:
This check didn't have a submission button...would make consistent for all questions.


comment:
Can the word "protocols" in the Japan section explanation be changed to processes?


comment:
Instead of the last 2 best practices, Can we add a best practice that 1)sponsors of the clinical trial need to be identified and FD needs collected for all sponsors of the study. 
2) Consult with the CRP and regulatory to determine the roles that FD should be obtained for.


comment:
For medical director role can the following sentence be changed to "I also complete the Covered Study Determination letter to confirm whether.....


comment:
Can the third row be changed to Request reconciliation reports and request updated information to be obtained if any discrepancies are found.


comment:
Also the study manager does not compile the FD information, the site manager does this task also, so there are 3 tasks that the study manager does not perform from this list.


comment:
For the second downstream impact, it should state steps should be taken by the site manager to obtain updated financial information so it can be determined if thresholds were met.


comment:
For third impact, the second sentence should state If enrollment at site is determined to  to introduce bias then additional guidance is needed on how to proceed with the data collected from the site.


comment:
For study manager response, can it be changed to I request the reports form the GCBC representative if financial disclosure was required. I compare these reports with the financial disclosure forms and reconcile them. This ensures updated financial information is collected should any discrepancies be found and determine if thresholds were met for bias review of enrollment.


comment:
I thought the accurate response is 90 days before the last study participant visit for the trial or regulatory submission plan.


comment:
2 questions prior the response was 90 days after the last patient visit, but I thought it was 90 days before and this response is saying the correct on is immediately after the trial ended so this contradicts the prior response.


comment:
Since we discussed the 2nd best practice a lot can the following be put as the 2nd bp instead: All trials should collect financial disclosure regardless of country unless the 2 exception criteria of BE/BA studies or phase 1 study that will not be included in a submission are met. (This criteria was mentioned at the beginning of the module but very important and where a lot of confusion exists-may want to use the same description from that earlier question for the wording of the exception criteria)


comment:
Since this is geared more at the site manager's role and if the current BP#2 is added to the best practice section prior to this one, then can we put for this best practice that any item marked yes on the financial disclosure form needs to be communicated to the study manager.  For BP #3 can this be changed to: If there is any discrepancy reported during reconciliation by the study manager, the site manager needs to obtain updated financial information from the investigator.


comment:
format, displaying information about each patient's risk factors.


comment:
change understand to understanding. 

Second sentence: She instructs learns to continue...


comment:
Change all references to The Next Ultimate Assay Gourmet


comment:
mousing over the completed judges makes them pop out. Please disable this or don't make them go behind the table at all.


comment:
PLease change placeholder text to question 1, question 2, question 3. Right now they all say question 1. Just so the client can see that they aren't stuck in an endless loop


comment:
Change to TV/MG everywhere on this screen, including feedback


comment:
This should all be CT/NG on this screen. (TV/MG should always precede CT/NG since that is the focus of this launch.) Swap the screens and double check text on both screens for consistency


comment:
you need to get to know your patrons, judges, and competitors.


comment:
Just thinking out loud. Is it odd that all of our characters are illustrated and these are photos? I know it might be fairly time consuming to create new illustrations and not in scope. Thoughts?


comment:
Don't capitalize Risk in her speech bubble


comment:
I think you an remove title placeholder on all these slides and have them say TV/MG top competitors or CT/NG top competitors


comment:
Let's make this 3 so they don't get bogged down in having them all be "right"


comment:
This isn't needed for DP, but when it comes to create Alpha, the screen text should update to tell the learner to click on the next module.


comment:
This should probably mention the patrons


comment:
I clicked resources to check it out and have no way to get back to the screen I was just on?


comment:
You've met your patrons, heard what your competitors are saying......


comment:
I think Menu should take you to this screen and not the screen before.


comment:
The map has changed - some rewording to these boxes is needed. i'll saved the latest Word extract of the process on the collab site.


comment:
Instead of SAM say Site Activation Management (SAM)Representative


comment:
Does SAM representative apply for the clinpharm audience?


comment:
Instead of CDOS landing page, say Manage Financial Disclosure: the url can stay the same


comment:
Should this be Close Out Activities vs. Closeout?


comment:
Define financial disclosure and the importance


comment:
Describe the ROLES involved in the financial disclosure process


comment:
Click each box to learn if the situation will require the collection financial disclosure information


comment:
These types of trials typically involve healthy volunteers with the purpose of determining how a drug will absorb into the system.

I think last sentence needs to be revised as well as it isn't really an exception since the new procedure does not require FD to be collected for these types of trials.


comment:
For the second example, I think you need to reword the sentence because this is a phse 1 trial....


comment:
Revise to something like: Although this trial is being implemented outside of the United States, it is required because it is a late phase trial where study participants are taking drug and the safety of the study participants are being being monitored.  Actions must be taken to minimize the bias for investigators that have financial ties to Lilly?


comment:
I would change the title to something like: Explaining Financial Disclosure


comment:
I would say something like this example could be similar to investigators participating in the clinical trial.


comment:
clinical investigator or investigator - be consistent throughout the course


comment:
I would remove: which should be avoided at all times


comment:
I think we need more of an introductory slide prior to this one explaining "what" financial disclosure is and sponsor obligations


comment:
I would remove this slide and include a few potential issues that result from bias on previous slide.


comment:
The trainee has not had enough training in this deck yet to be able to answer this question. This is coming too early


comment:
This section should better frame "when during study development process" these activities are done


comment:
This training needs to focus more on understanding what Sponsor Decision means? As well as "key roles" that FD should be collected from. Agree that the lines about the 3454 submission forms need more clarity that those are only at point when a compound is pulling together an NDA


comment:
Financial disclosure is a method for ensuring bias is minimized.


comment:
Once financial disclosure information is provided, Lilly can take the appropriate actions to minimize any bias.


comment:
A new trial is about to begin and the investigator is participating as an investigator on another Lilly trial.  Does financial disclosure information need to be collected?


comment:
Yes.  You must collect financial disclosure information from the investigators regardless if the information was already collected from them from their participation in a previous trial.


comment:
This information has not been presented in the course yet for someone to know how to answer


comment:
If the investigator responded "yes" to any of the questions on the financial disclosure forms, inform the Study Manager.


comment:
it isn't really an exception because it is allowed per the procedure...


comment:
why is the last box in a different color?


comment:
These steps need much more framing and background in the pop up notes as to timing of each activity and what its meaning is


comment:
Do we want to include anything here about determine the roles which to collect FD from?  Also, what about specific instructions per trial (multiple sponsors, etc)....?


comment:
When you use the term financial disclosure process or process, should we use the process map name and use this consistently throughout the course?


comment:
when site personnel reports financially disclose-able information on the Financial Disclosure Form.

also...should site personnel be used?  What terminology do we want to use throughout course?


comment:
The next steps are documented in the Decision Log and the appropriate parties implement the required actions.


comment:
Pop-up box for #6 - remove period after or

Also what is the second bullet saying?  It is confusing so may need to  revise slightly


comment:
for regulatory, could we also in here state that they are consulted to determine if roles other than PI and SUb-I need to collect FD because of trial specific roles?


comment:
For stats, don't they help at beginning to minimize bias if there are yeses?


comment:
As a Study Manager, I am responsible for many activities within the Manage Financial Disclosure process.  Which activities listed below do you think I am responsible for?


comment:
For the step, there is financial disclosure to collect..I don't think this is the site manager unless I am misunderstanding this step.


comment:
The downstream impact for the reconciliation shows discrepancy doesn't make sense with this step.


comment:
what about adding something in here about roles to collect FD from?


comment:
When is the best time to request the reports for reconciliation?


comment:
Now is a good time to request the report for reconciliation.


comment:
You should only provide the reconciliation reports when requests are received.


comment:
This seems duplicative with a previous question.


comment:
Aren't signatures required on these forms already?  Isn't this a requirement vs. best practice?


comment:
Site Managers have some major responsibilities in the Manage Financial Disclosure process.  Site Managers obtain, compile and share the financial disclosure information as well as obtain updated financial disclosure information when reports for reconciliation identify issues.


comment:
This question was already asked in the course earlier


comment:
remove: as he does have some previous Lilly ties


comment:
site managers don't have anything to do with the 3454 form.


comment:
the response is not correct for the question...we are talking about FDFs vs. report for reconciliation


comment:
remove the period in the third answer after information


comment:
should financial disclosure be capitalized?  Ensure consistency throughout course.


comment:
Last objective, could we just say Identify the key decisions made when generating consulting agreements?
At this stage learners wouldn't know what CBSO is


comment:
1st sentence, should we say "consultants who provides medical
research services performs any work"?


comment:
Do they only provide advice and feedback?


comment:
CTPMA = Clinical Trial Project Manager Assistant


comment:
requestor 1st box:
Evaluates the need to share... prior to executing the Consulting Agreement.


comment:
2nd box for Requestor is only needed if the answer to the 1st one is yes. Say, If yes, is a ...?


comment:
Agree with Tera that CAP needs to be explained


comment:
It doesn't make sense on this slide to have the CBSO Rep defining medical research - this is not something they do. I don't think this definition is needed. I propose to just keep the definition of consulting that the Requestor person says


comment:
for sentence Consultants are global thought leaders - replace with "may be" global thought leaders


comment:
After I click the last milestone of Invoice the Next button doesn't appear and I have no way of moving forward


comment:
The answer to the yellow pop up box is never given


comment:
When you return from Subprocess map you are returned to beginning of Process again rather than to step 3 of Process


comment:
Need to add instruction to tell user to select an option


comment:
Exception and Budget Approver - I agree with Tera as this reads like they go hand in hand, but I believe they need to be divided as they are separate pieces


comment:
I agree with comments as CCGO only oversees US agreements, and an LOC is needed if the answer is "yes" to the first box (ie: need to share confidential info)


comment:
I don't recall signing off on the IN/ACDD when requesting OUS contracts


comment:
Can you make the training go back to the beginning of the process vs. the next step/where you left off


comment:
This process only involves OUS contracts. Do we need to include the process for US contracts? They us CPS


comment:
my comment should be "they use CPS/PW" - central payment services/physicians world


comment:
for the OUS system, can we use "IMA" (we will need to spell it out obviously!) vs. SharePoint?


comment:
Can we use IMA vs. SharePoint? Also, should PW be CPS?


comment:
Can you use another term for 'fashion'. Maybe say 'different contracting path' (like what you stated later in the training)? or something along that line :)


comment:
I'm not necessarily sure we should mention change controls for message notifications since we won't have actual change controls.  Maybe we could use some other form of communication to mention?


comment:
Had we decided that we would only name the WIP tables and not explain what they represent?  I'm okay with this. I guess it's just a little misleading that it says to click each icon to learn more.


comment:
We mention Excel docs as potential developments.  Is this still going to be the case?  I thought maybe Excel developments had been pulled from 3.2


comment:
We mention electronic deviations here.  I know other groups still plan to use those, but would this be confusing for the user who won't be able to?


comment:
Are we still using ValGen for periodic reviews?  And are we still using revalidation schedules?


comment:
The execution simulation got stuck at the selecting the Record button.  I had to fast forward through the simulation to continue.


comment:
When we select Confirm document ready for routing under the Review portion of the simulation, we stil don't have the drop down menu to select "Review"


comment:
Change text: In this activity, practice uncovering the needs of your customers. Read each customer statement, then select the statements that provide the most relevant needs.


comment:
When I replayed roberto, the blue text here was duplicated and overlayed each other.


comment:
Also on replay the speech text for the dealer and customer both appeared, so the dealer text was over the customer.


comment:
The text in the blue boxes shifts once clicked.


comment:
Office manager image covers up the needs text.


comment:
Once I got this wrong, the text in the top box shifted and she was referred to as a homeowner.


comment:
The learning objective for this section is to adapt the business case info to fit the one page format. We have them do that in one case where they have to shorten it. Otherwise they just have to select the field that it goes in. Where is the pain point for this form? Is it that they can't find the info in what's provided to them by the other buisiness units? Is that they don't put it in the right field? or is it that they don't know how to modify it to fit in the form? That's what this section should then have them practice.


comment:
I got a message to enable flash player before I could start the course. It might just be my computer, but I never get that message so I just wanted to call it out!


comment:
customer-centric (add hyphen)
add a space between centric and (


comment:
Not sure of the lingo that is acceptable here, but I'd spell out F & B to features and benefits


comment:
All the correct answers for these three activities are the first one (I think!). Can we move this one so the correct answer is last?


comment:
The Kohler Characteristic doesn't tell me much. What about changing it to "Private, family-owned company that offers power generation for businesses and consumers across the globe."


comment:
Change opening to "That's correct.  Creating an account plan for Holds may not be needed because growth..."


comment:
Italicized text update to "It's the Sales Manager's responsibility to support and coach Account Managers as they begin and evolve their account plans"


comment:
Would it be possible for the arrows to be a different color? The black arrow is difficult to see next to the dark brown.


comment:
Additional edit to text, last sentence - "I didn't find anything and missed an opportunity."


comment:
host was capitalized in other screens. Please make consistent.


comment:
Update last sentence to "Good competitive position knowledge provides Cummins the best opportunity to succeed."


comment:
Remove bold of 'achieve balance" and bold "measure ourselves against key customer measures of success".


comment:
Highlight text areas to click to make easy to notice and know where to click.


comment:
Remove "Eureka" in case not universally understood.


comment:
We should point out that paying attention to the customer analysis and initiatives will help determine key resources to engage.  So we need to add in the initiatives tab which would point to some initiatives that would drive resources to pick.


comment:
Move plot to left so as people are put into the plot area, their text is not cut off on right side so one cannot read it.


comment:
Move this to before resources discussion without all details so after resources are engaged they can be assigned to specific initiatives.


comment:
Change text to 'An account plan aligns you with your customer's needs, identifies opportunities and engages resources to succeed.  You don't want to share every section of the account plan, but there are some sections that are valuable to share.'


comment:
These icons were shown once before and then pop up throughout, but don't mean much with one initial exposure.  Can we add a term to make the icons be more meaningful and act as a guide around the loop?


comment:
I'm wondering if HOA is universally known? Can we just say Homeowners Association?


comment:
Continue for the middle "okay" choice took me to a different customer.


comment:
I would change the textbox one to include the conceal part : The RS20A has a lower decibel level and can be put anywhere on your property. This allows you to conceal it from the street if necessary.


comment:
Oh, maybe continue is supposed to take me to the next customer even if I get it wrong? I assumed they should try again until they get it right for all customers, right?


comment:
Again, it seems like the top answer is always the correct one in this activity. Can we shift this around.


comment:
Do you need some key points for this screen?


comment:
I have a SL course that includes the certificate. I can send you my html and file if you want to use this as your starting point?


comment:
My first round review went great, but I don't see how we meet the last objective of Recognize the different markets beyond genset where Cummins operates. Maybe this will come more from the guide?


comment:
I see in the DP feedback that these should come from Tom. you can ignore my comment. sorry!


comment:
should we say: describe the roles &responsabilities of functions involved in the change management"


comment:
even if we have currently CT material  template issue in Trialforce (due to the dependant questions), this won't affect the screenshots Nancy has prepared for the module


comment:
To address that last objective I feel is missed, I talked to John and he just wanted to say how Cummins is in more markets than just engines. I think we can achieve this objective by offering a screen like this that is Cummins focused. That way they see the description and can also see that Cummins is in more markets. I can give you text ASAP.


comment:
Change to: With storm season coming again next month, (change soon to next month to avoid two soons so close together)


comment:
Delete is after my neighbor on the last paragraph


comment:
change in last sentence: after it is installed


comment:
In the sorry that's not correct feedback, change the last sentence to say "Now that you know what this customer needs, it's time to have a conversation about those needs and prepare to position the Cummins solution." It seems odd to say you know the need needs and now you need to understand them.


comment:
Load management is desirable to him because of his need to prioritize that his appliances and computer remain operational at all times.


comment:
In that's right feedback change last sentence to "Now you need to have a conversation with the customer about his needs and prepare to position the Cummins solution."


comment:
On sorry, that's not correct screen, In third sentence, delete comma after outage and put a comma after quality


comment:
Graphic, bottom: change "Closeout" to "Close out" to mirror this course's process map. Lilly global edit is to make course terminology match the process maps.


comment:
On the farmer, put a comma after fans. It seems like the feedback is combining with feedback from homeowner activity.


comment:
In the first gold bar, change 'it' to 'its'.
In the third gold bar, recommend changing 'study team managers' to 'study managers' (to be consistent with the rest of CDOS.


comment:
Remove the comma after power on the first answer choice in the farmer positioning statement.


comment:
In farmer there's a better choice feedback the speech bubble text runs into the feedback text box


comment:
Same comment as a above in the correct feedback screen for farmer


comment:
which role is the Risk Assessor? is it a function?


comment:
I agree with Sharon I think you should have to get the best answer to move forward.


comment:
Intro text: I know it's pulled directly from Becky, but shouldn't it be "...for the official location of the TMF record."? (change 2nd "for" to "of")


comment:
I would say: france regulatory agency required the collection of an extra blood sample to be collected..." etc. it is easier thanks


comment:
Recommend changing the second sentence to "This process is used when a protocol amendment and/or the addition of a new protocol addendum after protocol approval is being considered."


comment:
alpha edit, row 38: Says "3rd bullet: either say periodic, or annually (not both)". The 3rd bullet still has both words in it. Remove "Periodic" at the beginning?


comment:
I think this should should be scripted to the best of our ability here.


comment:
CRP: it should be used addendum instead of amendment.


comment:
We don't provide links directly to the process maps in the other courses, just the single Resource link to the CDOS landing page at the end. I don't see an edit in the spreadsheet for including these here - was that decided for this course to take this approach? If not, I'd recommend removing the learning agent speech bubble and the non-CDOS landing page url.


comment:
In all other courses, when we introduce a character, Lilly wants a popup on them that states their role; in this case, Study Manager. See Leo or Erika's courses for an example of this.


comment:
Alpha edits, row 49 - I don't see the verbiage requested about discussing options with her manager to get the review completed.


comment:
Isn't the answer to this question TRUE? I thought missing or inaccurate information at the trial level impacts site and country levels, and that the feedback should be TRUE, missing or inaccurate information at any level can impact other levels.


comment:
Ignore my comment - For whatever reason, I thought it said Incorrect and then gave me that feedback. We're good!


comment:
Have we defined "IMP" before in the course? I don't recall seeing it...need to define it the first time it's used, if not.


comment:
Modify my previous comment regarding the resource links - if they are both linking to the original URL, and mirror what's at the end (this page), then they are fine to use.


comment:
Agree to change the second sentence.  An alternative sentence could be "This likely means the protocol needs to change and I need to work with other functions to understand the impact of the change."


comment:
Edit from course #1 alpha review: "This applies to all courses. Need a paragraph something to this effect: Process maps, quality documents (procedures, required tools), and supporting materials are available to support the performance of your work." I would copy/paste this statement directly into this course above "To learn more..."


comment:
Recommend changing the first sentence to "Two critical elements needed to effectively manage a change are the impact analysis and the implementation plan."


comment:
An impact analysis is only required for levels 2 and 3 changes, but an impact analysis can also be used for level 1 changes.  Please clarify this in the Impact Analysis box.


comment:
An implementation plan is only required for levels 2 and 3 changes, but can also be used for level 1 changes.  Please clarify this in the Implementation Plan box.


comment:
Please change the intro paragraph to "In the investigation phase, the impact analysis tool is used to identify the trial changes to include in a robust implementation plan."


comment:
Please correct the first introduction sentence to "It's important for the right people to attend the study team meeting."


comment:
In the scenario, the CRP is referred to as 'her', but the icon used for the CRP looks like a man.  Recommend changing the scenario reference to 'him' or changing the icon to a female.


comment:
Agree to correct the first sentence of the second paragraph to read correctly.


comment:
In the first sentence, can 'impacts' be changed to 'impact'?  It doesn't read well.


comment:
Please search the entire module to determine if the word 'impacts' should be changed to 'impact'.


comment:
Delete "that" in the second bullet point


comment:
Delete comma after "IMPACT" in first bullet


comment:
Delete comma after "IMPACT" in second bullet


comment:
Delete comma after "IMPACT" in third bullet


comment:
Add "out" after closed to read "...have been closed out or cancelled."


comment:
Remove the apostrophe on Cummins in the last bullet of Section 2


comment:
Remove "that" in first paragraph
Change "has been" to "is" in first paragraph
Add a comma after "August 1" in first paragraph
Change "get" to "are" in second paragraph
Remove "that" in third paragraph


comment:
last bullet on section 2 - change to "...markets beyond generator sets (gensets)." then use gensets everywhere else for the rest of the course


comment:
Update text and bolds to align with seller course alpha feedback.


comment:
Change text to "As a team leader, I know what resources they..."


comment:
In menu dropdown, it says Set-up, and no hyphen on screen - make them match


comment:
Screen title - it's odd to have a comma and &... should we just change the & to and since that is how it also appears in the course title? Make the change in the menu and on screen


comment:
Last sentence of sTMF text box: ..."so that the trial is inspection-ready..." (remove "that")
First sentence of eTMF text box: "...to ensure that the trial..." (remove "that")
Last sentence of eTMF text box (add "the" after "through")


comment:
Adjust gray box for overview to be the same width as the transparent white box it is attached to


comment:
Swap subject and predicate in both third and fourth bullet points to read:
third bullet: "A litigation hold banner...if there is a litigation hold."
fourth bullet: "Transitory records and convenience copies are deleted...if there is no hold or if an existing hold has been lifted."


comment:
Move bkgd image over to fill white gap between pic and outer shell (left side)


comment:
Second paragraph, first sentence: "...and accurate so that the trial team..." (Remove "that")


comment:
Not quite feedback - 1st sentence reads weird. How about "Remember, this customer told you he wanted to get this generator installed soon, and he doesn't want it to keep him up at night."


comment:
first paragraph, second sentence: "Site information gets transferred..." (Change "gets" to "is")
second paragraph, first sentence: "Ruth noticed that the TPO..." (Remove "that")
second paragraph, last sentence: "...the site won't have the safety mailings they need." (Change "they need" to "it needs")


comment:
second paragraph, first sentence: "At the same time, she's maintaining..." (Change "she's maintaining" to "she maintains")
second paragraph, last sentence: "...she's recently learned..." (change "she's" to "she")


comment:
The decision log is used to document the completion of all of the trial change tasks, but not necessarily used to track progress.  Recommend changing the 3rd bullet to "Review the implementation plan to verify the team member tasks are complete."


comment:
third answer option (remove comma after "site"; remove comma after "information")


comment:
I may have accidentally clicked the wrong answer and not realized it but just check: I chose the right answer but my result was incorrect


comment:
In the pop up summary, include a statement that says something like "Document the completion of all implementation tasks in the decision log."


comment:
The screen title/intro text/direction text is a little hard to read here with the dark bkgd


comment:
Remove apostrophe on Cummins in customer's speech bubble


comment:
Incorrect feedback popup - customer's speech bubble needs to extend further left to be "behind" him


comment:
Next button is disabled - will continue to next page after I clicked it


comment:
customer's speech bubble needs adjusted on all popups, not just incorrect


comment:
Recommend changing "medium" to "moderate" to align with the required tool verbiage.


comment:
Ruth is a female, so please change "him" to "her"


comment:
Capitalize C in Competitors on mod title in Menu dropdown


comment:
The way I read the question and selections, all 3 apply.  The criticality of the change does determine the level of detail needed in the documents.  If the 3rd bullet should not apply, consider rewording the question to "When developing the impact analysis and the implementation plan, what factor(s) influence the need for more detailed documents?"


comment:
Update menu dropdown to say Value of Cummins for this screen


comment:
The same comments from The Change Mgt Mindset Section 1, page 10-11 apply to this scenario.


comment:
Recommend changing the last bullet to "Document the completion of the implementation tasks"


comment:
Remove the exclamation mark on the course title


comment:
this should be about small business, not mid-size. so adjust opening text to "The Light Commercial Small Business market consists of small business owners and professionals." You'll also need to adjust the bullets. I would not think the 2nd one would be true. And the third would be "Includes small retail businesses and restaurants, law firms, and local doctors offices."


comment:
also adjust her speech bubble to whatever is in the source about small vs. mid-size


comment:
Some of your text can match the popup for Dr


comment:
Update icon in popup to the chicken instead of plant


comment:
Will need to update mid-size to small here, too. I mentioned yesterday, but maybe it would make sense to make this a small deli or bakery or something and we can refer to them losing lots of refrigerated ingredients if there were a power outage


comment:
Text by icons for name of market - can we put these in a white box that goes behind the icon? will make it more legible instead of text sitting on all the varied colors of the map bkgd


comment:
Shouldn't we now be on Customer B instead of A?


comment:
Also, I don't think the woman in wheelchair should have a label on her... she's just a resident, not a customer


comment:
special reqs popup - maybe change to ...who are critically dependent on medical devices in the.... ?


comment:
also change apparatus to devices in first popup


comment:
Guy in incorrect feedback popup is a different person - he has lighter skin and is a little beefy-er haha


comment:
Incorrect feedback - there are multiple labels at the bottom of him


comment:
Change to Customer C throughout scenario


comment:
Change her label to Apartment Manager instead of Lawyer


comment:
Change to apartment owner instead of property owner in blue directional text


comment:
Change to Apartment Manager in all cases in the scenario (not apartment owner as I mentioned in another edit here)


comment:
Special reqs popup - missing a space after the first sentence


comment:
Special reqs popup - 5th line - missing d in brands


comment:
The dropdown menu is not ordered the same as the course takes you through each of the 6 people


comment:
Update per earlier edits for this to be small not mid-size. Perhaps these people are retail shop owner (instead of chain), deli/bakery owner, etc.


comment:
I'm realizing now we have names on these people that earlier we referred to Customer A, B, C. Let's give those people names, too


comment:
Give this woman a name and use throughout scenario


comment:
He should be a Poultry Farmer instead of Dairy. Other person can be a Hog Farmer (These are the only 2 they want to cover in ag - hog/poultry). Also give them names throughout the scenario.


comment:
per DP feedback, they want the names of the markets to appear like you have them later as they click and return to the map for each of these pins


comment:
per DP edits - names of all markets should now be visible along with the pins


comment:
Suggested working changes for the red pop up...The process for the creation of a satellite location SEC is not applicable for satellite locations associated with a network.  Please contact your SME if you have any questions.


comment:
This is much closer to an "alpha with gaps" - I'd recommend only making the PMO character an active clickable element. It's OK to put onscreen for a DP that only one character is active at this stage (identify which one though!)


comment:
Typically, acronyms should be identified the first time they're used. Recommend spelling each role title out, following by the acronym in parentheses - "Research and Development (R&D)", e.g.


comment:
This text is still somewhere between a DP and an alpha, which makes it confusing. Recommend shortening to "The learning agent introduces himself as an IPM with RMS to tell a story about not following template guidelines for a business review." Spell out acronyms the first time you use them (I entered this comment later in the course as well).


comment:
I'd recommend a different position for the learning agent here so that the text boxes have the same layout.


comment:
It's fair to put a note onscreen for the client to say things like "Glossary button is active, but no content exists at this time. Should the glossary be active throughout the course or only at the end?"


comment:
Reduce size of the text box to minimize extra white space. It's unnecessary.


comment:
If these characters remain clickable here, I would recommend a visited state (grayed out or similar) since the learner must click each before they can advance.


comment:
Recommend incorporating jc's previous comment in the last sentence: "...learning the order and purpose the phases of the business review process." This gives the client a clearer picture of what the activity covers.


comment:
Directional text: If incorrect answers do not 'stick' (i.e. if learner has to get answers to the right spot to advance), include this in the blue directional text. e.g. "Incorrect answers won't 'stick'."


comment:
Directional text: "Drag the correct questions to the Proposal Phase document to complete it." Capitalize Phase since it's capitalized on the document, and call it the Proposal Phase document since that's the drop location.


comment:
Incorporate jc's feedback with placeholder text: "Feedback text goes here."


comment:
Back button does not work. Confirm function globally.


comment:
Same comment as previous: add directional text that incorrect answers won't stick if that's the case.


comment:
Answer option text: "...what is Roche market position?" Is this supposed to be "...what is Roche's market position?" or "...what is the Roche market position?" ?


comment:
The provided image is very grainy - recommend either replacing with a box that says "Placeholder for SharePoint image" or replacing with a clearer image, if we have one.


comment:
General comment: your feedback boxes are being used as an introduction to the next screen. The feedback boxes should be used to provide specific feedback on the learner's performance on this screen. Use introductory text at the beginning of the activities rather than in the feedback in the activity prior.


comment:
The yellow on active state of the tombstones looks a little brighter than it should be. I sampled it at #fbc11a and it should be #e2ab26 (i think these are ones you revised? because they don't match what i made in my source .ai)


comment:
Is the button standard for these courses to have it change shape on rollover? The corners get more rounded on over than they are on up. I haven't noticed that in looking at any of the other courses.


comment:
As a layperson here...should directional text be "Click the monitor to open the waterfall and access the datasheet."? I didn't know what to do when it said click the waterfall...


comment:
The background image changed here but there's no indication that the learning agent is going to cover new information, or reinforce existing information. This seems like a good opportunity for the learning agent to do that...otherwise, why did the background image change?


comment:
I meant to put this edit in many screens ago. I have no idea what these acronyms mean, and only found out after I dragged them to the correct location in a previous interaction. Should there be a set up screen (like a table) near the beginning that describes what each of these phases are? It can be placeholder at this point.


comment:
Recommend labeling the RMD (US) and RMD (EMEA) red buttons as plot points since I had no idea what I was supposed to do here after reviewing the slides.


comment:
The Continue button has a varying amount of lag after the learning agent text box appears. Double-check and make consistent. (honestly, I'd say remove the lag entirely)


comment:
Folder popups - these boxes are very different from all of the other popup boxes, text boxes, and feedback boxes. Is there a reason why we're using a blue background and white font? There's also a ton of unused space on each of them. They don't look as clean as a lot of the other boxes.


comment:
Further suggested wording for the red pop-up:  The process for the creation of a satellite location SEC is not appplicable for satellite locations associated with a network delegated by Lilly to perform site qualification.  Please contact your SME if you have any questions.


comment:
I suggest to change the format, the 2-line text with the little score is difficult to read and operate


comment:
How does CDC notify to CRA which locations need visit?


comment:
Just as comment, I get this window freeze the first time I click on it. I think the problem was my connection but I want to let you know. I solved the freeze window by displaying the directory with the arrow in the top left of the screen


comment:
I suggest to include also the accronym. (Subject Matter Expert (SME))


comment:
Purple button should said "Satellite iSEC"


comment:
The instruction still says Proposal phase even though it is DG.


comment:
slight revision to SV first comment....or after the qualification and selection of the primary site


comment:
I need to check as I believe if a site has contracted with an external lab to collect and ship labs to Lilly's central lab we need to assess that location or verify that the site has asked the necessary information


comment:
CDC will notify the CRA that there are satellite locations and the CRA determines if monitoring needs to occur


comment:
suggest:  A primary site may use a satellite location to increase enrollment capabilities or provide an added convenience for study participants by having a choice of using a different location that may be closer to the study participant.  We can word smith but you get the general idea


comment:
need to reword the VO : if it is determined that the location will conduct clinical trial activities that require an evaluation then the CDC will perform an evaluation and complete the necessary documentation in the Satellite ISEC form.  The documentation will be specific to what clinical trial activities will occur at the satellite location.


comment:
I am confused as to the VO and what is being shown on the screen


comment:
should we add to the last sentence of the VO ...the CDC needs to probe further to assess if this would be considered a satellite location that needs evaluation.


comment:
maybe we say...additional questions will appear in the Satellite ISEC for the CDC or you to answer


comment:
maybe revise the last sentence to read...stick to the facts and don't use subjective language


comment:
We may want to add a pop up that identifies what "other" could include i.e. eConsent, electronic diaries....see if the CDCs think this would help


comment:
first sentence:  ...and therefore only certain questions may need to be answered within the satellite ISEC; we have stated elsewhere about the SPI so I think we can leave off this slide to Di's point


comment:
I think we should remove for a primary site from 1st sentence- they are just collecting lab specimens as a secondary location


comment:
same comment re:  questions will pop up- maybe replace as per earlier comment to sound more professional?


comment:
I just noticed that the statement associated with the first question is incorrect and need to tell Di to correct- I will need to provide you with a new snapshot


comment:
when I send the new snapshot I will leave out the GLP since all the rest are being shown this may cause confusion


comment:
not sure how #2 got in here but it doesn't fall the laboratory questions


comment:
The following is missing under the question and before the "yes":  Does the satellite location have access to all the necessary equipment listed in the critical equipment question?


comment:
I would add to the box.  You will clarity your answer in the comments section of this section since all of the equipment is not checked.


comment:
for box:  ...not sure we need to mention SPI- let's see what CDCs think if we need to call it out again or just move through the questions


comment:
Leo the wrong equipment list was used it should be the one with the Centrifuge, thermometer and refrigerator for CT material- now I know why this whole thing is so confusing


comment:
The statement at the top should read:  this location is performing screening visit activities therefore the CDC needs to ensure the location has all the necessary equipment as per trial protocol.  In this case centrifuge and thermometer


comment:
as per my email list all of the accreditations because one is checked off- CLIA waiver


comment:
I didn't know you have to scroll down to see the rest- we should indicate this better for the learner as I missed the list of accreditations on the prior slide as a result so disregard my comments; for this the answer is to be no for #2 and that is what is in the email I sent so not sure where yes came from?


comment:
VO would say other changes and not circumstances


comment:
the first slide for the change form is missing questions which make it confusing: should show the leading question which it does:  is there a change at this satellite location in CT Material processes? then the next question Will the site be transferring CT Material to this satellite location from another location?  Then the long question which is shown should appear


comment:
suggest revising to read....The PI informs the CDC that they will now be using this location to store and dispense study drug to study participants.  As we discussed and we can change if the group thinks it is better- we are using study drug because we are reiterating what the site told the CDC and site isn't going to use Lilly terminology i.e. CT Material- if the group doesn't think this will get across just change and say CT Material


comment:
VO suggest adding distributing or dispensing CT Material to study participants


comment:
add to the box Satellite Location Change Form


comment:
box:  ....yes to this question the CDC must gain an understanding of what the CT Material transportation process is and that it meets....


comment:
when we spoke Friday you were saying that you were going to use my snapshots...now that you are I may need to provide new ones as Di has informed us that the form cannot be set up the way it is on the screen and therefore the flow of questions will be different.


comment:
box:  the additional comments section should be used to provide specific details as to why the answer is no-  I will let you know if this will change based on the changes to the form


comment:
the box statement is incorrect- to KS comment these are the recent revisions and we are no longer using the term central pharmacy and we are implying the use of a 3rd party as per the statement that comes after the question


comment:
suggest adding some of the comments Di sent via email i.e. the satellite location can not be qualified and selected until the primary location is qualified and selected etc.


comment:
CDC: Remove last sentence "In addition...  It's confusing and I'm not sure that it's likely to happen.


comment:
CRA: remove "and then" from the last sentence.


comment:
The system did not allow me to repeat the exercise.  It says I finished the activity if I try to go back and then next to return to the slide.


comment:
Back/next button would not allow me to repeat exercise.


comment:
The first question sounds like a primary site location change.  It should be rewritten if the intention is for it to be a initial satellite evaluation.


comment:
Change the color of the Initial Evaluation Form box.  My first impression is that it was "grayed-out" because it was not an option.


comment:
The site contracted labs or imagining centers should have the proper local regulatory approvals. For example below, it is site responsibility to ensure the lab has all training and proper credentials. I can think of IATA training for managing dry ice... however for the concept in this training, those areas are not satellite locations, so are not assessed as such.


comment:
CDC: The CDC informs the CRA that a site has satellite locations and the activities that are conducted at each location.
It is not clear the statement that site personnel did not add a satellite location after ISEC.. if there is a new location, the CDC has to assess it.


comment:
Product Delivery Team: I do not know if everyone is familiar with the soft number, if there is any reference of it in the site selection guide book, it is fine. I am thinking on a new CDC with no ClinOps background


comment:
Direction text: change exclamation point to period. I seem to recall that they have an aversion to them, so better safe than sorry :-).


comment:
I thought that there were now only 3 markets instead of 6, and that instead of doing one rep from each market, we would do like 2 from one, 4 from another and 1 for Ag? Maybe this has changed, but that's what I remember from my last call...


comment:
I forwarded you the email we got from Tom Bakritzes regarding the market categories. I think there are only 3? Residential, Light Commercial business, and Ag. Residential includes homeowner, condo owner/apartments, and senior living. Light Comm business includes small business owners and professionals (doctors, lawyers, etc.) and Ag is hog and poultry farms.


comment:
change "North America" to "North American"


comment:
module 2, bullet 1: change "find out" to "learn"
module 3 bullet: remove comma after categories


comment:
As I recall, they don't like having the word "module" on here. So, perhaps change the text at the top to: "This course has three lessons." Then, remove "Module 1:", "Module 2:" and "Module 3:" text from the gray bars.


comment:
Add  "They are" at the beginning of bullet 3 to make a complete sentence


comment:
see slide 2 on the DP edits. They want to have the name of the market appear next to the pin when it's selected or visited. So, the selected/visited states of the first pin should have the word "Residential" next to it. I need to confirm with Christa, but I'm pretty sure there should only be 3 markets and not 6.


comment:
remove the space between the p and second a in apartment (first sub-bullet)


comment:
*disregard previous comment* just looks like there's a space but I don't think there is :-)


comment:
No header/intro for bullets?

speech bubble: change "which is not good" to "which isn't good"


comment:
third if statement: make doctor's lowercase
third then statement: make lawyer lowercase


comment:
To further clarify Christa's edit: there should be 3 markets: 1) Residential, 2) Light Commercial Business, 3) Agriculture. The first three pins should be for the Residential market, and the names of the pins should reflect that. Example: the house pin should say "Residential: Home Owner". The next pin should say "Residential: Apartments". The third one should be: "Residential: Senior Living". Then the 4th and 5th should go with Light Commercial Business, so 4 should be "Light Commercial Business: Bakery" (or whatever the business type is) and 5 should be "Light Commercial Business: Doctor". Finally, the last one should be "Agriculture: Hog Operation" (or poultry farm or whatever you made it in the course).


comment:
Nice to have: I think you should give the customers names--like "Fred" instead of "Customer A".


comment:
fourth bullet: remove "often" to make bullets parallel and since you already say "in general" in the header

(this may be okay, i'm still learning the rules :-))


comment:
second speech bubble: change "vacation house" to "vacation home"
third speech bubble: change cannot to can't


comment:
I think I would move the first sentence in the Q2 layer ("With a job, a family, and two homes, I don't need another thing to worry about.") out of that layer and make it the first sentence in the Q1 layer instead. I think most people will click these in a top-to-bottom fashion, so I feel like it's better to establish that this guy needs generators for two homes in his response to Q1. Hope that makes sense!


comment:
I think you need to change the reference to "your station" to "your home" in the feedback.


comment:
Change the reference to "your station" in the third option to "your home" also.


comment:
second speech bubble, second paragraph, second sentence: remove "a" between "be" and "life"


comment:
second speech bubble, third paragraph: change the comma after comfort to a period and capitalize if to break the run-on into two sentences


comment:
Screen title: Change to "A Deeper Dive: Residential". Change the reference to "Single Owner Residential" to just Residential in the text.


comment:
Screen title: change to "A Deeper Dive: Residential". Maybe change the text to something like, "Let's get to know another customer in the Residential market category."


comment:
third speech bubble, fourth sentence: "...devices are not damaged when running..." - change "when" to "while"
third speech bubble, fifth sentence: change "finally" to "also"


comment:
I would name the customer. Agree with Christa about the label on the senior citizen. Also, I think the red text across the top should say: "Residential: Senior Living Facility" and the screen title should also say "Senior Living Facility". That's the name of the market and business type...the customer is the service operator, but you should just have the type of business listed at the top.


comment:
Screen text: since this is still the residential category, but just a different type of residential business...I think you need to change the first sentence. How about: "Residential businesses like senior living facilities:"


comment:
Need to make sure the label on the customer is correct. I would name the guy and make sure it says "Senior Living Facility Service Operator", or at least "Facilty Service Operator" under his name ( not gas station owner)


comment:
first speech bubble, ninth line: change comma to a period or semicolon
first speech bubble, ninth line: add apostrophe to "its"
first speech bubble, last line: remove extra space after "until"


comment:
Yep, your customer changed! Also, check all layers for the label on the customer...sometimes it's gas station owner.


comment:
second bubble: add a space before "Exercise"


comment:
third option on main layer--change reference to "your station" to "your facility"


comment:
On the labels, make sure you're capitalizing each word (Home owner should be Home Owner). Also, the pin title for pin 2 should be the title of the market and market type, not customer- i.e., "Residential: Senior Living Facility"


comment:
under "Sorry, that's not right" - remove space between "agreement" and the period


comment:
Change screen title to: "A Deeper Dive: Residential". Change reference to "more customers" to "one more customer" in the screen text.


comment:
Let's talk on Monday and confirm with Christa, but I think that the "breadcrumb" should be the Market followed by the business type, not the customer. So, in this case, it would be: "Residential: Apartment Complex" or something like that. Then, the screen title would be "Apartment Complex" and the customer would be "Apartment Manager" or "Building Superintendent" or something like that.


comment:
remove "Next" and change "talk to" to "talk with"


comment:
Change the first sentence/first bullet to: 

In general, apartment complexes in this category:
 - Are residential businesses with a single owner.


comment:
Let's discuss: Should it be Apartment Manager or Owner? I wonder if Owner isn't more accurate based on bullet 3 in the content (it says that gensets are purchased by the owner or a contractor). the customer should be the person making the purchasing decision in each of these scenarios.


comment:
remove that after animals in first speech bubble


comment:
in any option that refers to "your station"...need to change that reference to suit the scenario. In this one it should be changed to "your building".


comment:
Make sure that the customer label is accurate on every layer. Sometimes this one says "Lawyer"


comment:
change setup to "set up" in second speech bubble


comment:
change depend to "depends" in third speech bubble


comment:
remove comma after engine in third speech bubble


comment:
there may be an extra space between Having and Jurisdiction i can't tell


comment:
Change screen title to: "A Deeper Dive: Light Commercial Business". Change text to: "Next, spend some time learning about the needs of a customer in the Light Commercial Business market category."


comment:
change last bullet to keep parallel bullet structure


comment:
Change "Small Business Owner" to "Small Business" in both red and black text at top of the screen. Make Jane be a bakery owner or a floral shop owner or something like that.


comment:
change the first sentence to: "In general, small businesses in this market category:"...also, double-check the source content and make sure that the bullet points match small business and not mid-sized business. I think that the text might be inaccurate as it is currently.


comment:
This whole scenario needs to change...let me know if you need help!


comment:
Title: "A Deeper Dive: Light Commercial Business". Text: "Next, learn about a different customer in the Light Commercial Business market category."

Pin label for pin 3: "Residential: Apartment Complex"


comment:
pin label, pin 4: "Light Commercial Business: Small Business"


comment:
Bread crumb text and screen title: Change red text to "Light Commercial Business: Professional Services". Change screen title text to "Professional Services". Change first sentence text to: "These businesses include medical practices, law offices, and companies that offer other professional services. In general, they:"


comment:
Change title to: "A Deeper Dive: Agriculture"


comment:
In blue text, say "poultry farmer" rather than chicken farmer.

breadcrumb: "Agriculture: Poultry Operation" 
screen title: "Poultry Operation"


comment:
third bullet: change "will regulate" to "regulates"


comment:
On this slide, when you select the wrong answer the speech bubble 'are you sure.....' comes up.  This should fade out after x seconds and return to the original question - otherwise the user is guessing again.


comment:
This screen needs to make it more clear that the course is complete in my opinion.  Otherwise the user might click on the shovels and be taken back to work that is already complete, and could frustrate.


comment:
Yearly add it is a good time to review if we have account plans in place for the right accounts.

Quarterly edit "great for account performance reviews."

Combine weekly to Bi-weekly / Monthly and use the language under Weekly.  Remove the Monthly separate flag and text.


comment:
Can we add North America here? We may have discussed this before and why it should not be here, but it makes sense to add if we mention it the first thing on the next page (unless NA is included in the title on our LMS)


comment:
For correct answers, it makes sense to have green around the box instead of red.


comment:
Update buckets to just be yearly, quarterly and bi-weekly/monthly.

Yearly:  Remove "what deals have we made..." and add question "Do we need to stop or start an account plan for any customers based on our criteria?"

Quarterly:  change to "How is the account performing and what are our next big steps?"


comment:
For Bi-weekly / Monthly add "What is the status of your initiatives?  Show me in your account plan."


comment:
The word owner is cut off in the first sentence


comment:
In third if/then line, lawyer firm should be law firm.


comment:
Can you replace the billboard header? (re: biz segments) Maybe with the Vision? Let me know if there's nothing that will fit in that space.


comment:
Svc Ops popup: hyphenate customer-centric


comment:
Edit Svc Support popup: "The globally-connected Service Support sub-function helps customers..."


comment:
Edit Svc Tech Trng popup: "...to increase the technical competencies and product knowledge of technicians."


comment:
Edit Diagnostics popup: "...accurately and quickly lead to a successful repair."


comment:
Instructional text: Is there a space before "Click Next to continue?" Make sure.


comment:
There's a stutter in the audio for "What are your responsibilities" - "...which may l-lead me..."


comment:
Is there any way to allow the transcript to stay open when a new layer appears?


comment:
Instructional text, line 2, should be "help" instead of "helps"


comment:
Seeing Sharon's comment, let's remove "Mike will be your tour guide" from the inst text


comment:
Technical Trng popup: Remove the comma after "overview"


comment:
Technical Trng popup, hyphenate "on-the-job"


comment:
inst text, line 2: should be "help" instead of "helps"


comment:
Stop #2: Edit last sentence, "Starting with how we greet the customer, the way we stage the repair, create a quote, make the repair, and invoice the customer are all steps in the process to provide a consistent experience for our customer, whether in the shop or at the customer site."


comment:
Stop #3: Edit Bullet 1, "..in order for a technician"


comment:
Decision guide page 4 - feed back was not working. Please confirm that we offer the harnesses for the AC products


comment:
Stop #3 Edit bullet 2: "the faster we can help the technician pinpoint the issue, the faster our customer..."


comment:
Stop 3: Please make last sentence of last bullet a separate, non-bulleted line


comment:
First clip - can you fade audio all the way out so there isn't an abrupt cut?


comment:
Need to take a look at the text in the first two clips - they overlap each other re: "I can have someone there in 3 hours." I know this has been poked and chopped - let's make sure it flows logically.


comment:
Add first sentence to Mike's bubble: "The Service function is always striving to improve to deliver Legendary Service."


comment:
Replace attendant's question with, "How are you doing today?" Edit response: "Great! I am onboarding with the Cummins Service function, where I am learning how we deliver an excellent experience for our customers, just like you have done for me."


comment:
Can you do something - like put a film over the bkgd - when Correct Answer/Your answer appear, so that they're more legible? Not worth spending tons of time on, nice-to-have.


comment:
Back button did not work for me on these reflection screens


comment:
Edit sentence 3: We will be talking to the service manager.


comment:
I thought we were removing the WWID requirement? Some dealers don't have WWID's/


comment:
Last question, bullet 1: "In North America, customers for light-, medium-, and heavy-duty engines include Peterbilt, Bluebird, and SeaRay (for marine application)."


comment:
First bullet should be changed to 'Own mid t0 High-end homes"


comment:
Hold the phone. If Jose is answering all these questions, edit 3rd sentence to say: "We will speak to the service manager in a moment, but first, what questions can I answer about the Cummins Support Network?"


comment:
Could we have a more positive begining?

For example: "We have new Business Review formats that are more lean and objective! Let's get into it with this example!"


comment:
Should rephrase this during alpha; the OnePager is an input.


comment:
Really good, please take note of removing the Investment and Launch Dates from this view. When creating a new OnePager you only see the naming fields in the gray box.


comment:
We need to tee up the video. Can you give Jose a speech bubble that says, "Howard's story gives you an idea of how you can personalize your path in the Service function."


comment:
I'm fine with the pdf, but needs cummins logo somewhere.  (Small, in title header?)


comment:
Needs click next inst text after clicking both items.


comment:
The instructions text box should stand out more, blink/flash, or have some kind of highlight.


comment:
The yellow highlight on the field for LATAM and APAC Potential disruptor (last drag & drop item) should be stronger as of now is hard to notice.


comment:
"Sales" is an automatically calculated field by the OnePager, no need to have a drag and drop item for it, only for ASP and Units Sold.


comment:
All numbers on the P&L Summary are automatically calculated by the OnePager, no need to have drag and drop items for this view.


comment:
I would find a way to reword "The RS20A is a better quality product that will last longer".  That could be a matter of opinion, without any life expectancy data.


comment:
OP within 10Y + Years of Invest. is also automatically calculated by the OnePager, no need to have a drag and drop for it.


comment:
Switching Fuels is simple for all brands, it's not an advantage to Cummins, albeit ours doesn't require parts.  This is part of the Installation, customers have no idea about Fuel switching.


comment:
Lets have the following fields grayed out:
LPN Number
PPN Number
Porfolio Domain
Project Code

Project Phase by default at "Proposal" when creating a new OnePager


comment:
Do we have any data that shows our Power Quality is superior ?  I haven't seen anything yet.
Also,
Are we sure we can say our Generators are quieter than competition ?
Also,
I don't think we're the most fuel efficient with the new models.


comment:
These outcomes are correct but they are the outcomes of the Business Review. 

It's looking great!

Let's include more instructions for each of these outcomes during Alfa, specially on how to move the OnePager to the Next Phase.


comment:
Very nice, looking forward to complete and polish the training during alfa. Specially about updating the OnePager and moving it to Next Phases.


comment:
This one could work with a story about a Business Review presentation that had 150 slides and in the end everyone fell asleep.


comment:
Agreed about having further discussion on this part of the training.


comment:
I came back to this slide after completing it the first time and now it doesn't let me move forwward. Will try to re-boot the presentation.


comment:
Page looks empty, needs a suitable image on right hand side of page


comment:
I think the final text from the customer should be more like :- I want to keep the lights on and would like some power for the TV and such obviously, but most importantly, I want back up power for my appliances and computer


comment:
First time you have to click the dealer, he is not outlined in red


comment:
Definitely missing the right answer combination


comment:
For each of the three competitors do we have their key selling point that they focus on when selling? would be good to add this to each of the three competitors


comment:
Agree with GW, can we find something eels to focus on as an advantage for our sale


comment:
I am commenting on positioning statement 3 with the grey haired guy. This feels like a repeat of statement 2 regards the ability to switch fuels without changing parts. Maybe as he doesn't have technical people we should focus on the remote monitoring capability via the clear and easy to use display?


comment:
we don't seem to have covered the last point from the agenda ie the other markets / applications


comment:
Is it mandatory to go to the print certificate screen, I would think it should be optional as individuals will have their completion recorded in the LMS system and many today do not have a wall to display certificates etc on so do not print them. We should keep it as an optional item


comment:
Will this menu allow the learners to jump into Proposal/DG, DI/DO, or DO/LD sections of the training?


comment:
Would it be better to just have the training go in the Standard Business Review order? :

1.-Proposal / DG
2.-DI/DO
3.-DO/LD

Instead of letting them jump into DI/DO, go back to Proposal/DG and finally DO/LD, etc, disregarding their right order. (Prone to confussion)


comment:
We need to align with seller feedback on this section.  Gaps in the account plan are not necessarily driving the right resources to engage, but knowing what the goals are with the account, customer roles involved and key initiatives with the account will drive what support functions/resources to engage on the team.


comment:
Using customer roles and gaps in relationship / knowledge is a good example of what may drive resources to engage and have visit the customer.


comment:
Fill out the metrics tab.  Not a great example of what would drive resources to pull in unless there was an issue/ improvement need.


comment:
Edit opening exercise text to align with prior changes "...gaps in what the Cummins team knows about customer roles and some initiatives don't have the needed resources engaged.  Who else..."


comment:
change something similar to "a similar concept" and add a comma after concept, remove "that you might be more familiar with"


comment:
*DISREGARD PREVIOUS COMMENT* change sentence to: "It isn't always obvious while a player is kicking the ball around the field, but they may show signs of sponsorships from time to time..."


comment:
add comma after well, change is not to isn't


comment:
change last two sentences to one: "Again, safety could be at risk in this situation, and data integrity could be impacted."


comment:
change "you should keep in mind when" to "to keep in mind while"


comment:
medical director, first line: change will need to needs


comment:
medical director, third line: change need to needs; seventh line: change I also am to I am also


comment:
site manager, fourth line: change "in addition, i collect" to "i also collect"


comment:
regulatory: remove commas after Manager and reported; change I also am i I am also


comment:
went back to this page & it wont let me move on to the next page


comment:
third option: change period after information to a comma


comment:
I guess I don't understand why this game is called pap attack? What's attacking?


comment:
change "I just don't" to "I do not" under quote.


comment:
how much of a pain is it to do the page # progress markers in the game too?


comment:
can you mix up the question order so they aren't all good to bad? Nice to have edit


comment:
first time the score splash screen comes up, can there be a highlight on the hamburger menu that says "Want to see your score? Click here and select Score." Sort of like it's a tutorial in the game on how to navigate. (Nice to have edit)


comment:
consistency thing - make sure Pap Cytology all the way thru. (Last question on this screen missing caps)


comment:
make colposcopy a correct responses too.


comment:
see if you can get Erika to spell out what BX diagnosis means.


comment:
adjust directions - Click a tool to review it or select the box below to use it with the customer. Click the Next button when you've chosen the tools you wish to use."


comment:
Let's change sentence one to  "You could have used the ____, _____, _____, and _____ tools with Robert. Now..." (Fill in blanks with correct answers from previous screen.)


comment:
The 2 segments for Residential should be combined into 1, and the Agriculture is to specific there are other opportunities than poultry


comment:
Under agriculture- When did we start milking hogs???


comment:
Process step boxes: we haven't put a yellow arrow between any other boxes; recommend removing it from this screen


comment:
Resources popup: Alpha review feedback indicates that the CDOS landing page URL should be titled with the name of the process map(s) that apply to the course. Is there one map that applies to this course that we could change "CDOS site" to?


comment:
Font looks different from the other courses on the learning objectives text. I think the other ones are just bolded entirely with the specific words in uppercase. Double-check.


comment:
1st sentence: "...includes the activities that drive..." (change the to that)


comment:
3rd paragraph, 1st sentence: "its" should be "it's"


comment:
The first time the learning agent is seen after the LOs is on the Course Topics screen. Recommend moving his Role label there. Also, please center the label to his character, it's a little bit to the right here.


comment:
The submit button is hanging off the text box. Recommend moving the Study Manager over to the left, centering the text boxes to the screen, and moving the Submit button to the center of the bottom text box. That way the Study Team Member character's arm also isn't covering the box so much.


comment:
Slight modification to my original comment (I thought this might be a 'select all that apply' question): for single response questions, the question can auto-advance to the feedback, no need for a Submit button unless it's a select all that apply question. Global for the curriculum.


comment:
Yellow box, 1st sentence: "...the activities that drive..." (change the to that)


comment:
Menu screen title is from the Manage Trial Change course. Update to the current title.


comment:
Secondary instructional text, 1st sentence: "Clinical trial processes are composed of the activities that drive each process." This provides clarity and matches the verb and subject.


comment:
Double-check the placement of the instructional text on each screen. It seems to jump between slides.


comment:
Monica's polo - is it meeting branding requirement? "C" on a blue background?


comment:
Need a Cummins logo on the advisor's polo?


comment:
The description in grey box is not accurate. It should be Friday's topic.


comment:
The Technical Training and Service Capability sub-functions are not included.


comment:
Bullet 1: delete comma after management; Bullets 1 AND 2, the word "manage" should actually be "management"


comment:
Instructional and directional text: Recommend changing 'requirements' to 'compliance requirements' to make it super clear and differentiate them from the business expectations.


comment:
Global: it doesn't make sense to say "the set up, manage, and close out activities." Replace manage with management, or word differently.


comment:
If you click the instructional text, the directional text updates to 'Click Next to continue' even if the Significance of Requirement boxes haven't yet been revealed. Recommend locking the function so each significance must be revealed before advancing.


comment:
In last sentence, are all those topics in the same course, or should the last word, be "courses" ?


comment:
Directional text says "Click the Next...", remove "the"


comment:
Same as before, recommend "compliance requirements'


comment:
Correct feedback box: put the two items in a bulleted list, otherwise you have a very long run on sentence with lots of commas.


comment:
Directional text says "Click the Next..." remove "the"


comment:
First sentence - add apostrophe to co-worker's


comment:
Same as before, clicking outside the graphic changes the directional text to "Click Next to continue" even though the significance boxes haven't yet been revealed.


comment:
"Click the Next..." do global search to remove "the"


comment:
change "The intent is give you..." to "The intent is to provide you with..." and remove comma after processes


comment:
The two steps have a big white space gap between them. Doesn't seem to be a missing step there, just a gap. Tighten up the boxes so they are next to each, like in the other tables.


comment:
Clicking outside the table advances the directional text, double-check globally.


comment:
Sentence 2 is a mess. Rewrite: "The activities identify which tasks will be accomplished during each phase of the process and who is responsible for each one."


comment:
correct feedback: remove comma after trials


comment:
My apologies on the white space comment - this is fine. Just make sure the boxes line up (the bottom gray box doesn't line up at the top with its significance box)


comment:
Study Manager popup, 1st sentence: "I provide...", remove "am"


comment:
Instructional text says click Next to continue, but literally everything is clickable on the screen and no Next button is visible. Change instructional text to indicate that ppl should click each activity type to learn more, and change that instructional text to be "click next..." after both have been clicked. Make sure screen is reset to initial state.


comment:
Directional text: change "hear" to "see" or "read" - no audio, so doesn't align.


comment:
change "process starts" to "process begins"


comment:
CRP popup text, 1st sentence: Notification is capitalized, but should 'approved records' also be capitalized? Seems weird that only 1 word is capitalized mid-sentence.


comment:
first bubble: change bullet format to have parallel structure


comment:
second bubble, third bullet: change finalize to finalizes


comment:
Medical Direction popup, 2nd paragraph: Is it "I also ensure complete documentation of approval and rationale for terminating a trial early,..."? (add complete, or something similar), otherwise I'm not sure what the first part of the sentence means.


comment:
"review the significance of the..." (Change for to of)


comment:
Functional Contributor popup: spell out LOI as "Letters of Intent (LOIs)" since we haven't defined it previously


comment:
correct feedback box: need period at end of sentence


comment:
change significance for to significance of


comment:
header: remove "that" and add comma after meeting


comment:
The colors seem weird here. Recommend making the role boxes teal to differentiate them from the activities boxes.


comment:
add period at the end of second "significance of requirement" box


comment:
I'd make this a landing screen where the three scenario types are shown - then they go into the "Set up" scenario, after which they return to the landing page. Now the "Set up" scenario is grayed out, and they enter the next one - that would help to clarify the high level activities and orient them to where they are in the process.


comment:
Study Manager Notify of Approvals popup: missing the word "for", "responsible for the pre-work"


comment:
last bullet: remove comma after contract


comment:
Medical Director Financial Disclosure popup: missing the word "for", "responsible for determining"


comment:
CRP/CRS Notify of Approval popup: should "approved records" be capitalized?


comment:
CRP/CRS Close Out Trial popup: change CRST to CRS


comment:
Functional Contributors IMPACT Data popup: missing an "e" on "the"


comment:
1st key point: "includes the activities that drive...", change the to that


comment:
To follow up on Dennis's comment, make the gray boxes the same height as the beige ones, and center the text.


comment:
site manager: add and before documenting


comment:
I like this recap screen, but the blue boxes appear in random locations. Create a single box location on the right side where the 3 popups are layered on top of each other.


comment:
study manager/consulting agreements: add for after responsible


comment:
Add role titles to their corresponding popups


comment:
Functional contributors/Consulting agreements: add comma after finalizes


comment:
Study manager: Delete ", and" in second to last bullet


comment:
Maybe just me, but the instructional text looks like the spacing is off. Please check.


comment:
Communications popup - has the Templates icon instead of the Communications one


comment:
study manager/financial disclosure: change spend to spending


comment:
Financial Disclosure popup: "Financial disclosure form" is listed as an input and an output. Accurate?


comment:
study manager/close out trial: remove comma after close


comment:
Financial Disclosure is a legal term, and is requested to be uppercase for both words. Please do a find/replace all for this.


comment:
Nice job on these screens, john. Lots of content here, organized nicely.


comment:
Directional text: Bold "click" and "option" only.


comment:
Question text: "The timeline process includes...", pluralize "include"


comment:
When you click "distribution", it shows as the correct answer, but the wrong "distribution" is now orange.


comment:
Make sure this screen is reset to initial state


comment:
What does IB stand for? I don't recall seeing it earlier in the course. Feel free to correct me if I'm wrong!


comment:
Space #3, costs and expenses are the same thing. Change expenses to something like "revenue."


comment:
remove extra spaces between "processes" and "occur" & "set up" and "and"


comment:
trial change outputs: change to "Change record approved"


comment:
Notify is spelled incorrectly in the Menu


comment:
Once all correct answers are inserted, the instructional text reverts back to the timeline and budget text.


comment:
"Notify Required Personnel of Approved Records" is the title of the step in the process map. I believe it should be capitalized in the instructional text and the paragraph being built; the screen title should mirror this as well.


comment:
SAE form is singular as an answer, but plural once it goes into the paragraph. Make it plural in the answer options.


comment:
Communications is plural in the answer option, but singular in the paragraph once selected. Believe it should be plural for both.


comment:
complete and distribute templates: add commas after completion, templates, and forms


comment:
manage trial communications: add commas after creation and distribution; add period at end of sentence


comment:
manage trial budget: add comma after finalization


comment:
notify required personal...: remove extra period at end of sentence


comment:
develop and manage: add comma after Consultants/Institutions


comment:
set up trial meetings: change to process "of"


comment:
timeline box: 2nd sentence, capitalize "it" at the beginning of the sentence


comment:
remove "be" between "to" and "communicate"


comment:
communications: missing a comma after creation


comment:
second bullet: add "to" after "contributes"


comment:
Nice to have: Change "Purpose" header to "Purpose - what does it cover?" That way you can delete "This covers from every single box below.


comment:
Notify required personnel: Extra period at the end of Purpose column text.


comment:
Instructional text after clicking IMP LYXXXX arrow: "...include things like the...", add the word like


comment:
Per other alpha review calls, add the following text below "To learn more...": "Process maps, quality documents (procedures, required tools), and supporting materials are available to support the performance of your work."


comment:
Change "CDOS site" to the name of the process map where most of this is pulled from; I assume "Set up, Manage, and Close Out Activities"


comment:
I'm a little iffy on why we start with the inputs and outputs before we cover the purpose of the process. Assuming we want to keep this sequencing, I recommend moving the tables (or better yet, re-use the input/output icon popup screen) to come before the fill-ins, then use THAT as the review, instead of the first exposure to the info.


comment:
The characteristics in the intro text are the most important part of the next few screens. Find a way to re-write so you can bullet that they operate in parallel, occur to manage activities for all trials, and happen prior to trial-level activities


comment:
develop and manage trial timeline, second paragraph, last sentence: add comma after budget


comment:
If compound activities happen before trial activities, that box should appear on the left


comment:
complete and distribute...: remove comma after "approval"


comment:
notify personnel...: remove extra space between "trial-level" and "records"; remove extra space between "regulations" and the period; remove "that" after "ensure"


comment:
In bullet one, the important word is "requirements"


comment:
set up trial meetings: remove "being" before shared


comment:
manage financial disclosure: change "is a way of determining" to "can determine"


comment:
manage trial change: add comma after "implementing"


comment:
third bullet: add comma after "function"


comment:
incorrect feedback: add comma after "functions"


comment:
incorrect feedback: remove "does", change "when" to "while", add period at end of sentence


comment:
change comma after "assumptions" to "and"; add comma after "functions"


comment:
incorrect feedback: remove "to" after "help"


comment:
what to do/set up: add comma after communication


comment:
what to do/close out: add period after Activities


comment:
second paragraph: remove comma after activity


comment:
when i complete all clicks, go to next screen, then come back, Next button is not enabled


comment:
intro text - close out should be 2 words


comment:
change occur to occuring; change semi colon to a period and capitalize some


comment:
suggest moving the select alls up a little so it isn't so close to the bottom of the content area. also they don't look evenly spaced right now


comment:
submit button is in Arial instead of DIN


comment:
The text in this table is pretty small. Could we have the speech bubble first, then click to see table and speech bubble goes away so you can have the table text be larger?


comment:
table heading - shouldn't close out be 2 words here?


comment:
close out - also in each row of close out column


comment:
middle cell - is there a reason why this is title case? just seems like a sentence like it should be "When major changes occur"


comment:
correct feedback: remove "that" after "Study Manager"


comment:
Setup/When to Do it cell: Dash between timeline and first is smaller than others.


comment:
third option: remove "that" after "Study Manager"


comment:
screen title and title in menu don't match


comment:
Course title as it appears in my browser tab also has close out as 1 word instead of 2


comment:
change "spending more than you have" to "over-spending"


comment:
budgets developed and finalized, study team, second bullet: add comma after "Finalize"


comment:
directional text - get rid of the before Timeline


comment:
align with business unit: change spend to spending


comment:
"develop/finalize CRO costs" - remove space between the slash and finalize


comment:
"Develop, finalize global investigator budget" - change comma to and


comment:
fourth bullet: add comma after "Finalize" and period at the end


comment:
remove "the" before trial in directional text


comment:
the outer gold outline of the box overlaps with the outer teal storyline shell at the bottom


comment:
suggest making all the study team silhouette people a lighter gray


comment:
change "Review of" to "Reviewing"; change "Approval of" to "Approving" (or change finalizing to finalization)


comment:
de-pluralize "Intents" (I may be wrong here...)


comment:
site manager bubble: remove extra space between "is" and "up"


comment:
medical doctor bubble: remove comma after decision


comment:
Notification Prepared tombstone - move down so there's no white hairline between it and outer teal shell


comment:
first bubble: add comma after "service"; last bubble: change "when" to "while"


comment:
replace "and" after "advice" with a comma


comment:
add comma after "property" in third bullet


comment:
CBSO Rep: pluralize "Complete"; add "and" at end of third bullet


comment:
I don't believe footnotes for * in other spots have been italicized?


comment:
All but the last guy are down too far where they are overlapping the bottom teal area


comment:
Text label for first girl looks blurry compared to the others


comment:
Both of these people need to move up a little so they aren't overlapping the bottom teal area


comment:
prework, is the valid..." - add "and" before "the Requestor"


comment:
finalize and execute consulting agreement: remove "that" after is


comment:
confirm/applies when: add comma after submitted


comment:
target icon text: add comma after first "US"; change comma after "Site" to a period, capitalize "if", add comma after second "US"


comment:
Resource button: Pluralize "Resource" since there are multiple there.


comment:
*Disregard previous comment* I meant to say add "and" after "tax forms,"


comment:
move comma after "that" to after "trial"


comment:
change "Participating" to "Participation" ; change third bullet to read: "Attendance of telephone or web conferences"


comment:
"Investigative product" should be "Investigative Medicinal Product (IMP)"


comment:
Add period at the end of the directional text.


comment:
target text: add comma after "two years"


comment:
received/impact: remove "that" after "ensure" ; add comma after "provided"


comment:
combine the first two sentences/change the period to a comma


comment:
Nice to have: visited state for each item clicked


comment:
"Specific activities occur during each phase" (change occurring to occur)


comment:
I second Manuel: consider having IPM explain how using the SPM tools (OnePager & Business Review Templates) helped him achieve the desired outcome from his business review (approval)!  Now he wants to share his experience.


comment:
Can we swap this facial expression with the one on the next slide? He should smile here and be more exaggerated when describing a viral outbreak.


comment:
It was not clear to me that I needed to click the 'New Project" in the image, can we highlight or show an arrow?


comment:
Can we ensure that users click all fields before they are able to move to the next slide


comment:
Disregard prior comment, it's built that way already.


comment:
We shouldn't use MSA in any of the training, this is an acronym for Medical Scientific Affairs at Roche and do not support the business processes we are training on. 
We also need to rephrase for alpha as most groups are contributors to required fields in SPMT but Finance is main function who supports business case development.


comment:
If I am familiar, I will know where to drag and be good but if I have no clue I might be here all day dragging. Can we have a message for incorrect, or number of incorrect attempts?


comment:
Also suggest making Potential Disruptor (LATAM) smaller or placed to the left as it covers the regions.


comment:
I would like to see the business case build as we move through the slides and remind users, based on information submitted - what is the OP? Have them click to display OPs, then drag those values.


comment:
Consider converting paragraphs to the left into bullets or condensed, it's alot to read.


comment:
For alpha need to either elaborate more on the impact of excluding value creation or place or have a note after dragging values that excluding this info results in reports not showing in Tableau.


comment:
Should we say ... from clinical plan set up through trial close out ?


comment:
1st bullet: add "after the LY # has been assigned"?


comment:
start of 1 sentence: should we say "IMPACT data should be managed..."


comment:
rd bullet: The Trial PDO closes out the trial in IMPACT after it has been confirmed that all sites and countries are closed or cancelled.


comment:
the blue text after "Click Next", can we say "the collaboration site" instead of just site. Site means often something else for the audience and the term may create confusion here.


comment:
Change header in organge frame to Collaboration Site Reviewed and Closed Out


comment:
1st paragraph: propose to remove the words
"by ensuring it runs efficiently"


comment:
Can we not add the name to the right of each location after it has been selected?


comment:
Should we point out explicitly that each of these that we mention at each location/market are examples since we are mentioning other examples in each market?


comment:
Should be "apartment complexes in this category" not apartment complexes this category


comment:
Should be "a higher end brand" not higher end brands in tab that is What special requirements do you have?


comment:
Was Generator appearance mentioned in the customer requirements/questions part?


comment:
Describe the Manage Financial Disclosure PROCESS (this is the name in BWL....not sure if it needs to match here?)


comment:
Again not sure if it needs to match: Describe the ROLES involved in the Manage Financial Disclosure process.  If yes, I would check throughout training course and update accordingly.


comment:
I would rename the first button to Financial Disclosure Defined as well as the Click the Financial Disclosure Defined button to get started based on recent changes to terminology used in process map and quality docs.


comment:
Change Investigators or other site staff to site personnel


comment:
I think it would be helpful to provide more background on the FDA regulation..

FDA Code of Regulations (21 CRF Part 54) requires applicants submitting an original or supplemental US NDA/BLA to submit certain information concerning the compensation to, and financial interests and arrangements of, any clinical investigator conducting clinical studies covered by the regulation.

Under the applicable regulations,3 an applicant is required to submit to FDA a list of all clinical investigators who conducted covered clinical studies and to identify those who are full-time or part-time employees of the sponsor of each covered study (21 CFR § 54.4). For each clinical investigator who was not a full-time or part-time employee of a sponsor of the clinical study, the applicant must provide either a certification, using FORM FDA 3454, that none of the financial interests or arrangements described in 21 CFR § 54.4(a)(3) (see Section III.B. below) exists, or completely and accurately disclose, using FORM FDA 3455, the nature of those interests and arrangements to the agency and describe any steps taken to minimize the potential for bias resulting from those interests and arrangements (21 CFR § 54.4(a)). If the applicant acts with due diligence to obtain the required information but is unable to do so, the applicant may certify that it acted with due diligence but was unable to obtain the information and include the reason the information could not be obtained (21 CFR § 54.4).

Link to guidelines for more information: https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm341008.pdf


comment:
Financial disclosure information must be collected from all site personnel that requires financial disclosure for all trials except Phase 1 trials that have not been identified to potentially have subsequent pivotal/registration trials, including non-bioavailability or non-bioequivalence clinical pharmacology trials.


comment:
The last sentence where you describe BA/BE trials: These studies may directly affect marketing applications...if they affect marketing applications, then why aren't they included?  

Also - trial vs. study

Also - I think we should be consistent throughout course with how the term marketing applications.  In the procedure and process maps, we use: original and/or supplemental US NDA/BLA.  I think we should use this in the course too for consistency.  Also we need more context in definition around US NDA/BLA because this is the first time we say anything about marketing application....


comment:
It isn't really an exception that is granted for Phase 1 trials since procedure says they aren't required to collect FD.  We changed this wording in procedure and process maps.  Suggested rewording: Financial disclosure is not required because this is a Phase 1 trial and later phase trials will be run separately.


comment:
Financial disclosure is required for all trials except Phase 1 trials that have not been identified to potentially have subsequent pivotal/registration trials, including non-bioavailability or non-bioequivalence clinical pharmacology trials.  Therefore, financial disclosure is required for this trial.

I don't think the second sentence really fits here, so I would delete: Actions must be taken to minimize the bias for Investigators that have financial ties to Lilly.


comment:
Needs to be changed to site personnel vs. investigators throughout course


comment:
It appears that there is a white flashing on the bottles that appears with the flashing buttons. Can this be fixed?


comment:
Many questions have feedback for the incorrect answers and others do not. Should the incorrect feedback include information other than "Incorrect, try again"?


comment:
There is white flashing on the bottles in addition to the flashing lights.


comment:
Had to click on the Next button instead of the Complete Learning Checkpoint button to get to the certificate screen.


comment:
Getting an "error 404" screen instead of the certificate page.


comment:
Many questions have feedback for the incorrect answers in addition to "Try again". Should the incorrect feedback always include other information for the learner?


comment:
The title of this slide says an introduction but it isn't really just being introduced because there was a question earlier about it.  Might consider revising the title slide.


comment:
I would remove: This trial does not meet any exception requirements.


comment:
Suggested revision: Does Financial Disclosure information need to be collected?


comment:
Suggested rewording for Incorrect response :Not quite.  If the Investigator participated in another trial where financial disclosure information was collected, you must collect financial disclosure information for each trial regardless.


comment:
I would suggest revising for the other responses: correct and maybe.more information is needed


comment:
I think you can remove: Gold steps are for all trials....technically it isn't for all trials because there are a few trial types that we don't collect for.  The gold steps are really the milestones for the process when FD is required


comment:
Financial disclosure information is collected for trials except....add the language around Phase 1....


comment:
step 2: Consult Regulatory and the Medical Director to determine if a partner is involved in the development of the drug.  In addition, determine what site personnel roles will need to provide financial disclosure information.  At a minimum, financial disclosure information needs to be collected from the primary investigator and sub-investigators and may include other roles such as the pharmacist, raters, nurses or others involved in the treatment or evaluation of study participants.


comment:
The circles don't look teal to me until you click on circles.  Maybe we should say steps 3-10 are only sponsor/co-sponsor...


comment:
For step 6, suggested re-wording: If the trial will be included in the US NDA/BLA submission, continue with steps 7-15. Otherwise, the process is complete.


comment:
After submission planned has occurred, request the Payments of Other Sorts report and reconcile the information in the report against the summary of financial disclosure information.


comment:
Step 8 - Resolve any discrepancies between the summary of financial disclosure information (vs. financial disclosure forms) and the Payments of Other Sorts report.


comment:
For step 11 - do you want to mention anything about the quality doc here that can be used to summarize the information:

Supplemental Site Personnel Listing for Forms 3454 and 3455


comment:
For step 12, do you want to reference the 

Supplemental Site Personnel Listing for Forms 3454 and 3455


comment:
I would be consistent with steps 12 and 13 with how we refer to the FDA forms....for example Complete Certification of Financial Interests Form (FDA Form 3454).


comment:
Step 14 is also only if Lilly is sponsor/co-sponsor.


comment:
Disregard comment about step 14 and only if Lilly is sponsor/co-sponsor.  It applies to step 15 vs. step 14.

Both 3454 and 3455 and supplemental form is provided for submission, not only certification of financial interests...


comment:
need to be consistent on how we are referring to FDA forms throughout steps and course


comment:
Manage Financial Disclosure process - would ensure consistency throughout


comment:
Key point 1 - should be Financial Disclosure information needs to be collected by sponsors of the trial vs. for?


comment:
Key point 2 - it should be CRP/CRS/CP not only CRP

Also should we say documented as well and mention the resource document that is available to document:  
Financial Disclosure Trial Sponsorship and Site Personnel Roles


comment:
For key point 3, I would suggest adding some more to this like appropriate assessments must be done to ensure bias is avoided as much as possible?


comment:
For Medical Director - I am consulted by the Study Manager to verify that Financial Disclosure is required for the trial.

I would remove the next sentence that references the Covered Study Determination Letter...this isn't in the process maps or quality docs.

Last sentence would move up after the first sentence and have slight revision: I am also consulted by the Study Manager to determine if roles other than the primary investigator and sub-investigator require the collection of financial disclosure information.


comment:
Site Manager - 

I also collect updated financial disclosure forms as needed if a discrepancy between the summary of financial disclosure information and the Payments of Other Sorts report is identified.


comment:
Regulatory - 
I am consulted by the Study Manager to determine if roles other than the primary investigator and sub-investigator require the collection of financial disclosure information due to trial-specific needs.  I am also consulted by the Study Manager when financially disclosable information is reported and guidance and direction is needed on the potential for bias any on any actions that need to be taken to minimize the bias.


comment:
Statistical Representative - 
I estimate the impact of any bias that may exist and make suggestions on how to mitigate the bias on enrollment.


comment:
GCBC - 
I provide the Payments of Other Sorts report to the Study Manager which will be reconciled against the summary of financial disclosure information provided by the Site Manager.


comment:
The Clinical Trial INvestigator Financial Disclosure Defined section seems to be more than just defining..it goes through entire process and roles/responsibilities so maybe this should be renamed?  Financial Disclosure Definition and Process.


comment:
You may want to include some language here around completing activities if Lilly is sponsor/co-sponsor.

Also some suggested wording tweaks: 

Determine and document appropriate actions if there is a "yes" on a Financial Disclosure Form.

Request the Payments of Other Sorts report and reconcile the report against the summarized financial disclosure information and request updated financial disclosure information to be obtained if discrepancies are identified.

Notify site personnel that their financial disclosure information is being included in the submission to the FDA.


comment:
I am confused on this one...it says above that Study Managers must consult with other roles and then below it says to learn about which require consultation from the Study Manager..


comment:
I think in the first key step, you are trying to articulate that: 

A "yes" was indicated on the financial disclosure form.

Consult the Study Manager

Need to understand the appropriate steps to take to minimize the potential bias and this should be documented.


comment:
Payments of Other Sorts report and Summarized Financial Disclosure information show a discrepancy.


comment:
Steps should be taken by the Site Manager to obtain updated financial disclosure information from the site personnel, so it can be determined if thresholds were met.


comment:
Site personnel vs. Investigators meet the threshold


comment:
If there are sponsors other than Lilly for the trial vs. There is a Sponsor for a trial.


comment:
The downstream impacts aren't really downstream impacts - they are providing more information....so either you need to provide why is it important and what happens if we get it wrong or change the header to more information or something like that


comment:
Identify the site personnel roles that require financial disclosure vs. There may be other key roles involved with study participants.


comment:
I think you want to say something about documenting all site personnel roles that require FD....at a minimum, need primary investigator and sub-investigators; however, there may be other role which require it that are trial-specific....


comment:
Title of Slide: Payments of Other Sorts Report for Reconciliation

Throughout the process, the Payments of Other Sorts report is provided for reconciliation against the summary of financial disclosure information to ensure that the financial disclosure information collected is accurate and complete.


comment:
GCBC - 
I provide the Payments of Other Sorts report to the Study Manager.


comment:
Study Manager - 
I request the Payments of Other Sorts report from the GCBC Representative if financial disclosure is required for the trial.  I reconcile the Payments of Other Sorts report against the summary of financial disclosure information provided by the Site Manager.  This helps to ensure that the financial disclosure information is accurate and complete.  If any discrepancies are identified, I will ask the Site Manager to obtain updated financial disclosure information from the site personnel.  I consult the Statistical Representative if any site personnel meet the thresholds to prompt a bias review.


comment:
Slide title: Payments of Other Sorts Report: GCBC Representative 

A trial ended a few days ago.  When is the best time to request the Payments of Other Sorts Report?

Where you say reports for reconciliation, I would change to Payments of Other Sorts reports throughout.


comment:
What do you mean reports?  Is this report for each trial?


comment:
Key point 2 - I think use same terminology as previously used.


comment:
From determining requirements for Financial Disclosure for the trial all the way to providing the financial disclosure for the submission, Study Managers must be sure to follow the process closely.  This helps to ensure that bias is minimized to protect the safety of study participants and data integrity as well as the financial disclosure information provided in the submission is accurate and complete to avoid rejected submissions to the FDA....or something like this.....


comment:
Site Managers obtain and compile financial disclosure information as well as obtain updated financial disclosure information from site personnel as needed when discrepancies are identified during the reconciliation of the Payments of Other Sorts report and the summary of financial disclosure information.


comment:
I would be consistent if we are going to use the actual number or spell out the number: 2 or two for example.


comment:
There was a site that indicated "yes" on one of the financial disclosure forms.


comment:
Response doesn't match the question.  It should be that if site personnel answer yes to any of the questions in the financial disclosure form, the Study Manager needs to be notified to determine the appropriate next steps to minimize bias.  I would update the answer to both responses.


comment:
I am also working on a trial in Europe.  Even though the trial is not in the US, I need to collect financial disclosure information from site personnel.


comment:
I would delete the second sentence and make consistent with the other answer.


comment:
The sentence to frame the key points doenst make sense because the key points are broader than just about yes on the financial disclosure forms.  Maybe tweak to: There are some important points that Site Managers need to consider in the Manage Financial Disclosure process.


comment:
I would adjust this question....is this whether the site manager has any other responsibilities, if yes, they really don't.  If you are asking whether any more activiites are needed with regards to interacting with our sites, the answer should be no and that's true because we would notify sites if their information meets the threshold and is reported to the FDA


comment:
One of the financial disclosure forms received had a "yes" included on it.  Because we need to get sites activated very quickly, I do not need to provide information to the Study Manager.

I would check all questions and ensure consistency with verb tense and whether we say "I" or "SIte Manager"...etc.


comment:
The response does not match the question.  It should be: Regardless of how quickly sites need to be activated, the Study Manager needs to be notified if any financial disclosure forms have a "yes".  Also change both responses.


comment:
Without teamwork, we would not be able to  minimize the bias on the trial to ensure we protect study participant safety and data integrity.  This is why the Manage Financial Disclosure process is so important to study participants, sites and Lilly.


comment:
You've learned a lot about the Manage Financial Disclosure process in this course, but do you recall the key points?


comment:
this is the first time in the course that we mention financial ties to Lilly change..I think it should be mentioned earlier in the course.


comment:
It is important to follow the process and procedures in the Manage Financial Disclosure process but why?


comment:
Obtaining accurate and complete financial disclosure information ensures that the appropriate evaluations occur to minimize site personnel bias.  This will help ensure the safety of study participants and protect the data integrity and avoid rejection of Lilly's NDA/BLA...or something like this....


comment:
I think there are key decisions mentioned in the course other than for study manager..I would revise to say Identify Key Decisions made during the Manage Financial Disclosure process.


comment:
Let's change the use of blue to the "teal" color in the new pallet.


comment:
Instead of the host of the next ultimate assay... it should be the host of the second season of the ultimate assay gourmet.


comment:
switch the order and note the assay first and then the systems.


comment:
Please send list of systems questions from launch training.


comment:
Doesn't make sense to include a differences chart. They are totally different tests and shouldn't be compared.


comment:
See Kate's content for TV/MG & CT/NG with TV/MG combined.


comment:
Feedback from the last training noted that this section was very confusing. Can we find a different way to present/test on this information?


comment:
The old template is appearing on top of the new template.


comment:
Add "Finacial Disclosure allows the FDA to evaluate potential sources of bias in covered clinical studies that may be related to an investigators
compensation, proprietary interest, significant equity interest, and/or significant payments of other sorts."?


comment:
Correct feedback: say ... you must have Finacial Disclosure for each trial...


comment:
Step 5: do we want to mention that the Financial Disclosure Tracking Log should be used?


comment:
SMEs: do we say Last Study Participant Visit or Last Patient Visit (LPV)? (Under GCBC rep)


comment:
Say LPV instead of Last Study Participant Visit?


comment:
In the scenario, should we say "when was the best time to..."? Given that the trial has ended and the best time is 90days prior to LPV, you are too late already


comment:
Does this knowledge check add value? If not, propose to remove


comment:
Same comment as previous: does this knowledge check add value?


comment:
Key point 2 has been mentioned several times in the course and is not specific to the study manager? Remove?


comment:
The previous content in this specific module (study manager role) doesn't really highlight these key points


comment:
Change: "SmartStyle Mobile App and SmartStyle.com Check-in Training" to "SmartStyle Mobile App and Online Check-in Training"


comment:
The background and banner colors are reversed. In the original, the background was gray and the SMARTSTYLE banner blue. The new colors should be grey->new grey (if different), and blue->primary teal color, both in style guide doc on Basecamp.


comment:
In the original course, the image on the phone was SS 03 (page 3 of the edits list document); this image here looks like SS 04.


comment:
Ignore my previous comment...I think your image is correct based on the description on-screen. Can you show me where we were told to replace the image though? I'm just confused...


comment:
The "Your Time" button isn't centered in the red highlight box. Please lower the red highlight box so that the button is centered.


comment:
Same here, please move the red highlight box so the button is centered.


comment:
Double-check all red highlight boxes are adjusted so the button they highlight are centered.


comment:
Is the "Void" box supposed to be onscreen here, before they click the "X" hotspot? The image replacement requested is Ticket 6_Wait_Serv Screen, and it doesn't have a Void box on it. It seems like you should only see the Void box after selecting the X.


comment:
The Void box that shows up after you click the X hotspot should be replaced with the image titled "Ticket 6_Void Ticket_No Show". I think the 2nd Void box should be removed entirely, and the 1st Void box should only appear onscreen AFTER the X is clicked.


comment:
The colors for the "How You Manage It" button don't match (primary teal, and the hover state) the rest on the landing page. Please update.


comment:
These images need to be updated with the Photoshopped ones.


comment:
When I clicked 'Target', 'Star' and 'Auctioneer', it gave a box that stated 'Are you sure that's how we should label this account'.  I am not sure if that should be in there?


comment:
Disregard my previous comment!  I figured it out.


comment:
Course completion certificate dont have the training course name for which the candidate will be certified post successful completion. Currently it is mentioned as null


comment:
The Exit button still dont operate on my laptop. I cant exit the course using Exit button


comment:
Change highlight for selected answer to be more obvious.

If they get it wrong, don't make them do another click to clear it by selecting "Try Again"


comment:
For the second scenario, if you select a partial correct answer, it still makes you think it is completely incorrect.  Please add different response if they pick part of the answer correctly to state that is correct and also consider ....


comment:
I think we are asking too much (like in seller e-learning) expecting them to interpret account plan initiatives / needs well enough to rule out or in resources to engage.  The key is we want them to think about the different resources to engage and help their account manager understand why that resource could be valuable to engage.


comment:
Both answers are correct for engaging legal and finance versus just one as currently written.  We should allow two to be selected and if only pick one notify them that both are correct.


comment:
For Sales App Engineer, make incorrect answer more wrong.  Use other resource answer like help sorting out logistics.


comment:
Overall it seems like it would be more helpful to have 3 correct resources and one wrong resource for learning.


comment:
Change text to "...which pages have content they could share?


comment:
Change text to "...to share appropriate information from the Strategic Alignment, Initiatives and Metrics pages."


comment:
Make sure in these pages we are referencing it as sharing some information from these account plan pages, not sharing all the content in that section as documented.

Ex.  "Sharing appropriate information from the Strategic Alignment section lets the..."


comment:
Remove submit button after response entered to avoid confusion on selecting that again or Next to proceed.


comment:
The third response on sharing initiatives can be correct too so need to allow more than one or make more incorrect.


comment:
In this section remove the repeated text and then allow them to select the differentiated part of the response since it will reduce the text they have to read.

Ex.  Sharing the status of key metrics that the customer measures us by or would have interest in ...
 - answer 1


comment:
In the metrics section answer 1 and 3 are correct so need to allow multiple, combine or make one wrong.  

The text to the right/wrong answer is talking more to an overall account plan than key metrics which measure our performance against areas important to the customer so start needs revised to focus on metrics.


comment:
Curious if there was reason for excluding menu from the OnePager training?


comment:
Maybe not "trickiest" - could we use a different term but currently no thoughts on what to put??


comment:
Looks great, for alpha I would think of emphasizing in the text that the pairings relate to content comment elements that are in encountered in the two or three phases.


comment:
This seems out of place, it breaks up the focus of the two phases and the market attractiveness slides that are in both phases. Can we think of putting it either in the very beginning (what tools are available and where to find them) or at the end.


comment:
1. My prior comment refers to the excersise on where the templates are located
2. The thinkcell image should also show the headers (Competitor 1, Addressed Market, etc.) - without it I am just entering numbers blindly


comment:
Unclear that I am to enter the information in a specific order. 
Also not initially clear that I am to follow the instructions to enter specific data in a cell
Last - once I entered the screen froze


comment:
The major challenge with the waterfall slides is the understanding how an IPM would use avail data to segment and how the waterfall is built - by blindly asking them to enter numbers and not spending time on the output, we have lost a huge opportunity to connect them to: how to use the data they have, how to enter that data into waterfall slide, and what story the output is telling us.


comment:
This is a good slide, maybe in the prior slide the training could spend a few moments to review the output and why it looks incorrect


comment:
Is there any reason why "health care" and "providers" start with upper case and "patients" and "regulators" not?


comment:
Instead of saying it on a negative way, I would say.  "Lilly uses medical research consultants when we need topic expert feedback or need information on the external environment."


comment:
Minor detail here - but I don't think the shirt is in compliance with brand standards for the color. Should be white on red.


comment:
On the Medical Research Consulting Examples, last bullet point, should we write Medical Research Advisory Boards Related to a Clinical Trial, or, Medical Research Advisory Boards related to a clinical trial?


comment:
The responsibilities of this Service Advisor example...do they overlap with those in Cummins Care group? Specifically the call center?


comment:
In the Valid Confidentiality Agreement question.  Answer should be:
If the answer if yes, confidential information will be shared prior to the execution of the consulting agreement.  If the answer is no, the Requestor collects a signed Letter of Confidentiality (LOC) prior to sharing confidential information.


comment:
Would it be worth including a distributor region map of NAD in the course resources?


comment:
Should we emphasize here and are there other places too about the need for the manager to ask for / reference the account plan to reinforce value and use?


comment:
We need to discuss the structure of the training. It will be more valuable to train on the OnePager while we are going through the actual Purple Fever Business Case.


comment:
The source for the risks are the LCT members, for example:
-Commercial: IBL
-R&D: Technical/Development Lead 
-Manufacturing
-Legal: Regulatory Affairs and Legal Representatives


comment:
Take away this slide and re-structure.
To be discussed the next meeting.


comment:
Change to one click to show how does everyone contribute at a high level.


comment:
Should we change this since we have a change mgmt. module separate from this one and include something that does not have a separate module for training? For example, I received an invoice from a vendor or a request for an additional supplies from a site. How do I manage this request?


comment:
If we stay with this scenario, we need to change the order or provide different examples because documenting and communicating the decision should have already  occurred before the implementation plan was started.


comment:
Based on the feedback from the prior screen, may need to change this.


comment:
For first row, under manage, can this be changed to: Update, document and communicate any changes, revisions or needs appropriately (or something like this)


comment:
For second row, under manage, can this be changed to "when change or updates occur"


comment:
For second row, last column-lets discuss rewording this


comment:
Are all these columns applicable to study close out? May want to think about changing this title or illustrating this objective differently.


comment:
For feedback under Timeline communicated and managed, 3rd bullet can this be changed to stated the study manger and study team members (remove specificity to Lead SAM)....


comment:
For feedback on SAE form can this be changed to The SAE form provides sites with a way to document serious adverse events that occur during the study"


comment:
prescreening logs, supply re-order forms are other forms that may need to be created in addition to the other three, so this should be clarified somewhere and including them as a distractor may be confusing


comment:
Again #1 distractor is a form that study manager creates for the study, so not sure this is best distractor to use


comment:
for the second paragraph, shouldn't this be all RTO documents and not jut CSR?


comment:
Can we change title of someone else does this to CPM or study manager with compound level responsibilities?


comment:
CRP/CRS is also included in the training materials for investigator meetings so we need to revise this statement


comment:
should medical doctor be medical director here?


comment:
medical doctor should be medical director


comment:
Document early trial termination should go under study manager


comment:
Determine if early termination is warranted should go under someone else does this


comment:
change doctor to director and maybe consider changing the correct answer to "The decision to terminate the trial early based on the rationale must be reviewed and approved." The study manager will in almost all cases be the one to document the decision and approval


comment:
Typical Pap & Cytology testing is jargon.  Replace it with Pap cytology testing.


comment:
The symbols of the women and colors make no sense without a legend.  What is the difference between the blue ones, the green ones and the two orange ones in the first screen?  In the second screen their orientation is different...does that happen for a reason?  Does it mean something?


comment:
replace the word undetermined on this slide with the word "inconclusive."  More testing "is" required...not may  be required.


comment:
special magnifying device called a colposcope.

The visual on the right with the color coded images don't tell the story.  What is the color legend?  What does it mean?


comment:
you can't tell this story without a color legend for the women you are picturing.  It doesn't make sense without the legend being included.


comment:
It is not about a path to cervical cancer diagnosis.  The path is for cervical cancer prevention.  Please change this.


comment:
The women look too American for a global module.


comment:
for cervical cancer prevention.

It is the Roche Cervical Cancer Portfolio.  It is not Cervical Cancer Solutions.


comment:
why Pap cytology screening is a flawed gold standard and needs to change.


comment:
The map and procedure are now Set Up, Manage and Close Out.  Please update throughout all modules.


comment:
The study managers facilitate and document the consultations on the key decision points in the process. I recommend modifying last gold bar to "...key decisions managed by Study Managers...".


comment:
We replaced 'investigator' with 'site personnel' throughout the FD map and FD quality system documents (this does not apply throughout set up, manage...).  Recommend changing this throughout the FD module as well.


comment:
We also removed 'clinical'.  I can go either way on this one.  I'm just pointing it out!


comment:
Discuss the use of "(BA/BE)" after "non-bioavailability/non-bioequivalence" with Teri.  She asked that we not use it in the procedure because they are referred to in the 'non' format when spelled out and the not in the 'non' format in the abbreviation. It can be used, however, when 'non' is not in the abbreviation.


comment:
Now that I've read the description of the first bar, I'm not sure 'non' should be in the gold bar.


comment:
Third bar-last paragraph of answer applies to the first bar as well.


comment:
Clarify that step 10 is an enrollment bias assessment.


comment:
Recommend including a sentence in the intro paragraph that steps 11-15 are apply when Lilly is the applicant.


comment:
For step 15, please add that a summary of steps taken during the trial and results of the enrollment bias assessment are included in the notification to the site personnel.


comment:
Key point 2 response should say medical director in stead of CRP/CRS/CP to align with the map and procedure.


comment:
In the planner for Monday we say 'CMI' should we use Cummins here instead given the audience?


comment:
Response to key point 3 - recommend changing to "Bias is mitigated before a trial begins and an enrollment impact assessment is completed at the end of a trial.


comment:
Recommend adding the following to the end of circle 4 - "Confirm steps to minimize potential for bias are implemented prior to confirming the site is ready to enroll."


comment:
Medical Director - the map and procedure also state MD is consulted to identify the sponsor/co-sponsor.


comment:
The blue shirt/white Cummins logo looks like the old branding


comment:
Regulatory - he/she is also consulted to identify sponsor/co-sponsor


comment:
Should be using 'Warranty' vs 'Claims Management'


comment:
Where we say 'A technician can call to get troubleshooting help over the phone' can we instead say 'A technician can reach out for troubleshooting help'  - moving away from phone to other means of contact click to chat, etc.


comment:
I am very confused by this scenario. I'm not sure why a study manager would consult with a site manager when FD is to be collected. The downstream impact seems more like what the site manager does vs a true impact.  A site manager cannot 'ensure' thresholds are not being met.  The site manager identifies when a threshold has been met and communicates it to the study manager. if this is not done correctly or on time (before ready to enroll), then the impact is that we (the sponsor) have not met the compliance requirement to mitigate bias.


comment:
For warranty, let's change reimburse service providers 'fairly' to 'competitively'


comment:
2nd scenario - Downstream impact should be "The Site Manager obtains updated financial disclosure information in order to appropriately identify which site personnel meet the reporting threshold."


comment:
In general, consider renaming "Downstream Impact" to "Downstream Activities".  Using the word "Impact" can also mean consequences if the scenario isn't completed correctly, which doesn't seem to apply in this case.


comment:
The Service Support text at the bottom is highlighted twice during the video, but is only truly utilized during the second instance not the first.


comment:
Scenario 1 - recommend putting "sponsorship/co-sponsorship" in front of "...requirements are met"


comment:
Perhaps we should be 'calling Service Support and the Level 1 agent performs XYZ...' vs 'calling Level 1' people may not understand what that means.


comment:
Key point 1 - I wouldn't consider this a best practice.  It is required if applicable.


comment:
All key points are required.  Please remove 'best practices' from the intro sentence.


comment:
Recommend not calling out a Lilly-specific role in case it changes to another role with Lilly and to avoid confusion for project-sourced trials.


comment:
Key point 3 response doesn't connect with the intro sentence. Recommend changing intro sentence to "...keep in mind throughout the financial disclose process." or something like that.


comment:
The scenario led me to believe this was the initial notification of 'yes' to the study manager.  However, the responses seem to be about reconciliation.  Please align the scenario and responses.


comment:
In Tera's suggested change, add "...and meet regulatory financial disclosure reporting requirements".


comment:
I agree with Tera's comments about the use of 'ties'.  maybe change the first selection to 'Whenever there is a change to sponsorship/co-sponsorship'


comment:
I agree with Tera's suggestion.  The collection of FD does not ensure an investigator is not biased. FD collection and reporting is about financial transparency with study participants and the FDA and serves as a reminder to site personnel that they are to remain objective regardless of their financial interest in the trial results.


comment:
Explanation for the second example is not correct


comment:
The instruction to click the professor should be in a different location. It isn't visible without scrolling.


comment:
Is there a desire for these sections to require the right answer to move on and hit next? Right now, I can move forward with wrong answers and just hit next.


comment:
might want to describe the icon so folks know what to click here.


comment:
Is the first statement in need of qualification? For example, "Based on feedback from sales managers... "


comment:
Should we indicate that the questions will not stick if incorrect?


comment:
the monthly graphic appeared grainy to me when it was enlarged on this screen.


comment:
it could have been user error but I kept having issues with this page. I couldn't get the magnifying glass to work.


comment:
X actually implies x'ing out. Is there some sort of other icon to add them to the team?


comment:
Course completion button should be more obvious and in the middle or to the right instead of left.


comment:
In the pop up for Manage Financial Disclosure replace US IND submission with US NDA/BLA submission


comment:
Should be Final Country Allocation instead of Finalized


comment:
Under Study Manager - it should say "finalizes grants or CRO costs


comment:
its just Decision Log instead of Decision Log tool


comment:
Last bullet "Provide the Lilly Medically Qualified Personnel name


comment:
Remove "tool" after decision log in the sentence


comment:
the statistician reviewing the presentations and CRP approving presentations only happens if it is a data results meeting. These 2 steps would not happen for a rejuvenation meeting


comment:
Red activities can also be from Lilly Business requirements not just compliance requirements


comment:
Suggest saying "which required activities" instead of compliance requirements


comment:
third bullet should be "in" TMF instead of "on"


comment:
Its Decision Log instead of decisions log


comment:
Again the Stat and CRP steps are only of its a data results meeting


comment:
Distribute Medically Qualified Personnel only needs to be listed once instead of twice


comment:
Notify Required Personnel Step should have full name Notify Required Personnel of Approved Records


comment:
CRP does not approve grant budget, nor do they sign the certification of financial interests forms


comment:
Medical Director provides supervision of "Medical" staff


comment:
The Stat "may" complete impact assessments - not always


comment:
last part of Site Manager role - the obtain updated financial disclosure "if a discrepancy is found". Its not the Site Manager who would identify the discrepancy therefore suggested wording in quotes


comment:
the bubble under Manage trial Budget talks about managing the trial timeline - should title be changed or bubble description?


comment:
For CRP role under Manage Trial Budget - no where on process map do I see the CRP noted as needing to approve grant budgets?


comment:
Site Manager bubble - the Site Manager distributes "who" the medically Qualified Personnel is, to the sites


comment:
Financial Disclosure - MEdical Director - may be consulted to determine if FD needs collected.
For Stat role - add to end of sentence "if that investigator met the financial threshold"


comment:
Close Out trial - Site Manager role add at end "to the sites"


comment:
Inputs for Financial Disclosure Process should be trial worksheet and Financial Disclosure trial Sponsorship and Trial Personnel Roles
Outputs should be Completed Financial Disclosure Summary, Certification of Financial Interesst form, Disclosure of Financial Interest Form, List of Site Personnel to be listed on Forms 3454 or 3455


comment:
In trial change overview -closing changes is mentioned twice


comment:
Change course name in storyline shell to match as it appears in red text on this screen


comment:
Per the DP review call - space between Cummins logo and red/white text in black top bar should be equal to the size of the Cummins logo - so need to move it to the right more


comment:
Per DP edit sheet, they requested Define a generator... be changed to Describe a generator..


comment:
sometimes g in genset is capitalized, sometimes lowercase. Needs to be consistent (and of course is fine to have George Genset a capital G even if the rest is decided as lowercase)


comment:
LTP bullet 1 - add a period at the end to be consistent with the others


comment:
Email sentence 3 - add a comma after chemical energy


comment:
1st box say "Need to share confidential info PRIOR to executing consulting agreement?"


comment:
Wording of pop-up under the pre-work tab seems off. Should this say:
During this activity, the requestor evaluates the need to share confidential information with the consultant.  A consultant may request such information to decide if whether or not they would provide their services.


comment:
2nd step in Pe-work. the pop-up
the last part of the sentence, say:
the Requestor verifies if a confidentiality agreement is already in place with the consultant, if not the requestor collects a signed confidentiality agreement.


comment:
We may be late in the game, but I feel we have already covered this sufficiently in the process review. Remove this screen?


comment:
1st sentence orange box, change "acceptable" to "adequate"?
to avoid saying it's accpetable to accept :-)


comment:
Pop-up box, 1st sentence
there seems to be a "the" too many.
Once the requested changes...


comment:
the link to the CDOS UI didn't work for me. Can you check if you have the correct url? http://lillynetcollaboration.global.lilly.com/sites/CDCI/os/SitePages/Home.aspx


comment:
Remove the words "landing page" after 1st bullet


comment:
the course didn't close when I clicked "next"


comment:
There are little green lines at each corner of the image


comment:
First paragraph above bullets - 2nd sentence is not a complete sentence


comment:
Suggest changing this screen title to just "Where is it?" - the word at is not grammatically correct


comment:
Confirm this is a different image. DP edit to change the image, but not sure what it was before?


comment:
George speech bubble, 2nd paragraph - should be co-workers (plural)


comment:
first bullet reads odd.. suggest changing "for example" to to "such as"


comment:
should o in overload (4th bullet) be capitalized? I wouldn't think so, but don't know if this is some sort of proper noun term?


comment:
Blue directions should change to click next after all 4 have been visited


comment:
email text - missing first t in alternator


comment:
For all other spots, I'm able to click another without closing out the popup but on this one I can't


comment:
Other options seems weird. Maybe put a yellow note instead asking Cummins if there are any other options they'd like to include?


comment:
Same thing on this alternator layer as base frame layer. Not able to keep clicking the circles without closing out the popup


comment:
1940s (remove apostrophe) in both the timeline and the 1940s popup


comment:
Use of kW is not consistent - in 1940s, it has a space between number and kW, here no space. Use consistently throughout


comment:
What does "Controls were relay-based" mean? Is this common knowledge to the learner or do we need to explain?


comment:
Match timeline label to popup - "1960s to 1970s"


comment:
Match timeline label to popup title - "Mid-1980s to mid-1990s"


comment:
Match timeline label to popup title text - "Late 1990s"


comment:
First dragger - extra space between operational and control


comment:
Correct feedback is still placeholder text


comment:
Correct feedback - per DP edit, should be green outline like it is here on all other screens, too. (So this edit applies to other feedback screens, but not this one)


comment:
Email text, 2nd sentence - "I know that genset systems are..." (genset should be singular)


comment:
Email text, 3rd sentence - "...with modular designs" - make design plural


comment:
R-ball on PowerCommand should be superscripted


comment:
5th bullet - Remove the word "the" before PowerCommand


comment:
5th bullet - add a comma - "...PowerCommand electronic control, which provides.."


comment:
Bullet 3 - extra space between the and flexible


comment:
Use standard SF checkmark - it is light blue - will send in my basecamp reply


comment:
Remove the word "Provides" at the end of 1st bullet


comment:
5th bullet - add 2 commas - "...electronic control, which provides total system integration, including..."


comment:
Second sentence should be "met" not "meet"


comment:
Add a yellow note to Cummins to see if we can get some higher resolution images of these gensets. These 3 are quite blurry


comment:
5th bullet - same fixes as when this text appeared on prior screen


comment:
Really the whole intro sentence seems kind of pointless... Suggest just removing it and only having the directional text


comment:
Once you click the boss, her speech bubble is still placeholder text


comment:
On the last click, the "you can learn more" and the controller info box come up at the same time. I read those top to bottom and that's out of order. Suggest the fourth genset box comes up first, then the learn more box slides in a few seconds later.


comment:
"That is not correct" popup on Q3 - Continue button doesn't work


comment:
In the prototype, the idea was to click on specific parts of the genset for things to pop up. Why the change here? Because I'm just clicking the main picture, I'm looking at the text boxes, but not really attending to where the little red line points on the genset itself...


comment:
George speech bubble - remove apostrophe on Cummins


comment:
directions tell you to click next to continue, but then you wouldn't see the boss's speech bubble


comment:
Boss speech bubble - change semi colon to a colon, make each site bulleted, remove comma at the end


comment:
If a person is just now learning what a genset is, will they know what "no utility parallel" means? Need to make this more descriptive.


comment:
Correct feedback - extra space after first sentence


comment:
Why are some bullets full sentences and others not? Will the target audience know what consistent vs. variable load is?


comment:
Correct feedback - suggest making "You will also find.." its own sentence


comment:
"Cummins developed a new ratings classification for data center power generation systems." Why is this important?


comment:
Directional text tells me to click exit but there is no exit button


comment:
Module title in black bar should match menu


comment:
Menu dropdown - add a ? to the module title


comment:
Remove the word intro from the screen title


comment:
Change screen title in menu to match what is on screen


comment:
Having all the options be correct doesn't give the learner an opportunity to discern right from wrong answers. There should be some distractors so the learner can truly test his/her knowledge.

Also, the design says you're suppose to see the boss' reaction - what happened to that?


comment:
Revising my previous edit - change course shell title to be "Know the Basics: Gensets" (just lowercasing the t) and text in red - remove the word Diesel


comment:
Nevermind about the boss reaction comment - I see now that went to the "how a genset works" activity rather than who the customers are.


comment:
I get what you mean, but "Where is it at?" is horrible English...


comment:
Oops - my comment went to the previous screen :-)


comment:
Why is it important for a salesperson to know the evolution of gensets? Suggest including that in boss' text.


comment:
There was a DP edit to change the alternator outline and decision of "will work with SME to correct alternator outline." but Sharon R put that John said to ignore? Why aren't we doing this after we said we would do it? If we don't have the information, let's at least include a yellow note asking them so they don't think we are blatantly ignoring it


comment:
Again, there should be distractors. If learners figured out in the first activity it's just a "check all the boxes" activity, they definitely won't read this one closely...


comment:
On this screen and the next, the bullet lists aren't parallel (some are sentences, some not). Since the type of information included for each genset looks to be the same, you could do tables instead (that would also give learners a break from looking at bulleted lists).


comment:
Again, all answer options should be about the same length. Also suggest moving the right answer to where it's not first (it was also first in the last activity).


comment:
2nd bullet. Revise to: "They are designed to operate with a consistent load."


comment:
the 3rd bullet needs "planning" after element.


comment:
Recommend changing the second sentence to: "They would question if the work is truly medical research if there is not a clinical trial (protocol trial alias) associated with this work.


comment:
What happened to the product spec screen? did they say to get rid of it?


comment:
George second speech bubble, second paragraph: change "...more familiar with our products and the industry" to "more familiar with the genset industry" or something like that to make it less repetitive


comment:
Check triggers on this screen. After all of the locations are visited - instructional text state should change to say "Click Next to continue."


comment:
make comma after fuel a period; change second sentence to "Gensets offer a logical choice for industries that rely on uninterrupted electrical power in many different situations."


comment:
change last bullet: "Typical applications include: base loading, paralleling with utility to provide additional power, and combining heat and power (CHP)."


comment:
first bullet: change "where there is" to "with"


comment:
Email text: remove "that" in "...and that a genset is an engine..." and remove comma after electricity


comment:
Only 2 of the 4 listed roles are called out in the introduction. Recommend all or none be called out.


comment:
1960s to 1970s: change sentence to read "Throughout the 1960s and 1970s,..."


comment:
mid 1980s to mid 1990s: remove comma after 1500kW


comment:
remove comma after 2000kW, add period after 20MW, remove comma after large in last bullet


comment:
change "again increased" to "continued to increase", change comma after improvements to a period, remove comma after design in last bullet


comment:
Recommend changing the second paragraph to "A contract must be fully executed before any work with an external party can begin, which is per the ..."


comment:
in the "Provides operational control..." text, remove extra space between operational and control


comment:
Can the pop-up process box be somewhere in the gold box with the text?  It might be difficult to locate on the man since they will be focused on the words to the right of him.


comment:
change third answer to: "Gensets are built with modular design and interchangeable subassemblies."


comment:
email text, third line: "are bigger than they were, and..." - remove comma after were


comment:
In the first sentence after clicking the icon click, please add "the" in front of protocol.


comment:
intro text: remove comma after warehouse


comment:
C2000 D5, bullet 3: remove "It has a" and add period at the end; bullet 5: start bullet with Equipped


comment:
C1400 D5, bullet 2: remove "Can be"; add period at end of bullet 3; start bullet 5 with Equipped


comment:
C3750 and C250 and C500: remove "Can be" in bullet 2


comment:
change Q2 to read: "Which of these options best explains how a genset works?"


comment:
add commas after "continuous power" in first and third options


comment:
incorrect fdbk: add comma after continuous power


comment:
after receiving incorrect fdbk, the continue button will not work


comment:
In the first scenario like this one, IMPACT was the consequence if the work wasn't done correctly.  In this module, it seems more like the benefit of the review. Should we use consequence or benefit as appropriate instead of impact?


comment:
bullet 3: change "where there is" to "with"


comment:
Please replace 'studies' with 'trials' when describing trial types.


comment:
Course gets stuck after Invoice - instructions say to click another milestone but there isn't another milestone to click?


comment:
The first paragraph is duplicated from the Intro screen. Should we remove it?


comment:
Let's add a Note to Cummins about getting us a more hi-res image of the 90's genset, if possible


comment:
In this slide under Strategic Fit description it will be good if we replace word Supplier with Cummins or Our firm's ability to capitalize on an opportunity....


comment:
I need to write the Correct feedback for this screen.


comment:
Per DP feedback, since the learner clicks Continue to progress, remove/disable the Next button.


comment:
This slide seems incomplete or waiting for information on Strategic Alignment contents.


comment:
After Barb (boss) talks, change directional text to Click Next to continue.


comment:
I recommend that the first bullet be to determine if there is a litigation associated with the trial and, if so, request a Litigation Hold banner and follow the instructions on how to maintain the site.

The current order could lead a user to believe records can be deleted before determining if a litigation hold banner is required.


comment:
Per Alicia's comment on repetitive bullets (#2 and #5 for most screens) we can add these to preface the warehouse tour and remove them from each genset


comment:
I need to write Barb's text for this screen


comment:
Consider renaming this page.  Following procedures is a requirement, not a best practice.


comment:
Consider making the first paragraph into 2 sentences. "...trial running smoothly. These process activities are initiated once resources..."


comment:
Recommend the following change in paragraph 2: "The Study Manager oversees and/or executes these activities and..."


comment:
Update first paragraph with earlier comment.


comment:
It seems to be locked in a loop.  I click on Simon and read his story then press the back button.  It takes me back to the screen with "Click Professor Simon..." screen but there is no next button appearing.


comment:
I'm not aware of any levels of bias.  I recommend deleting the first sentence.


comment:
In addition to Janel's comment on the second paragraph, I recommend the following change: "...process is use to collect and report..."


comment:
Change opening statement to "If potential for bias due to financial interests is unavoidable"


comment:
Please make the following change to paragraph 2: "...approving, and implementing changes when there is a request to amend a protocol/protocol addendum or to add new addenda..."


comment:
FD is not contingent on whether Investigators have financial ties so the first sentence needs to be revised...Financial Disclosure is the regulatory requirement for Investigators to provide information regarding their financial interests or arrangements with the sponsor(s) of studies covered under 21 CFR § 54.4.  Studies are categorized as covered by the medical director if the study is designed to establish that the product is effective (including studies that show equivalence to an effective product) or any study in which a single investigator makes a significant contribution to the demonstration of safety.


comment:
Since the Medical Director determines what studies are covered under 21 CFR 54 and documents the decision on the Covered Study Determination required tool, can we confirm that the required tool will remain and simply explain who is decides when FD is needed and where it's documented?


comment:
Last sentence of first paragrapgh - expanded access trials.


comment:
First pop up should be bioequivalence clinical pharmacology trial or any trial in which a single investigator makes a significant contribution to the demonstration of safety


comment:
For the 3rd bullet, can we say "Communicate with study team members and functions? I also don't think it's necessary to call out site communications for the study manager role since it is very rare site communications come directly from this role.


comment:
I think this example needs to be the opposite timeframe.  If the real FPV is Apr 1 and gets set to Aug 1.  The supplies would not be ready.


comment:
Since Medical Director should determine whether FD should be collected for a study, I suggest changing the question to "What is the purpose of Financial Disclosure?" check all that apply:  
1) Identify potential for bias early in the study so take action to minimize potential
2)  Meet regulatory requirement
3)  Ensure Investigators understand all sponsors involved in the study


comment:
Change Key Point 1 to "All Sponsors of the clinical trial need to be identified on the form so that each sponsor is conidered individually when responding to the questions."

Change Key Point 3 to "Emphasis should be on obtaining financial disclosure to identify individuals would could financially benefit and take action to minimize potential for bias due to their financial interests."


comment:
·  #1-should also be included in the Medical Director row; change text box to "Financial Disclosure will be collect for all trials that the medical director has deemed covered under the regulation."  
·  #3- change text to "Notify the Study Manager if site personnel report financial information that meets thresholds on the form."
·  #4-Consult with Regulatory and Medical Director
·  #5-Clarify that when compiling the summary the site manager should confirm that FD is being provided for all individuals whose role and participation require disclosure.  If the Site Delegation Log indicates an individual was in a roles and participated in the study but didn't provide FD then follow up must be performed to obtain FD from the individual and documentation of follow up must be retained to meet FD requirements at the time of NDA/BLA submission.  
·  Shouldn't #5 and #6 be under the heading "Financial Disclosure collected"?    
·  #8-instead of resolve discrepancies with payments of other sorts report should the advice be to take the greater amount?


comment:
·  #10-reword "steps are determined to evaluate trial results for potential bias"  since at end is too late to take steps to minimize 
·  #11-reword "Obtain information...(Lilly and any additional companies)".   "Summarize and document actions taken during the trial to minimize bias and results of bias review by stats."   
·  #13-reword "Complete the FDA Form 3454 (Certification of Financial Interests) to list those site personnel in the defined roles who either did not have financial interests above the thresholds or, in the rare event, that financial disclosure was not obtained despite attempts to contact the individual including brief description of due diligence efforts."  
·  #14-Either include all documents or revise to "Completed FDA Forms and required supporting documents are given to appropriate individual for inclusion in the submission."  
·  #15-A 3455 isn't always completed per individual so it would probably be best to reference the letter that can be sent making them aware that they will be reported on the 3455.


comment:
If this scenario stays, it needs to be revised.  A team will need to complete an impact assessment in order to develop an implementation plan, the decision should have been documented earlier and all functions should already know (and were a part of the impact assessment and implementation plan development).


comment:
On the previous screen, I provided an incorrect answer and there is not a back arrow button here.


comment:
For medical director role, I recommend replacing the first 2 sentences with "I determine if the trial is covered or not covered under the regulation.  If I've signed the Covered Study Determination letter indicating the trial is covered then I'm verifying that Financial Disclosure is needed."

For stats rep role, I recommend striking "or mitigate bias on enrollment" from the second sentence.


comment:
Clicked on an incorrect response on the previous screen and now there is no back arrow.


comment:
Recommend different content unless I misunderstand the intent
·  Whether to collect Financial Disclosure->Medical Director->If Financial Disclosure isn't reported but the FDA considers it applicable this would impact the NDA/BLA submission.
·  Compiled Financial Disclosure information includes an individual but not their responses.->Site Manager-> Steps should be taken to ensure individuals who participated in the study in a role designated by medical and regulatory have provided financial disclosure.  Steps should be taken to only include individuals who participation in the designated roles and not just those listed on the initial 1572 otherwise it appears as incomplete reporting and due diligence to contact the individual would be needed to prevent impact to NDA/BLA submission.
·  After starting the study the Investigator reports a change and now meets the financial threshold but the site wants to revise their contract to increase enrollment.->Statistics Representative and Medical ->With the financial disclosure update, actions to minimize bias are essential to maintaining FDA confidence in results and their expectation that sponsors take action to minimize potential bias due to financial interests.


comment:
·  There could be other companies involved in development of the compound.->Medical Director and Regulatory ->Not obtaining financial disclosure for all parties considered as a sponsor would have impact on the NDA/BLA submission.   

·  Consider for the downstream impact for the last example:  Site personnel delegated responsibility for assessments related to or part of the primary endpoint would meet the definition of evaluating study participants and financial disclosure should be obtained.


comment:
In general for this module, I recommend changing the 'manage trial' scenarios and examples with when to use the decision log.  This is a critical document used to tell a trial's story during an inspection.


comment:
The study manager has specific required tasks to complete (not just be available to study team members).  Was there a reason these weren't included?


comment:
Suggest re-wording the second sentence as follows:  "If the changes are not accepted, the request could be terminated if all parties cannot agree to the terms."


comment:
The process states that the CPM confirms 'trial design element planning' is complete.  Should we use this throughout for consistency?


comment:
Could we change this sentence to read:  "US Consultant.  The system used to submit consulting agreement requests is based on the country of residence of the consultant."


comment:
First sentence for Regulatory "Manager" right before the comma


comment:
Can the first sentence be re-worded as follows:  "An Italian consultant has been asked to participate in a medical research advisory board to be held in the US."  Second sentence is fine as is.


comment:
Bullet number 4 is also correct, just not the best choice.


comment:
Modify the first sentence to read:  "If not truly medical research, the request should be processed via a different contracting path (i.e., non-medical research via IMA or procurement)."


comment:
This course is about Fin disc not consulting agreements


comment:
Recommend modifying the last sentence as follows:  A medical research consultant does not provide tangible services such as reading and interpreting patient mammogram results.


comment:
Modify the first sentence as follows:  Lilly utilizes the services of medical research consultants when Lilly does not have the expertise internally or desires to collaborate with the external environment.


comment:
I'm working on a global phase 3 study.  Even though some investigators are not located in the U.S., I will still request Financial Disclosure information because the study is pivotal to the NDA submission.


comment:
What about the TCED?  Should we really include Risk Profile in this list since it is technically a part of the TCED?  Reminder: the Risk Profile document itself is not distributed to sites/reg authorities/ERBs.


comment:
The end of the "**" statement needs to read "...Records tool for trials with 2 or more countries."


comment:
"Sorry, she's not scheduled today, but I can take care of you. Next time you can visit smartstyle.com to see if Jenny is working that day and can check in online."


comment:
Update second response to:
"You're very welcome! I recommend downloading our new app for your next visit. It lets you check wait times and check in from your phone."


comment:
For study manager role in regards to manage trial change, can this be updated to state something like: ...documenting the decision for the change and facilitating and communicating the  associated tasks and impacts.


comment:
The CRP does not have much of a role in the activities listed so may want to remove this role or add an activity such as trial meetings, where they do have responsibility.


comment:
The tasks for study manager listed under FD are responsibilities for study manager in managing the trial budget. For FD, the study manager is responsible for determining financial disclosure, documenting the sponsorship and roles that require FD and document decisions for mitigating enrollment bias when disclosable information is identified.


comment:
For study manager responsibilities in "Notify of approvals" this should read "....prepare trial level notification, identify and confirm distribution list and distribute the notification."


comment:
Middle module where CSA and customer interacting, told no techs best be can do is 3 hours - maybe reality but comes across negative with unhappy customer.  Technician in later scene has blue overall (not Cummins colors), plus stands with folded arms, need more positive photo/image.


comment:
For the statistician in the FD section this should read at the end ...bias, when financially disclosable information has been identified.


comment:
For data results meeting can this be changed to trial meetings? These meetings are not only for data results but also can include meetings such as investigator training meetings, etc


comment:
For notify personnel of approved records can we list the first column to state Right to Operate documents such as Investigator's Brochure


comment:
For compound related activities-can this state create compound level notification for the approved and/or updated RTO documents


comment:
For trial- level activities- change the first bullet to: notification of trial level documents, e.g. triggered from compound notification or trial level document approval


comment:
The second bullet is one of the few site-level distribution requirements in this process map and procedure.


comment:
Please add 'representative' after Compound RTO


comment:
The study manager consults with the study team and documents the rationale and patient care decisions.
Agree with Rachel - the medical director documents approval/non-approval of the request.


comment:
Same comments on bullet 2 that I provided a few screens back


comment:
This is a confusing question.  The recommendation (by study team) and approval/non-approval (by medical director) are already documented in the required tool.  Is there an additional step to document the decision to terminate the trial?


comment:
Agree with Janel. here is the definition of business requirement (red activity): a specific, necessary, and non-negotiable (1) activity the business must perform or (2) position to which the business must adhere


comment:
Please remove 'compliance' in front of requirements.  I don't think it is necessary to delineate between compliance and business requirements in this module unless you are quoting a specific regulation.


comment:
There has been a decision to no longer use 'rejuvenation' meeting. Please change the question to one of the following:
"Investigator training meetings
"Affiliate training meetings
"Re-training meetings (e.g., for low enrollment, lessons learned)
"New sites or additional training
Also, please review the map again to identify all of the required activities before one of the above mtg types can occur.


comment:
The last 2 rows are only true for interim/end of trial results mtg that are not a part of the Disclose Plan.
Also, remove 'study' from the last row.


comment:
The map lists the Compound RTO rep as "Study Manager with compound responsibilities" instead of CPM. The Compound RTO rep consults with regulatory and medical director to 1. determine if it is a substantial/non-substantial amendment and 2. identify guidance to include in notification.


comment:
The Significance of Requirement for the second row is after compound-level and trial-level communications. The relevant recipients for each level of communication (compound and trial) are located in the procedure.


comment:
Another required step in this process is obtaining the appropriate signature on the Notification of Approved Records.  For all IB communications, the medical director globally responsible for the drug/device signs the form.


comment:
Can we have two female silhouettes on this screen? If so, please change the Manager/field leader to a female.


comment:
Should "Meeting Owner" be removed from the study manager label for this scenario?


comment:
The study manager should also determine if the study team member changes requires a distribution of medically qualified personnel information to the site manager.


comment:
Are we identifying sponsor trial master file requirements in other training modules? The process and procedure in scope of this module do not include filing steps.  I recommend the focus be on what good looks like when entering a decision in the log and what good study team minutes look like as opposed to when to file in TMF/eTMF.


comment:
The CRP/CRS does not ensure documentation of approval and rationale for terminating a trial early.  The study manager populates the form with the study team and obtains the medical director's decision to terminate/not terminate the trial early.


comment:
The CRP/CRS only signs the notification of approved records for trial-level documents.  The medical director signs for IB communications/decisions.


comment:
The map indicates the study manager with compound RTO responsibilities creates and distributes notifications of compound approved records to study teams.


comment:
CPM: The process map indicates the study manager completes the impact assessment with trial changes in the manage trial change process.  Is this the impact assessment being referenced?


comment:
Ignore my comment about the CPM not doing the impact assessment.  
Can we change this sentence in all of the roles to something like - partner with the study manager to complete the impact assessment...?


comment:
study manager/communications - please add 'and distributing medically qualified contact information to the site manager'


comment:
study manager/IMPACT Data - does this column need to be in this module?  If so, should it be more like "the study manager is the trial-level primary data owner"? the bubble language is not logical.


comment:
Med director/financial disclosure - they also sign the Disclosure of Financial Interests Form


comment:
stat/FD - they conduct (not review) an enrollment bias assessment.


comment:
CRP/CRS - signs notifications for trial-level records.


comment:
CRP/CRS; Close Out Trial - they do not document or approve the early trial termination.  they ARE consulted on the decision rationale and study participant care instructions.


comment:
A couple of the circles changed to gray without me clicking on them.


comment:
I don't think I would include a PDO responsibility under functional contributors.  PDOs are study managers at the trial level and site managers (which includes many job titles) at the country and site levels. I would consider functional contributors as customers of IMPACT.


comment:
Notify Personnel of Approved Records 
INPUTS - there are other inputs that trigger this requirement such as protocol/addendum, protocol/addendum amendments, trial-level consent documents, CSRs.
OUTPUTS - Recommend NOT repeating a requirement from sponsor trial master file process/procedure.  Recommend just stating "Documented notification of approved records" because sometimes an email communication is sufficient.


comment:
Trial Change Overview: please change "and closing changes" with "and confirming implementation complete" to align with the process and procedure.


comment:
Close Out Trial Outputs - can we add "Distributed treatment assignments"?


comment:
This process does not include closing a change.


comment:
Can we say something different than "The templates process ensures..."?  Maybe "The creation and distribution of trial-level templates to the sites ensures..."


comment:
Second fill-in-the-blank paragraph: "The communication and documentation process..."


comment:
Please change "Communications" box to "Communication and Documentation"


comment:
The first and third bullets seem to conflict.  Can we clarify them?


comment:
change 'study' to 'trial' and 'study patient outcomes' to 'study participant outcomes'


comment:
Add a cover slide to this section to preface the scenarios:

How can your salon make the most of mobile app and online check-in? 

YOU play an important role in SmartStyle Mobile App and Online Check-in at your salon. 

Keys to Success:
"	Encourage guests to check in on smartstyle.com and to download the app
"	Enter any pre-scheduled guests into the POS every morning upon salon opening
"	Check all guests into the POS immediately (walk-ins and call-aheads)
"	Move tickets through the correct service stages
"	Manage schedules and breaks
"	Monitor wait times. Regularly review tickets and clear no shows as needed.

Questions? Contact Helpline 855-MYREGIS


comment:
Do not base the comparison on 100 women. Use the same exact portfolio brochure "circular" image for both screening and manage when explaining the issues with Pap cytology.  Pap cytology as a test works as the screening and managing tool (there is one caveat with HPV testing that we can work in later (ASC-US triage with HPV testing).  also need to work in the legend early so the learner understands the significance of the colors.


comment:
This slide tells a good message, however, It may work best to start by showing the RCCP portfolio of Screen/Manage/Diagnose, with messaging from the RCCP brochure and the "radar" slides from the RCCP story ppt deck.  Beginning with the solution (which affiliates should know by now), and then going into how Pap cytology does it (missing disease and not always sending the right women to colposcopy) may be a better way to explain it, and work in the circular imagery that is in the current marketing materials. It may be best to separate the sent home and further testing/treatment my graphical emphasis in the circular screening image.   Again, need legend to explain who is who.


comment:
This needs to be word smithed:

Using Pap Cytology, Pathologists use a microscope to examine the cervical cells, and classify the patient's samples into the following categories:
ASC-US:  There are cells that look slightly abnormal, which may be due to an HPV infection or not.  Additional or follow-up testing is usually required.
LSIL: The cells are abnormal, considered a "low grade" pre-cancerous lesion, usually associates with an HPV infection
HSIL: The presence of Moderate or Severe precancerous cells.


comment:
Here use the circular screening graphic to show how Pap cytology does it missing disease in the women sent home and not always sending the right women to colposcopy in the group sent for further testing/colpo. Again, need legend to explain who is who.   NOTE:  on the initial version of pg 4, you only show what happens to the group of women for further testing/colpo


comment:
EDIT to MT's comment:  "further testing/Colpo" not treatment.


comment:
Suggested Text for pg 4:  "Although Pap Cytology identified women who should receive follow-up testing, including Colposcopy, peer review publications show that Pap Cytology screening is limited in accuracy, including missing cervical pre-cancer all together, or undercalling disease.  Pap cytology can also overcall disease, or send women to colposcopy who do not need the procedure."          to BLP: the problem with Pap cytology is missing disease in the population of women called NILM, and overcalling disease in the population of women who have abnormal Cytology (usually in the ASC-US and LSIL categories)


comment:
BLP: Start by showing the entire table without the callout bubbles.  Regarding the text,  remove the first line of text and the last line of text (reserve this for the end) . Start with the second line.  Then use this:   "To demonstrate this, below is a data table from a well known peer review publication where 2 sets of pathologists read the same pap cytology cases."  Pop in the ASC-US callout with 57% misdiag. then add the text,   "With ASC-US cases, 57% of the time pathologists disagreed, in the Cytology category with the most discordance among Pathologists.  [pop in the HSIL callout 53% misdiag, An HSIL Cytology result is a strong indication of cervical disease&&so 
 how in the World can Pathologists misdiagnose  HSIL  disease 53% of the time?
BOTTOM LINE&&.Cytology interpretation is subjective, lacks accuracy and misses cervical disease!


comment:
Move this to the beginning -  and use the same circles to explain the Pap Cytology situation (as I mentioned in previous slides)


comment:
In addition to BJ's comment -  This is PAP vs RCCP which equals Screen manage diagnose.


comment:
Should we add a box saying 'Study Manager' in the middle of the man? It would be easier to know where to click


comment:
CTPM clinical trial project manager  not CPM


comment:
The title should be Diesel Gensets (not just Gensets) as we have a Gas Gensets course also.


comment:
The last example of "Not a Satellite Location",  remove Trialforce reference here. Nothing to do with Trialforce.


comment:
need to correct the non-bioavailability info.


comment:
need to make the second one of phase 1 trials clearer


comment:
I assume the grayed out boxes are this way b/c they are covered in separate training courses.  Will this be clarified?


comment:
Why are the 3 circles on the right (manage trial change, manage FD and develop and manage consulting agreements) a different color?  Please clarify.


comment:
Not sure we should mentioned that ISEC is required for all satellite location created in Trialforce. Need feedback from CDC as they are the one asking this a lot without the training.


comment:
The first icon is grayed out after completed; the remaining icons do not get "grayed out" after completion.  Can the icon coloring be consistent?


comment:
the snapshot that is shown is not correct and I had sent the revised one with the other information last week.  I will find and resend


comment:
The exported version of the satellite ISEC is not the most up to date version please obtain from Di both the satellite & satellite change forms


comment:
Under Section 1, Learn and Recognize are not lined up


comment:
1St bullet point needs to be rewritten. Middle to high end


comment:
Is last bullet point true? or just common? Please rewrite


comment:
I don't understand the "Uncover Customer Needs" at the end of this activity as it's written. Every customer is checked off, but it sounds like I still need to complete an activity?


comment:
Is it true that it can be located 'Anywhere' on the property?  How far is the limit?


comment:
Title of course should be Diesel Gensets, not just Gensets as we also have a Gas Gensets course.


comment:
Agree with IK, make printing cert. optional


comment:
In the text on the second click of George, 1st paragraph, last sentence, "its" should be "it's"


comment:
Also, we could add the Control Panel Basics course in the upper right hand text box - but this is now a lot of text.


comment:
In the popups, don't have the image of the genset clickable/moveable.


comment:
I don't like how the oil filters and turbo are called out, but you can't see them.  I don't have an immediate solution, but would like to address it.


comment:
In the bosses 1st paragraph, I would use "advanced" vs "updated"


comment:
Ian - do you have access to any better images? These were best I could do through Dave.


comment:
I will upload higher res images to basecamp.


comment:
The second answer looks like there is an extra space in between "a" and "piece"


comment:
Ratings for data center applications are unique to Cummins. They are actually standby.


comment:
The answers need to be worded differently as data center applications are actually standby.


comment:
I would change the heading from "Cummins Genset Tools" to "Sales Tools"


comment:
I would add East Coast for Hurricanes as well


comment:
3rd bullet point needs to be rewritten. Of instead of and?


comment:
I don't know if it's accurate to say that Senior Living Facilities "Are often in disaster prone areas" - they are all over


comment:
the snap shot for this one isn't reflecting the current form I will send again


comment:
Once someone completes a module, when you roll over a completed module, the checkmark gets covered up. Is this fixable?


comment:
Okay, now I remember why we did this. We were trying to show that users have to scroll up to get to the screen where you see the services. So rather than having it look like the finger is tapping something, the screen should basically be rolling up about the same time the finger is going up (as if it's swiping up).


comment:
Okay - on the previous version, we made sure the checkmarks were entirely inside the circle, so when you rolled over you didn't see part of the check hanging out. That's what we need to do here.


comment:
When the finger appears here, the screen shot from the next screen (with the pic of the customer) should fly on. Check previous version to see how it works...


comment:
I think we need to reduce the font size here. You need a return between the first bold sentence and the second sentence.


comment:
The "Tap CHECK ME IN and you'll be added to the list" is still running off the bottom of the phone. Adjust so it's within phone window screen.


comment:
No longer want to use pictures of secondary containment damage. I'm not sure what we are going to use at this point. We can put a generic picture here though to begin. Will discuss tomorrow.


comment:
We will either keep this and delete the prior slide, or delete this one as this is how we've introduced the learning points before. I don't think we would have both unless there is more content than expected.


comment:
So this was a miss by me & Rich. They don't want the sites to see both forms since they don't use them. I wonder if we could use the same idea with the sites names listed where they have to click on them, then see a specific example of their form. Let me know your thoughts. One possible issue with this is that each site has several different forms, with each of their battery limit maps on them. Let's talk about it tomorrow.


comment:
Ok, so this is what I was talking about on the previous page. We may not need the previous page. I'll need to talk with you to see what we can do about the multiple forms. They don't want it to directly link to the forms to have to leave the course and go to Livelink. I'm really not sure the best way to go about this. Will brainstorm with you tomorrow.


comment:
We need to provide different images. TBD what these are.


comment:
2) Perform the Visual Inspection - will need to say Florida......or Louisiana........there are 2 different ones for each state due to each state's reporting requirements.


comment:
Step 3: Submit completed inspection to your supervisor. 
Step 4: The appropriate person will review the form for completion and accuracy. 
Let's review this document again - for all sites - because it states step 1, 2, 4...where is 3? They told me what I typed above but that's not in the document. I have a note about asking if we can again have one branch for FL, one for LA...I'm not sure how that will work.


comment:
We may have to add a disclaimer that this is an example of the phos acid/evap area at Riverview for the picture of the battery limit maps.


comment:
We don't like this splash image - will need to change. More discussion on this tomorrow.


comment:
need to change this image. For the images that are of secondary containment issues, we may have something after the scenarios that says if you see something like this, notify your supervisor. But the forms are only for reporting leaks/spills/releases. So they would not document secondary containment issues.


comment:
Detailed comment :-)
Can we captalize Representative to say SAM Representative? (as it is a role)


comment:
Is the screenshot here for question 2 correct? Just double-checking as it mentions "Is there a change" and we didn't have a change in the scenario...


comment:
trial level activities - remove period after first bullet


comment:
Change "Update the decision log to keep it inspection-ready" to "Determine if there are key decisions made during the meeting that should be entered into the decision log.


comment:
1st signif of req box: remove "and filed appropriately in the TMF". I think that's one thing they want removed based on the "remove references to filing" comments.


comment:
Per alpha edit, row 20: Decision Log is a formal title and should be capitalized throughout.


comment:
are some of the sections supposed to be deactivated...?


comment:
to clarify, by disabled I mean grayed out


comment:
"resources have been assigned and funding has been allocated." - change to "resources are assigned and funding is allocated."


comment:
I don't understand the last bullet: Is it "Distribute change of medically qualified personnel, as required."?


comment:
DISREGARD previous comments - question answered :)


comment:
"resources have been assigned and funding has been allocated" - change to are and is


comment:
gg's comment: it's an extra space after "forms", not an extra comma


comment:
"...I need your advice so I make..." change to - "...I need your advice in order to make..."


comment:
study manager/meetings: set-up -> "set up"


comment:
functional contributors/meetings: Letters of Intent (drop the s after Intent)


comment:
correct fdbk - "A new country being added to the trial..." change to - "Addition of a new country to the trial..." or "A new country added to the trial..."


comment:
incorrect fdbk - "...agreements need to be done." change to "need to be completed"


comment:
alpha edit, row 39: the stat role comment has not been addressed


comment:
Investigators Brochure should be "Investigator's Brochure" for consistency


comment:
Trial-level activities: 1st bullet, missing "e.g." between "documents, triggered"


comment:
"trial level" should be "trial-level" and "compound level" should be "compound-level"


comment:
Edits: 

"I conducted a Job Safety Assessment (JSA) to make sure the equipment and surroundings were safe to proceed with the repair." 

"Using COS practice #10...to understand our customer locations and improve our responsiveness.


comment:
Intro text: refresh my memory: we decided to keep the first sentence about "processes that keep the trial running smoothly"?


comment:
"The Service function is always striving to improve service to our customers"; take out the rest.


comment:
Per RT's email "Financial Disclosure requirements." should be "Financial Disclosure collection requirements."


comment:
Take out the first sentence;
Discard JH comment.


comment:
Take out "plus any additional resources". 

Change to world map with only the data "190 countries, 600 distributor locations, 7200 dealer locations" - take out the people data from the picture.


comment:
Change "Support Network" to "Service Channel" in the course.


comment:
First bullet - "providing..."; take out "consistent".
Switch the order of the last two bullets.


comment:
1.take out the dashes; 
2. "In North America, some examples of customers for..."
3. "Internationally, some examples of our customers..."
4. Some examples of our Power Gen.."


comment:
It should be 7200+ dealer locations; 
Spell out Parts Distribution Centers;
Remove Oil and Gas and Marine Center of Excellence.


comment:
There needs to be a transition between the supervisor role and level 3 role. The role description doesn't match in the video.


comment:
1. Agree with "blue overall" and "folded arms" comments.


comment:
Will send you a separate slide capturing changes in the video.


comment:
3rd paragraph, 1st sentence: "an investigators" should either be "an investigator's" or "Site Personnel's"


comment:
There's some additional text over the back and next buttons once all 3 buttons have been clicked


comment:
Intro text, add a sentence at the beginning: "Let's take a look at the Manage Financial Disclosure process."


comment:
step 11: make co-sponsors singular in parentheses.


comment:
step 12: replace the 2nd 3455 with the short-hand requested "Form FDA 3455"


comment:
step 13: since you already defined it, you can use the short-hand version in this text box "Form FDA 3454"


comment:
step 2: doesn't financial disclosure need to be capitalized since we're talking about the official regulatory process? I think it does. Applies to 2nd and 3rd sentences.


comment:
in general, is there a way to make the screen size to prevent scrolling? this is very difficult on a few screens?


comment:
the overall process has changed (e.g., "store" steps have been removed, so the screen shot will need to be replaced


comment:
step 8: is the text in parentheses aimed at us? e.g. did we say financial disclosure forms before and now they want to say summary of financial disclosure instead? Also capitalize Financial Disclosure. Do a double-check throughout the course, but particularly this process map is where I'm seeing it the most.


comment:
process has changed (Store content step has been removed).  however, the information in the pop up for that step is still general enough that it still works.


comment:
I think the boxes should be removed since they are not highlighted.


comment:
Store Translated R&R content step has also been removed.  the text in the box is still relevant, if it's needed.


comment:
See the Whole Process button link will need to be updated.


comment:
Site Manager popup" Remove "also" at the beginning since it isn't a 2nd responsibility being listed.


comment:
capitalize Financial Disclosure on this screen as well when it relates to the regulatory process (e.g. process, forms, maps, etc)


comment:
screen shots, Trial-Specific should be added in front of "Site-Generated"


comment:
Pop up of sub process - screen shot has changed, removed Store R&R content step


comment:
#8 - capitalize Site Personnel for consistency


comment:
Obtain approvals and acknowledgments - this process step/name has changed to "Obtain Regulatory/Ethics Approvals".  This impacts the screen shot and the pop up box.


comment:
Back button doesn't work on this screen or the one previous


comment:
Popup should read, "Regulatory/Ethics Approvals for R&R content must be obtained through the Obtain Regulatory/Ethics Approvals process.


comment:
Site Manager, last bullet should read:
Ensures the Regulatory/Ethics approval process is performed.


comment:
checked links - they are all still valid


comment:
Change directional text to "Select the best answer." This is no longer a T/F question.


comment:
Change resource Trial Branding Request Form to Study Branding Request Form
This only shows when clicking review the resources button  it doesnt show on any of the other resource screens.


comment:
"last patient visit" be "Last Patient Visit (LPV) per Lesli's spreadsheet.


comment:
disregard previous comment to change the name of the form.


comment:
It looks like from Lesli's spreadsheet, cell 119F that the text should be "There are some key points you should keep in mind throughout the Manage Financial Disclosure process." Correct me if I'm reading this wrong!


comment:
Let's put a big yellow note on this screen that says "Only judge 2 has been updated with new content. Please confirm the correct customer profiles for all 3 judges."


comment:
disregard, I forgot you need to click all the answers


comment:
For this Alpha, let's let them continue without click all 3 judges.


comment:
I could be wrong, but didn't we used to have green checkmarks appear on the correct ones? I think we need something to show the right/wrong answers.


# Modules

moduleName:
Build Your Implantable System for Remodulin Team


moduleName:
Enlist" Duo Herbicide With Colex-D" Technology


moduleName:
Chapter 3: The Human Resources Organization


moduleName:
Chapter 4: Human Resources Functional Excellence


moduleName:
Regulatory Considerations in Design Control


moduleName:
Software & European Conformity Marketing


moduleName:
Weed control and weed resistance management with Enlist Duo


moduleName:
Enlist Duo" herbicide with Colex-D" Technology


moduleName:
Stewardship guidelines for application of Enlist Duo" herbicide


moduleName:
Common Challenges with Grossing and Processing


moduleName:
Market Forces and the Customer Landscape


moduleName:
Transitioning Middleware to Downtime Mode


moduleName:
Admin Only - Adding a Test to Downtime Ordering Configuration


moduleName:
Admin Only - Adding a Profile to Downtime Ordering Configuration


moduleName:
Module 1: Getting Started with Requirements


moduleName:
Module 5: Developing Great Customer & Business Requirements


moduleName:
Scenario 1: Scenario 1: US Fault Code Error


moduleName:
Scenario 2: Scenario 2: QSK60 2MW Commercial Generator Issue


moduleName:
Follow the Sample - Control Unit and cobas Link


moduleName:
Get to Know the Analyzer: What Does it Do?


moduleName:
Get to Know the Analyzer: How Does it Do it?


moduleName:
Explore the Analyzer: Sample Probes, Containers, Controls, and Calibrators


moduleName:
Explore the Analyzer: Racks and Sample Containers Review


moduleName:
Medtronic: Get Ready for RIS - New Section


moduleName:
Module 1: The Develop, Finalize & Deliver Training Process


moduleName:
Lilly NGD: Dev. Site Act. and Enrollment Plans


moduleName:
Lilly NGD: Recruit Study Participants and Manage Enrollment


moduleName:
Module 3: The Protocol-Specific Training Content Design Tool


moduleName:
Scenario 4: Scenario 4: Commercial Marine Situation in Singapore


moduleName:
1A - 24 hour lab with cobas e 601 module(s) only


moduleName:
1B - Non­-24 hour lab with cobas e 601 module(s) only


moduleName:
2A - Non­-24 hour lab with cobas c 501 and cobas e 601 module(s)


moduleName:
2B - Non­-24 hour lab with cobas c 501 module(s) only


moduleName:
3A - 24 hour lab with cobas c 501 and cobas e 601 module(s)


moduleName:
3B - 24 hour lab with cobas c 501 module(s) only


moduleName:
6A - cobas c 501 and cobas e 601 module(s) connected to Pre-Analytics


moduleName:
6B - cobas c 501 module(s) connected to Pre­Analytics


moduleName:
Coach to Identify Where Account Plans are Needed


moduleName:
Module 2: The Value of Effective Training


# Pages

pageName:
12:Your Role: ISO/SC Settlements Analyst


pageName:
5 Introduction to Customer Support Excellence


pageName:
9 How will we achieve Customer Support Excellence?


pageName:
4 What Is the Impact of Customer Support Excellenc


pageName:
11 Applying the standards: physical space


pageName:
9a Applying the standards: written communication i


pageName:
9b Applying the standards: written communication -


pageName:
9c Applying the standards: written communication -


pageName:
9d Applying the standards: written communication -


pageName:
9e Applying the standards: written communication -


pageName:
9f Applying the standards: written communication -


pageName:
9g Applying the standards: written communication -


pageName:
9h Applying the standards: written communication -


pageName:
9i Applying the standards: written communication -


pageName:
9j Applying the standards: written communication -


pageName:
9k Applying the standards: written communication -


pageName:
10a Applying the standards: nonverbal communicatio


pageName:
10b Applying the standards: nonverbal communicatio


pageName:
10c Applying the standards: nonverbal communicatio


pageName:
10d Applying the standards: nonverbal communicatio


pageName:
12 Applying the standards: work deliverables


pageName:
1 What can you do to enable customer success?


pageName:
2.3 What can it do? (distractor 1 incorrect)


pageName:
2.4 Here's what I've learned (Steven's thoughts)


pageName:
09: Activity-Communicating in Transition (screen 1


pageName:
10: Activity-Communicating in Transition (screen 2


pageName:
11: Activity-Communicating in Transition (screen 3


pageName:
6: Activity-Working the Model (screen 1)


pageName:
7: Activity-Working the Model (screen 2)


pageName:
08: Communicating Customer Success Animation


pageName:
01: What Does Coaching Customer Success Look Like?


pageName:
Cummins Recreational Marine Market Share


pageName:
002: Discussion with the PI and Site Staff


pageName:
04 How Source Documentation is Like Taxes


pageName:
6: post video text-clip 1 AM (beta update)


pageName:
6: Decontamination and Infection Control


pageName:
9: Perms, Activators, Neutralizers, etc.


pageName:
3.14 Types of settlements files (bill determinants


pageName:
3.14 Types of settlements files (invoice)


pageName:
3.14 Types of settlements files (settlements state


pageName:
3 - Working Together: Internal and External Recrui


pageName:
4 - Working Together: Hiring Manager and Line HR


pageName:
7: How antibodies are created - cartoon base


pageName:
8: How antibodies are created - cartoon 1


pageName:
9  How antibodies are created - cartoon 2


pageName:
10  How antibodies are created - cartoon 3


pageName:
11  How antibodies are created - cartoon 4


pageName:
12  How antibodies are created - cartoon 5


pageName:
13  How antibodies are created - cartoon 6


pageName:
14  How antibodies are created - cartoon 7


pageName:
15  How antibodies are created - cartoon 8


pageName:
16  How antibodies are created - cartoon 9


pageName:
17  How antibodies are created - cartoon 10


pageName:
4 Direct Fluorescence - 2 attaching to protein


pageName:
5 Direct Fluorescence - 3 visible with microscope


pageName:
11 Indirect Fluorescence - 1 adding label


pageName:
12 Indirect Fluorescence - 2 attaching to antibody


pageName:
15  Direct enzyme detection - 1 adding label


pageName:
16  Direct enzyme detection - 2 attaching to prote


pageName:
17  Direct enzyme detection - 3 chromogen and subs


pageName:
18  Direct enzyme detection - visualize with micro


pageName:
20 Indirect enzyme detection - 1 overview


pageName:
21 Indirect enzyme detection - 2 adding label


pageName:
22 Indirect enzyme detection - 3 chromogen and sub


pageName:
24  Endogenous biotin staining - 1 endogenous stai


pageName:
29 Indirect non-biotin multimer (OptiView) - base


pageName:
30 Indirect non-biotin multimer (OptiView) -  1 mu


pageName:
31 Indirect non-biotin multimer (OptiView) - 2 HQ


pageName:
32 Indirect non-biotin multimer (OptiView) - 3 HRP


pageName:
33 Indirect non-biotin multimer (OptiView) - 4 chr


pageName:
2 Before you begin - 1 no perfect fixative


pageName:
3 Before you begin -  2 no perfect marker


pageName:
6 Before you begin - 5 everything positive


pageName:
9 staining patterns - nuclear and cytoplasmic


pageName:
12 staining patterns - membraneous and golgi


pageName:
15 - Use Your Resources; Other Colleagues


pageName:
08 - Submit a miscellaneous bid component (GHG)


pageName:
09 - Submit a miscellaneous bid component (GHG) (c


pageName:
10 - Entering real-time daily bid components


pageName:
11 - Entering real-time daily bid components (capt


pageName:
13 - Using the real-time bid summary (captivate)


pageName:
04 -  Submitting a self-schedule (captivate)


pageName:
06 - Submitting a supply bid (captivate)


pageName:
07 - Submitting a miscellaneous bid component (GHG


pageName:
08 - Submitting a miscellaneous bid component (GHG


pageName:
09 -  Submitting real-time daily bid components


pageName:
10 -  Submitting real-time daily bid components (c


pageName:
12 - Using the real-time bid summary S1Q1


pageName:
13 - Using the real-time bid summary S1Q2


pageName:
14 - Using the real-time bid summary S2Q1


pageName:
15 - Using the real-time bid summary S2Q2


pageName:
05 - Working in SIBR (simultion 1) (captivate)


pageName:
07 - Working in SIBR (simultion 2) (captivate)


pageName:
09 - Working in SIBR (simulation 3) (captivate)


pageName:
2: What Should Jane Do? (submit iHCP request)


pageName:
2: What Should Jane Do? (purchase the items)


pageName:
5: Answer Julie's questions 1 (incorrect)


pageName:
6: Answer Julie's Questions 2 (notebook)


pageName:
6: Answer Julie's Questions 2 (incorrect)


pageName:
7: Answer Julie's Questions 3 (notebook)


pageName:
7: Answer Julie's Questions 3 (incorrect)


pageName:
6: Your Role: SC bid/base schedule submitter


pageName:
01 Introduction to the Pump and Other Components


pageName:
13 Pump Refill and Longevity Estimation Table


pageName:
2 Prevent a market dispatch (transcript)


pageName:
3 Cycling a resource through its FOR (correct)


pageName:
3 Cycling a resource through its FOR (incorrect)


pageName:
4 Fixed output below desired point (correct)


pageName:
4 Fixed output below desired point (incorrect)


pageName:
4 Derrick's decision (scenario 1 correct)


pageName:
4 Derrick's decision (scenario 1 incorrect)


pageName:
6 Marissa's decision (scenario 2 - correct)


pageName:
6 Marissa's decision (scenario 2 - incorrect)


pageName:
8 Nick's decision (scenario 3 - correct)


pageName:
8 Nick's decision (scenario 3 - incorrect)


pageName:
2 adjusting for a load forecast error (base)


pageName:
2 adjusting for a load forecast error (transcript)


pageName:
2 adjusting for a load forecast error (scenario)


pageName:
4 adjusting for a new N-1 value (transcript)


pageName:
5 Return ACE to pre-disturbance (transcript)


pageName:
2 adjusting for a load forecast error (edwin's tho


pageName:
9 adjust load forecast STUC only (show it 4)


pageName:
05 Reports: All Results (By Location and Instrumen


pageName:
08 QC Summary (By Location and Instrument)


pageName:
09 QC Summary (By Instrument Type and Location)


pageName:
19 Test/Sample Count (By Location and Instrument T


pageName:
28 Generate, Save, and Mark as Favorite Demo


pageName:
2: When do I submit: - RDT startup (base)


pageName:
7: Intro to completing the RDT (transcript)


pageName:
7: Intro to completing the RDT (scenario setup)


pageName:
8: Completing the Resource tab (simulation)


pageName:
2: You try it: Introduction (transcript)


pageName:
5: Uploading the RDT (feedback-incorrect)


pageName:
04 Catheter Complications during Implant


pageName:
9: Completing the Ramprate,Heatrate,and Startup ta


pageName:
10: Completing the Ramprate, Heatrate, and Startup


pageName:
16 - Try It: Load HBV Adj, Cont, Samples


pageName:
17 - Try It: Load HCV Adj, Cont, Samples


pageName:
034: Try It: Load Controls and Calibrators (1)


pageName:
035 -Try It: Load Controls and Calibrators (2)


pageName:
036: Try It: Load Controls and Calibrators (3)


pageName:
2 Why the CTP Communication Protocols Matter


pageName:
10 Correct the Misperception: Question One


pageName:
11 Correct the Misperception: Question Two


pageName:
12 Correct the Misperception: Question 3


pageName:
10 Identify market infeasibility (transcript)


pageName:
13 confirm long-term balance (transcript)


pageName:
14 See it in action summary (transcript)


pageName:
14 See it in action summary (edwin's thoughts)


pageName:
4 first things first (incorrect 1, correct 2)


pageName:
4 first things first (incorrect 2, correct 1)


pageName:
12 confirm long-term balance (transcript)


pageName:
13 You try it summary (edwin's thoughts)


pageName:
3: RDT and its impact on market applications


pageName:
18 - Try It: Handling an Emergency Sample


pageName:
12: Multi Stage Generators - CONFIG RAMP


pageName:
12: Multi Stage Generators - CONFIG_STRT


pageName:
1: Energy Transfer System Resources (menu)


pageName:
3: Energy Transfer System Resource limits


pageName:
6: Energy profiles and transmission profiles


pageName:
3 what can it do (distractor 1 incorrect)


pageName:
3 what can it do (distractor 2 incorrect)


pageName:
7 understanding dynamic tabs (availability)


pageName:
7 understanding dynamic tabs (as availability)


pageName:
7 understanding dynamic tabs (max/min energy)


pageName:
7 understanding dynamic tabs (max/min load)


pageName:
7 understanding dynamic tabs (use limited)


pageName:
11 fixing an inconsistent outage (setup)


pageName:
13 modifying an outage without overlaps (setup)


pageName:
14 modifying an outage without overlaps (sim)


pageName:
15 modifying an outage with overlaps (setup)


pageName:
16 modifying an outage with overlaps (sim)


pageName:
12 modify an outage with overlaps (setup)


pageName:
8 fix an inconsistent outage (transcript)


pageName:
6: Map - Hospital full med facilities (layer)


pageName:
03 Review the Edits: Flyer (correct feedback)


pageName:
03a Review the Edits: Flyer (incorrect feedback)


pageName:
05 Review the Edits: Radio (correct feedback)


pageName:
05a Review the Edits: Radio (incorrect feedback)


pageName:
03 Why Reviewing Site Generated Content Matters


pageName:
07 Review the Edits: Web Banner (correct feedback)


pageName:
07a Review the Edits: Web Banner (incorrect feedba


pageName:
2.05a: Explore the Blueprint Sample Supply


pageName:
2.05d: Explore the Blueprint Reagent Cassette Draw


pageName:
2.05e: Explore the Blueprint Consumable Drawer


pageName:
2.12: Try It: Monday's Reagent Cassettes


pageName:
2.21: Try It: Loading Monday's Samples part 2


pageName:
2.22: Try It: Loading Monday's Samples part 3


pageName:
2.25: Try It: Finish Monday's Testing part 2


pageName:
2.26: Try It: Finish Monday's Testing part 3


pageName:
2.27: Try It: Finish Monday's Testing part 4


pageName:
2.28: Try It: Finish Monday's Testing part 5


pageName:
2.29: Try It: Finish Monday's Testing part 6


pageName:
2.30: Try It: Finish Monday's Testing part 7


pageName:
2.33: Try It: Tuesday's Processing Plates


pageName:
2.53d: An Emergency Sample follow up question


pageName:
2.53e: An Emergency Sample correct answer


pageName:
2.53f: An Emergency Sample incorrect answer


pageName:
2.59: Completing the Field Report cont'd


pageName:
2.60: Question Conqueror: Getting Started


pageName:
3.05a: Explore the Blueprint Plate Carrier popup


pageName:
3.05b Explore the Blueprint tip carrier popup


pageName:
3.05c: Explore the Blueprint stationary popup


pageName:
25- An Emergency Sample follow-up question


pageName:
3.05d: Explore the Blueprint sample popup


pageName:
3.05e: Explore the Blueprint reagent popup


pageName:
3.05f: Explore the Blueprint continue popup


pageName:
3.05g: Explore the Blueprint plate loading drawer


pageName:
04 The Reviewing Site Generated Content Process


pageName:
07 Content Reviewed, Finalize, and Distributed


pageName:
03 Recruitment and Retention Review Guide


pageName:
7a: No sourcing or sinking? (Sonee layer)


pageName:
7b: No sourcing or sinking? (Ariel layer)


pageName:
2 Your Role: PAH and Implanting Physician


pageName:
3.4 FMM Scheduling Point/Tie Combo LMP (2)


pageName:
3.4 Scheduling Constraint Shadow Prices (3)


pageName:
3.4 MPM Intertie Constraint Shadow Prices  (5)


pageName:
3.4 MPM Intertie Constraint Competitive Paths (6)


pageName:
3.6 System Load and Resource Schedules (1)


pageName:
3.6 Flexible Ramp Surplus Demand Curves (9)


pageName:
3.6 Uncertainty Movement by Category (10)


pageName:
4 The Budget and Contract Development Process


pageName:
08 Knowledge Check: Clinical Trial Materials


pageName:
10 Knowledge Check: Patient Reimbursement


pageName:
03 Review the Exception Request - Site One


pageName:
05 Review the Exception Request - Site Two


pageName:
16 Additional Information: Exception Three


pageName:
08 Review the Exception Request - Site Three


pageName:
12 Explain Your Reasoning: Exception One


pageName:
14 Explain Your Reasoning: Exception Two


pageName:
15 Maximizing Approvals: Exception Three


pageName:
01 Identify, Evaluate, and Select Sites Process


pageName:
02 Preparation for Site Evaluation Completed


pageName:
03 Identify, Evaluate, and Select Sites Process


pageName:
06 Judgement-Based Decision Making - Introduction


pageName:
08 Judgement-Based Decision Making Cont'd


pageName:
Validate outages going to the market intro


pageName:
Validate outages going to the market sim


pageName:
Operate outside standard market timelines intro


pageName:
Operate outside standard market timelines sim


pageName:
Operate outside standard market timelines


pageName:
Operate outside standard market timelines Q2


pageName:
Identifying and correcting topology errors intro


pageName:
Identifying and correcting topology errors sim


pageName:
03: Getting started with AIM (base layer)


pageName:
05:  Create a user and grant access (intro)


pageName:
06:  Create a user and grant access (Captivate)


pageName:
09:  Request and manage endorsed users (Intro)


pageName:
10:  Request and manage endorsed users (Captivate)


pageName:
12: Manage ACL groups (layer 1 - ACLform)


pageName:
12: Manage ACL groups (layer 2 - AddAsset)


pageName:
12: Manage ACL groups (layer 3 - ViewAsset)


pageName:
13: Manage email notifications (base layer)


pageName:
3: Create and manage user access (intro)


pageName:
4: Create and manage user access (Captivate)


pageName:
7: Request and manage endorsed users (Intro)


pageName:
8: Request and manage endorsed users (Captivate)


pageName:
003B: Trial Level Informed Consent Created


pageName:
3.5 Sufficiency Evaluation Demand Forecast (4)


pageName:
09 The Synflorix Incident: The Aftermath


pageName:
11 The Sponsor, the Study Participant, and the Sit


pageName:
1 - A closer look at your applications (menu)


pageName:
2 - A closer look at your applications: Your appli


pageName:
Expected energy allocation details report


pageName:
Show what you know - Uninstructed Imbalance energy


pageName:
show what you know - Instructed Imbalance energy


pageName:
Show what you know - Locational Marginal Price


pageName:
show what you know - Settlements Business Practice


pageName:
show what you know - Expected energy allocation de


pageName:
show what you know - Marginal Cost of Congestion


pageName:
show what you know - Marginal Cost of losses


pageName:
show what you know - Greenhouse gas component


pageName:
results: Instructed Imbalance energy def


pageName:
results: Uninstructed Imbalance energy def


pageName:
03 - Why Preparing for Site Evaluation Matters


pageName:
4 Safety Information and Product Handling


pageName:
2 Find the Screen- Alarm Volume and Tone


pageName:
3 Find the Screen- Drug and Dosing Information


pageName:
1 New System Implant Programming Timeline


pageName:
12 New System Implant Programming Review


pageName:
04 - Ask the Site - Existing Site Question


pageName:
06 - Ask the Site - Existing Site Question


pageName:
10 - Ask the Site - Existing Site Question


pageName:
13 - Ask the Site - Existing Site Debrief


pageName:
04 How Site Qualification is Like Choosing a Physi


pageName:
23 - Review Site Information - Robust Feasibility


pageName:
03 - Gather Information - Your Resources


pageName:
05 - Use your Resources: External Resources


pageName:
09 - Use Your Resources; Debartment Lists


pageName:
10 - Use Your Resources; Internal Resources


pageName:
11 - Use Your Resources; Internal Resources


pageName:
06: Resource-specific versus global issues


pageName:
09: Knowledge check (resource-specific) - 1


pageName:
10: Knowledge check (resource-specific) - 2


pageName:
11: Knowledge check (resource-specific) - 3


pageName:
12: Knowledge check (resource-specific) - 4


pageName:
13: Global resources troubleshooting guidelines


pageName:
02: Introduction to resource-specific scenario


pageName:
24: Introduction to global outage scenario


pageName:
5: Trial-Specific Topics in other sections


pageName:
4.12 View/export settlements (q 2 of 2) main


pageName:
4.12 View/export settlements (q 2 of 2) correct


pageName:
4.12 View/export settlements (q 2 of 2) incorrect


pageName:
4.12 View/export settlements (q 2 of 2) correct 1,


pageName:
4.12 View/export settlements (q 2 of 2) scenario


pageName:
4 How Documenting Site Selection is like School


pageName:
2-Change Trial-Specific Contact Information in Tri


pageName:
1-Trialforce - Investigator Site Change Form


pageName:
03: EIM market timing and charge codes - main scre


pageName:
03a: EIM market timeline and charge codes-T+75 (la


pageName:
03b: EIM market timeline and charge codes-T+40 (la


pageName:
03c :EIM market timeline and charge codes-T+37.5 (


pageName:
03d: EIM market timeline and charge codes-T+7.5 (l


pageName:
03e: EIM market timeline and charge codes-Flexible


pageName:
03f: EIM market timeline and charge codes- UFE


pageName:
03g: EIM market timeline and charge codes-Flexible


pageName:
03h: EIM market timeline and charge codes-Grid Man


pageName:
03i: EIM market timeline and charge codes - Foreca


pageName:
04: Pre-market validation charge codes overview


pageName:
06: Market results charge codes overview


pageName:
07: Market results charge codes (FMM IIE)


pageName:
08: Market results charge code  (Real-time IIE)


pageName:
08: Market results charge codes (Flex ramp)


pageName:
10: Meter results charge codes (Offsets)


pageName:
12: Administrative charge codes (Admin fees)


pageName:
03q: EIM Market timeline and charge codes - BCR


pageName:
4: Choosing the Right Tool - sale in process


pageName:
31: Which market conditions (drap and drop)


pageName:
54: Which market conditions (drag and drop)


pageName:
10: Which market conditions (drag and drop)


pageName:
007: Introduction to Reagent Preparation


pageName:
008: Introduction to Reagent Preparation (2)


pageName:
011: See the Components Temperature Controlled


pageName:
018: Try it: Match Barcodes_Refrigerated


pageName:
Scenario 1: Other charge codes that apply (1.2)


pageName:
Scenario 2: Other charge codes that apply (1.5)


pageName:
Scenario 4: Other charge codes that apply


pageName:
Scenario 5: What other charge codes apply? (1.10)


pageName:
03a: Explore Product Specifications Sheet - sectio


pageName:
03b: Explore Product Specifications Sheet - sectio


pageName:
03c: Explore Product Specifications Sheet - sectio


pageName:
03d: Explore Product Specifications Sheet - sectio


pageName:
02a: Warehouse tour 1- Product 1 (layer)


pageName:
02b: Warehouse tour 1- Product 2 (layer)


pageName:
02c: Warehouse tour 1- Product 3 (layer)


pageName:
03a: Warehouse tour 2 - Product 1 (layer)


pageName:
03b: Warehouse tour 2 - Product 2 (layer)


pageName:
03c: Warehouse tour 2 - Product 3 (layer)


pageName:
05a: The Decision - scenario (choice 1 layer)


pageName:
05b: The Decision - scenario (choice 2 layer)


pageName:
07a: What's the plan? (assessment layer)


pageName:
07b: What's the plan (implementation layer)


pageName:
02a: Trial Change Mgt Process (identify layer)


pageName:
02b: Trial Change Mgt Process (investigate layer)


pageName:
02c: Trial Change Mgt Process (approve layer)


pageName:
02d: Trial Change Mgt Process (revise layer)


pageName:
04: What does it mean to me? (case study 1)


pageName:
07: What does it mean to me? (case study 2)


pageName:
10: What does it mean to me? (case study 3)


pageName:
13: A Clarification to Protocol - Best practices


pageName:
01: A Change to Collect Times Introduction


pageName:
13: A Change to Collect Times - Best practices


pageName:
2.1 An Overview of the Clinical Trial Systems


pageName:
2.5 Who's Responsible for IMPACT Information?


pageName:
2.6 Using the Trial-Specific Collaboration Site


pageName:
2.8 The Trial-Specific Collaboration Site Process


pageName:
3.3 Managing a Trial: IMPACT (2) Feedback


pageName:
3.4 Managing a Trial: IMPACT (3) Feedback


pageName:
3.6 Managing a Trial: IMPACT (5) Feedback


pageName:
3.7 Managing a Trial: Collaboration Site (1)


pageName:
3.8 Managing a Trial: Collaboration Site (2)


pageName:
3.8 Managing a Trial: Collaboration Site (2) Feedb


pageName:
3.9 Managing a Trial: Collaboration Site (3)


pageName:
3.9 Managing a Trial: Collaboration Site (3) Feedb


pageName:
3.10 Managing a Trial: Collaboration Site (4)


pageName:
2.7 The TMF and Trial Collaboration Sites


pageName:
5 - Title Placeholder - Top Competitors Introducti


pageName:
9- Title Placeholder - Top Competitors Introducti


pageName:
10 - Title Placeholder - Top Competitors


pageName:
Get to know the customers - single owner


pageName:
Get to know the customers - Senior Living Facility


pageName:
Get to know the customers - Small Business Owner


pageName:
Get to know the customers - property owner


pageName:
3.14 (pi!) Decision drivers (apartment owner)


pageName:
3.15 Explain the value (apartment owner)


pageName:
02: When Do Clinical Trial Mgt Process Apply?


pageName:
03: Who is Responsible for Clinical Trial Mgt?


pageName:
04: What is Included in Clinical Trial Management?


pageName:
06: Requirements for Clinical Trial Management


pageName:
09: Requirements for Set Up Trial Meetings


pageName:
12: Requirements for Notify Required Personnel


pageName:
14: Manage Trial Level Communications Scenario


pageName:
15: Requirements for Manage Trial Level Communicat


pageName:
16: Manage Trial Level Communications Review


pageName:
08: Purpose of Notify of Approved Records


pageName:
09: Purpose of Communications and Templates


pageName:
2.1b Complete & Distribute Trial-Level Templates


pageName:
2.1c Manage Trial Communications & Documentation


pageName:
2.1g Develop & Manage Consulting Agreements


pageName:
2.1h Notify Personnel of Availability of Approved


pageName:
2.1 An Overview of the Clinical Trial Activities


pageName:
2.5 The Build is Almost Complete...part 1-1


pageName:
2.8 The Build is Almost Complete...part 1-2


pageName:
2.19 The Build is Almost Complete...part 1-3


pageName:
2.20 The Build is Almost Complete...part 1-4


pageName:
2.6 The Build is Almost Complete...part 2-1


pageName:
2.7 The Build is Almost Complete...part 2-2


pageName:
2.18 The Build is Almost Complete...part 2-3


# Releases

releaseNo:
NCAA Developing Leaders for Life Client Alpha


releaseNo:
Cummins: Leadership Essentials - Internal Alpha


releaseNo:
Cummins: Leadership Essentials - External Alpha


releaseNo:
Cobas 4800Virology - Infiltrate The Competition IA


releaseNo:
Roche Middleware Module 8 SEL - Internal Alpha


releaseNo:
Middleware 3b - SM Workspace Intermediate - IA


releaseNo:
Cummins- Program Orientation Internal GM Review 2


releaseNo:
6000 reTool - Customer Connections - EDP


releaseNo:
cobas IT 1000 competencies IB no captivates


releaseNo:
Harlan Learning Checkpoints - Internal Alpha


releaseNo:
Cummins OneSource Navigation - Internal Beta2


releaseNo:
Roche - HE600 Learning Checks - IA_edits


releaseNo:
cobas IT 1000 App Overview internal GM no cap


releaseNo:
VENTANA HE 600 Troubleshooting Library ALPHA


releaseNo:
Cummins: Leadership Essentials - Internal Beta


releaseNo:
Cummins: Leadership Essentials - External Beta


releaseNo:
Cummins: QuickServe - Portuguese Internal


releaseNo:
Cobas 4800Virology - Infiltrate The Competition EA


releaseNo:
VENTANA HE 600 - Story Pillars: Internal Alpha2


releaseNo:
VENTANA HE 600 - Story Pillars: Externall Alpha


releaseNo:
Cummins OneSource Navigation - Internal Beta


releaseNo:
Middleware 3B - System Maintenance - IA 2


releaseNo:
Cummins OneSource Navigation - Internal Beta3


releaseNo:
Middleware 3b - SM Workspace Intermediate - EA


releaseNo:
Cummins CSO Communication External Prototype


releaseNo:
Harlan Learning Checkpoints - Internal Beta


releaseNo:
Cummins: QuickServe - Portuguese External


releaseNo:
Roche - IVD Regulations Overview: External Alpha


releaseNo:
IAP - Data Classification Alpha - Internal


releaseNo:
IAP-Data Classification - External Alpha


releaseNo:
IAP - Data Classification Beta - Internal


releaseNo:
IAP - Data Classification Beta - External


releaseNo:
IR Rebrand: Wave 1 - Electrified Hardware: Externa


releaseNo:
IR Rebrand: Wave 1 - Exit Device Workout: External


releaseNo:
cobas 6888 - final challenge design proof


releaseNo:
cobas 6888 - intro design proof (external)


releaseNo:
cobas 6888 - workflow design proof (external)


releaseNo:
cobas 6888 - final challenge design proof (externa


releaseNo:
cobas 6888 - Lab of Tomorrow (internal beta)


releaseNo:
cobas 6888 - Lab of Tomorrow (external beta)


releaseNo:
cobas 6888 - Finalizing the Grid Alpha (internal)


releaseNo:
cobas 6888 Finalizing the Grid (External Alpha)


releaseNo:
Cummins OneSource Navigation External Beta


releaseNo:
Cummins OneSource Navigation Internal GM


releaseNo:
B3 - Boost the Connection: Internal Alpha


releaseNo:
B3 - Boost the Connection: External Alpha


releaseNo:
Roche - RegAffairs IT Emag - Internal Alpha


releaseNo:
Roche - RegAffairs IT Emag - Internal Alpha2


releaseNo:
Roche - RegAffairs IT Emag - External Alpha


releaseNo:
Cummins - Finance for HR: Internal Alpha


releaseNo:
Cummins - Finance for HR: External Alpha


releaseNo:
Cummins - Fuel Economy 101: internal alpha


releaseNo:
Cummins - Fuel Economy 101: external alpha


releaseNo:
Supercuts Mobile App Training - Client Alpha


releaseNo:
Roche Middleware Module 10 - Internal Alpha


releaseNo:
Roche Cobas 4800 - GRFT Design Proof Internal Alph


releaseNo:
Roche Cobas 4800 - GRFT Design Proof External Alph


releaseNo:
Roche Cobas 4800 - GRFT - Internal Alpha


releaseNo:
Roche Cobas 4800 - GRFT - External Alpha


releaseNo:
VENTANA HE 600 Troubleshooting Library design proo


releaseNo:
Roche Middleware Module 10 - Internal GM


releaseNo:
Middleware 3b - SM Workspace Intermediate - IGM


releaseNo:
cobas 6000 Learning Checkpoints Days 1-4


releaseNo:
cobas 6000 Learning Checkpoints-Beta (Internal)


releaseNo:
cobas 6000 Learning Checkpoints-Beta (External)


releaseNo:
Hybrid Online Orientation External Alpha


releaseNo:
Roche Cobas 6000 Onsite App - External Alpha


releaseNo:
Cummins Intro to HR - Spanish Translation


releaseNo:
Roche Cobas 6000 Onsite App - External Beta


releaseNo:
VENTANA - HE 600 Cave of needs: External Alpha


releaseNo:
cobas4800 - Infiltrate The Competition - IDP


releaseNo:
cobas4800 - Infiltrate The Competition - ExternalD


releaseNo:
Cobas 4800Virology - Workflow Module - IDP


releaseNo:
Cobas 4800Virology - Workflow Module - IA


releaseNo:
cobas4800 - The Power of Planning - External DP


releaseNo:
Cobas 4800Virology - Workflow Module - IDP2


releaseNo:
Cobas 4800Virology - Workflow Module - EDP


releaseNo:
Patient Experience Survey Internal Alpha


releaseNo:
Patient Experience Survey - Internal Alpha 2


releaseNo:
Cobas 4800Virology - Workflow Module - EA


releaseNo:
Cobas 4800Virology - Infiltrate The Competition IG


releaseNo:
Cobas 4800Virology - Workflow Module - EGM


releaseNo:
Introduction to Allegion in the U.S. Market - Inte


releaseNo:
Introduction to Allegion in the U.S. Market - Exte


releaseNo:
Roche - Path to Slide Success Internal Alpha


releaseNo:
Roche - Path to Slide Success Internal Beta


releaseNo:
cobas 6888 - Lab of Tomorrow (new project)


releaseNo:
Roche - Path to Slide Success Internal GM


releaseNo:
RMS - Transplant Academy - Course 1 - EDP


releaseNo:
Lilly NGD: Creating Country and Site ICFs IGM


releaseNo:
Lilly NGD: Creating Country and Site ICFs GM


releaseNo:
VENTANA HE 600 Onsite App Internal Alpha


releaseNo:
Salesforce - Social Studio: Course 2 - Internal Al


releaseNo:
MISO Access Managment Design Proof internal alpha


releaseNo:
Salesforce - Social Studio: Course 2 - Alpha


releaseNo:
Cummins- Program Orientation Internal Review


releaseNo:
Roche Middleware Mod 6 - Internal review


releaseNo:
Cummins- Program Orientation External Review


releaseNo:
Salesforce - Social Studio: Course 2 - External


releaseNo:
Roche Middleware Mod 6 - External review


releaseNo:
Roche Middleware SM Workspace-Users Alpha Internal


releaseNo:
Roche Middleware SM Workspace-Users Alpha External


releaseNo:
Salesforce - Social Studio: Course 2 - GM


releaseNo:
Roche Middleware SM Workspace Users - IA2


releaseNo:
Salesforce - Social Studio: Course 3 internal alph


releaseNo:
Salesforce - Social Studio: Course 3 alpha


releaseNo:
Cummins- Program Orientation Internal GM Review


releaseNo:
Cummins OneSource Navigation - Internal Alpha


releaseNo:
Cummins OneSource Navigation - External Alpha


releaseNo:
Middleware 5 - Rules Interface Overview - IA


releaseNo:
Roche Middleware Module 17 -Internal Alpha


releaseNo:
Middleware 5 - Rules Interface Overview - EA


releaseNo:
cobas IT 1000 User Management design proof interna


releaseNo:
Middleware 5 - Rules Interface Overview - IGM


releaseNo:
cobas IT 1000 Application Overview design proof


releaseNo:
Roche Middleware Module 17 - internal GM


releaseNo:
cobas IT 1000 User Management design proof


releaseNo:
cobas IT 1000 Application Overview External Design


releaseNo:
Roche Middleware Module 18 - Internal Alpha


releaseNo:
Middleware 6 - Rules Writing Intermediate - IA


releaseNo:
Middleware 6 - Rules Writing Intermediate - EA


releaseNo:
Middleware 6 - Rules Writing Intermediate - IGM


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - IDP


releaseNo:
Cobas 6000 - Get Ready for Install - IDP


releaseNo:
cobas IT 1000 Certification Next - Alpha


releaseNo:
cobas IT 1000 competencies Alpha 04/27/2016


releaseNo:
6000 reTool - Customer Connections - IDP


releaseNo:
Roche HE 600 Troubleshooting Library Internal Alph


releaseNo:
MEDRONIC Implant Practice Internal Design Proof


releaseNo:
6000 reTool - Customer Connections - EGM


releaseNo:
Medtronic: Get Ready for RIS - Design Proof


releaseNo:
6000 reTool - Customer Connections - IGM


releaseNo:
cobas IT 1000 Certification Basics Internal Beta 2


releaseNo:
cobas IT 1000 Competencies Internal Beta 2.0


releaseNo:
cobas IT 1000 Certification Basics Beta 2.0


releaseNo:
cobas IT 1000 Certification Next Steps Beta 2.0


releaseNo:
MDT: New Implant Programming Design Proof


releaseNo:
Cobas 6000 - Get Ready for Install - EDP


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - DP


releaseNo:
RMS 6888 Ready to Compete - Internal ALPHA


releaseNo:
cobas IT 1000 Server Administration Alpha


releaseNo:
RMS 6888 Ready to Compete - Internal ALPHA 2


releaseNo:
cobas IT 1000 Certification Basics Internal GM


releaseNo:
Healthy Families America: Know Your Personal Belie


releaseNo:
Medtronic: Get Ready for RIS - New Section iDP


releaseNo:
HFA: Infant and Childhood Development Prototype


releaseNo:
HFA: Infant and Childhood Development Prototype 2


releaseNo:
CAISO - 8 - Metering foundational concepts - IA


releaseNo:
cobas IT 1000 Server Administration Internal Beta


releaseNo:
RMS - Ready to Compete - internal Beta 1


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - IA


releaseNo:
cobas IT 1000 Server Administration Beta


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - EA


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IB


releaseNo:
cobas IT 1000 Drivers Clinitek Internal Alpha


releaseNo:
Lilly NGD: Managing Site Information Comic Activit


releaseNo:
Lilly NGD Select Sites Activity Sample 0907


releaseNo:
Medtronic: Implant in Practice Int. Alpha 2


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - IB


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - EB


releaseNo:
Medtronic: Get Ready for RIS - iAlpha_2.1


releaseNo:
Lilly NGD: Managing Site Overview Comic Activity


releaseNo:
Lilly NGD: Managing Sites Overview Alpha


releaseNo:
Lilly NGD: Managing Sites Overview Alpha New


releaseNo:
Lilly NGD Creating a ClinPharm ICF animation test


releaseNo:
Lilly NGD: Closing Out Sites Incomplete IA


releaseNo:
Lilly NGD Review Site generated content IA2


releaseNo:
Lilly NGD Creating a ClinPharm ICF Alpha


releaseNo:
Cobas 6000 - Get Ready for Install - iGM


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - iGM


releaseNo:
MISO Deep Dive: CTP Communication Alpha2


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - GM


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC -IA 1


releaseNo:
Lilly NGD:Dev Site Activation Enrollment Alpha


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC -IA 2


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - Alpha


releaseNo:
Cobas 6000 - Get Ready for Install - GM2


releaseNo:
Cobas 6000 - Get Ready for Install - GM3


releaseNo:
Cobas 6000 - Get Ready for Install - GMfinal


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - GM/Audi


releaseNo:
Roche - Becoming an FES Coach - Internal Alpha


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IA


releaseNo:
Roche - Becoming an FES Coach - Internal Alpha (AG


releaseNo:
Lilly NGD: Selecting Sites Overview Alpha


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IA2


releaseNo:
Lilly NGD: Selecting Sites Overview Alpha 2


releaseNo:
Lilly NGD: Vendor Budgets and Contracts Alpha


releaseNo:
Roche - Becoming an FES Coach - Internal Alpha Fin


releaseNo:
Roche - Becoming an FES Coach - External Alpha


releaseNo:
Lilly NGD: Dev Site Act and Enrollment Beta


releaseNo:
Lilly NGD: Recruit Part and Manage Enrollment IB


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - iBeta


releaseNo:
Lilly NGD: Selecting Sites Overview iBeta


releaseNo:
Lilly NGD: Recruit Part and Manage Enrollment Beta


releaseNo:
Lilly NGD: Selecting Sites Overview Beta


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - Beta


releaseNo:
Lilly NGD: Vendor Budgets and Contracts Beta


releaseNo:
RMS - Microbiology Course 2 - Alpha - Part2


releaseNo:
Lilly NGD Developing Effective PS Training iA


releaseNo:
RMS - Microbiology Course 2 - Alpha - Part3


releaseNo:
Lilly NGD: Creating Country and Site ICFs IA2


releaseNo:
Lilly NGD: Manage Site Information Overview IGM


releaseNo:
Roche - Becoming an FES Coach - Int_Beta


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - iGM


releaseNo:
Lilly NGD: Manage Site Information Overview GM


releaseNo:
Lilly NGD: Dev Site Act and Enrollment GM


releaseNo:
Lilly NGD: Rec Part and Manage Enrollment GM1


releaseNo:
Lilly NGD: Dev Effective PS Training Alpha


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - GM


releaseNo:
Lilly NGD: Writing An Accurate TCED External Alpha


releaseNo:
Roche - FES Coach Course - External Beta


releaseNo:
Lilly Negotiating Exceptions Audio Edits


releaseNo:
Lilly NGD: Write Accurate TCED Alpha 1 INT


releaseNo:
Lilly NGD: Rec Part and Manage Enrollment GM2


releaseNo:
Lilly NGD: Dev Site Act and Enrollment Final GM


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IGM


releaseNo:
Lilly Negotiating Exceptions igm (no audio)


releaseNo:
Lilly NGD: Vendor Budgets and Contracts GM


releaseNo:
Lilly NGD: Dev Effective PS Training iA2


releaseNo:
Lilly NGD: Creating Country and Site ICFs IA


releaseNo:
Cummins Information Fuels the Business - External


releaseNo:
Lilly NGD: Creating Country and Site ICFs Alpha


releaseNo:
CAISO - 21 - Settlements alpha - Int Alpha


releaseNo:
Lilly siteSelection: Site Evaluation ERB DesignPro


releaseNo:
RMS - Microbiology Course 2 - Beta - Proofer


releaseNo:
Lilly NGD: Creating Country and Site ICFs A2


releaseNo:
Lilly NGD: Creating Country and Site ICFs IB


releaseNo:
Lilly NGD: Dev Effective PS Training IGM


releaseNo:
Lilly NGD: Creating Country and Site ICFs Beta


releaseNo:
RMS - Transplant Academy - Course 1 - IA


releaseNo:
RMS - Transplant Academy - Course 1 - EA


releaseNo:
RMS - Transplant Academy - Course 1 - EA - New


releaseNo:
Cummins CSO Careful Communication Vignettes - iDP


releaseNo:
Cummins CSO Careful Communication Vignettes - DP


releaseNo:
Lilly NGD: Creating Country and Site ICFs Final IG


releaseNo:
Cummins CSO Careful Communication Vignettes - Alph


releaseNo:
RMS - Transplant Academy - Course 1 - IB


releaseNo:
Lilly NGD Qualify and Select Sites - ipAlpha


releaseNo:
RMS - Transplant Academy - Course 1 - EB


releaseNo:
Lilly NGD Qualify and Select Sites - Prealpha


releaseNo:
Lilly NGD Qualify and Select Sites - ialpha


releaseNo:
Lilly NGD Qualify and Select Sites - Alpha


releaseNo:
Lilly NGD Managing Satellites - prealpha


releaseNo:
RMS - Transplant Academy - Intro Animation - EB


releaseNo:
******Workflow App - Popup Text Final Edits


releaseNo:
RMS - Transplant Academy - Intro Animation - EGM


releaseNo:
RMS - Transplant Academy - Course 1 - IGM


releaseNo:
RMS - Transplant Academy - Course 1 - EGM


releaseNo:
RMS - Transplant Academy - Course 4 - IA


releaseNo:
RMS - Transplant Academy - Course 4 - IA2


releaseNo:
RMS - Transplant Academy - Course 4 - EA


releaseNo:
RMS - Transplant Academy - Course 4 - IB


releaseNo:
RMS - Transplant Academy - Course 4 - EB


releaseNo:
Lilly Trial - Consulting Agreements- iAlpha


releaseNo:
RMS - Transplant Academy - Course 4 - EGM


releaseNo:
Lilly Trial - Consulting Agreements- Alpha


releaseNo:
*******************Roche cobas 8000 Learning Check


releaseNo:
Mosaic - Visual Inspection Proceedures_IDP1


releaseNo:
Cummins - SalesForce - RLC Understanding Customer


releaseNo:
Mosaic - Visual Inspection Proceedures - EDP


releaseNo:
Lilly Trial - Consulting Agreements- iBeta


releaseNo:
Lilly - CTAS Financial Disclosure External Beta


releaseNo:
Lilly Trial - Consulting Agreements- Beta


releaseNo:
Lilly Trial - Consulting Agreements- iGM


# Sections

sectionName:
Choose Your Division or Conference Office


sectionName:
Cred Case Studes: Update An Aging Facility


sectionName:
What Makes Smart Cards: Syst Compatibility


sectionName:
What Makes Smart Cards: Assess Your Need


sectionName:
Making A Smart Choice: Talking to Others


sectionName:
Making A Smart Choice: Compatibility Concerns


sectionName:
Making A Smart Choice: Migration Concerns


sectionName:
510(k) Submissions and Predicate Devices


sectionName:
Process Green Rack and Daily Hands On Maintenance


sectionName:
Prepare and Load Calibrators and Controls


sectionName:
Verify and Record Photometer Check Values


sectionName:
Initiate a Run of Calibrators and Controls


sectionName:
Every 2 Months and Quarterly Maintenance


sectionName:
Use MyLabOnline, cobas link, and cobas e-Library


sectionName:
Follow Your Learning Path - Key Operator


sectionName:
Common Challenges with Grossing and Processing


sectionName:
Tasks completed during Operation or Stand By


sectionName:
cobas 8000 with ref. 2 - continue button


sectionName:
cobas 8000 without ref. 2 - continue button


sectionName:
cobas 6000 with ref. 2 - continue button


sectionName:
cobas 6000 without ref. 2 - continue button


sectionName:
Collecting Information & Researching Resources


sectionName:
Importance of Early Stage Requirements Gathering


sectionName:
Turning Good Requirements into Great Requirements


sectionName:
Roche Middleware Solutions and Out of Service


sectionName:
Demo: Twitter Use Case - Service Console


sectionName:
Processing Plates, Cassettes, and Amplification Plates


sectionName:
Behavioral, Cognitive, and Socio-emotional Struggles


sectionName:
Build Your Implantable System for Remodulin Team


sectionName:
Asking Probing Questions - Customer Convo


sectionName:
Tasks Performed During Operation or Stand By


sectionName:
Scenarios - 03 Bid/base schedule submitter


sectionName:
Scenarios - 09 User access administrator


sectionName:
Whats the right application? (Questions)


sectionName:
PI Recruiting Study Participants From Other Offices


sectionName:
PI and Sub-Investigator in Two Locations


sectionName:
Medical Research Agreement Versus Other Agreements


